Sentence,class,file
"PLoS Pathog 2014; 10: e1003990; PMID:24699458; http://dx.doi.org/10.1371/journal.ppat.1003990 [38] Orru CD, Groveman BR, Raymond LD, Hughson AG, Nonno R, Zou W, Ghetti B, Gambetti P,Caughey B.",OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"PLoS Pathog 2015; 11:e1004983; PMID:26086786;http://dx.doi.org/10.1371/journal.ppat.1004983 [39] Cartoni C, Schinina ME, Maras B, Nonno R, Vaccari G, Di Baria MA, Conte M, Liu QG, Lu M, CardoneF, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"JChromatogr A 2005; 1081:122-6; PMID:16013608; http://dx.doi.org/10.1016/j.chroma.2005.04.035 [40] Pirisinu L, Di Bari MA, D’Agostino C, Marcon S, Riccardi G, Poleggi A, Cohen ML, Appleby BS, Gambetti P, Ghetti B, et al.",OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Sci Rep2016; 6:20443; PMID:26841849; http://dx.doi.org/ 10.1038/srep20443 [41] Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"JClin Invest 2015; 125:2548; PMID:25961458; http://dx.doi.org/10.1172/JCI82647 [43] Watts JC, Giles K, Stohr J, Oehler A, Bhardwaj S, Grillo SK, Patel S, DeArmond SJ, Prusiner SB.Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Proc Natl Acad Sci U S A 2012;109:3498-503; PMID:22331873; http://dx.doi.org/ 10.1073/pnas.1121556109 [44] Watts JC, Giles K, Bourkas ME, Patel S, Oehler A, Gavidia M, Bhardwaj S, Lee J, Prusiner SB.Towards authentic transgenic mouse models of heri- table PrP prion diseases.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Acta Neuropathol 2016; 132:593–610; PMID:27350609; http://dx.doi.org/10.1007/s00401-016-1585-6 [45] Hainfellner JA, Brantner-Inthaler S, Cervenakova L, Brown P, Kitamoto T, Tateishi J, Diringer H, Liber-ski PP, Regele H, Feucht M, et al.",OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Brain Pathol 1995; 5:201-11; PMID:8520719; http://dx.doi.org/10.1111/j.1750- 3639.1995.tb00596.x [46] Benestad SL, Arsac JN, Goldmann W, Noremark M. Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"PMID:18187032; http://dx.doi.org/10.1051/vetres: 2007056 [47] Simmons MM, Konold T, Simmons HA, Spencer YI, Lockey R, Spiropoulos J, Everitt S, Clifford D.Experimental transmission of atypical scrapie to sheep.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"BMC Vet Res 2007; 3:20; PMID:17725818; http://dx.doi.org/10.1186/1746-6148-3-20 [48] Simmons MM, Moore SJ, Konold T, Thurston L, Terry LA, Thorne L, Lockey R, Vickery C, Hawkins SA, Chaplin MJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
Emerg Infect Dis2011; 17:848-54; PMID:21529394; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Proc Natl Acad Sci U S A 2005;102:16031-6; PMID:16239348; http://dx.doi.org/ 10.1073/pnas.0502296102 [50] Arsac JN, Betemps D, Morignat E, Feraudet C, Bencsik A, Aubert D, Grassi J, Baron T. Transmissi- bility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression anddonor prion genotype.",OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
PloS One 2009; 4:e7300; PMID:19806224; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Emerg Infect Dis 2009; 15:1214-21; PMID:19751582; http://dx.doi.org/10.3201/eid1508.081218 [53] Requena JR, Wille H. The structure of the infectious prion protein: experimental data and molecularmodels.",OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Prion 2014; 8:60-6; PMID:24583975; http://dx.doi.org/10.4161/pri.28368 [54] Barron RM, King D, Jeffrey M, McGovern G, Agarwal S, Gill AC, Piccardo P. PrP aggregationc a nb es e e d e db yp r e - f o r med recombinant PrP amyloid ﬁbrils without the replication of infec- tious prions.",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"Acta Neuropathol 2016; 132:611–624; PMID:27376534; http://dx.doi.org/10.1007/ s00401-016-1594-5 [55] Beekes M, Thomzig A, Schulz-Schaeffer WJ, Bur- ger R. Is there a risk of prion-like disease transmis- sion by Alzheimer- or Parkinson-associated protein particles?",Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
Acta Neuropathol 2014; 128:463-76;PMID:25073522; http://dx.doi.org/10.1007/s00401- 014-1324-9GSS TRANSMITS TO BANK VOLES AS A GENUINE PRION DISEASE 433,Non-OADS,/arxiv_data1/oa_pdf/f5/11/kprn-10-06-1239686.PMC5161296.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
The area of protein bands was determined by converting the gel lanes to a band-intensity chro- matogram using ImageJ (http://rsbweb.nih.gov/ij/index.html).,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
ORCID Carol L. Ladner-Keay http://orcid.org/ 0000-0003-0273-713X480 C. L. Ladner-Keay et al.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Science 2007;318:930-6; PMID:17991853; http://dx.doi.org/ 10.1126/science.1138718 [2] Caughey B, Baron GS, Chesebro B, Jeffrey M. Get- ting a Grip on Prions: Oligomers, Amyloids, andPathological Membrane Interactions.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Annu Rev Biochem 2009; 78:177-204; PMID:19231987; http://dx.doi.org/10.1146/annurev.biochem.78.082907.145410 [3] Race B, Phillips K, Meade-White K, Striebel J, Chesebro B.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Virol 2015; 89:6022- 32; PMID:25810548; http://dx.doi.org/10.1128/JVI.00362-15 [4] Wang F, Wang XH, Yuan CG, Ma JY.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
Science 2010; 327:1132-5; PMID:20110469;http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Biol Chem 2002;277:21140-8; PMID:11912192; http://dx.doi.org/10.1074/jbc.M111402200 [7] Wong E, Thackray AM, Bujdoso R. Copper induces increased b-sheet content in the scrapie-susceptible ovine prion protein Prp(VRQ) compared with the resistant allelic variant Prp(ARR).",Non-OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochem J 2004; 380:273-82; PMID:14969585; http://dx.doi.org/10.1042/bj20031767 [8] Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion.Nature 2003; 425:717-20; PMID:14562104; http://dx.doi.org/10.1038/nature01979 [9] Gomes MPB, Millen TA, Ferreira PS, Silva NLCE, Vieira TCRG, Almeida MS, Silva JL, Cordeiro Y.Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Mol Biol 2002; 322:153-61; PMID:12215421; http://dx.doi.org/10.1016/S0022-2836(02)00750-7 [11] Cordeiro Y, Machado F, Juliano L, Juliano MA, Brentani RR, Foguel D, Silva JL.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
J Biol Chem 2001; 276:49400-9; PMID:11604397; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"org/10.1074/jbc.M106707200 [12] Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA. Glycosaminoglycan sulfation determines the bio-chemical properties of prion protein aggregates.Glycobiology 2015; 25:745-55; PMID:25701659; http://dx.doi.org/10.1093/glycob/cwv014 [13] Kazlauskaite J, Sanghera N, Sylvester I, Venien- Bryan C, Pinheiro TJT.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochemistry-Us 2003;42:3295-304; http://dx.doi.org/10.1021/bi026872q [14] Saleem F, Bjorndahl TC, Ladner CL, Perez-Pineiro R, Ametaj BN, Wishart DS.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Prion 2014;8:221-32; http://dx.doi.or g/10.4161/pri.28939 [15] Jucker M, Walker LC.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Nature 2013; 501:45-51; PMID:24005412; http://dx.doi.org/10.1038/nature12481 [16] Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal compo- nents in vitro.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Structure 2013; 21:2061-8; PMID:24120764; http://dx.doi.org/ 10.1016/j.str.2013.08.025 [18] Zurawel AA, Walsh DJ, Fortier SM, Chidawanyika T, Sengupta S, Zilm K, Supattapone S. Prion Nucle- ation Site Unmasked by Transient Interaction withPhospholipid Cofactor.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochemistry-Us 2014; 53:68-76; http://dx.doi.org/10.1021/bi4014825 [19] Solforosi L, Bellon A, Schaller M, Cruite JT, Abalos GC, Williamson RA.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Biol Chem 2007; 282:7465-71; PMID:17218310; http://dx.doi.org/ 10.1074/jbc.M610051200 [20] Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. Cofactor molecules maintain infectious conformation and restrict strainproperties in puriﬁed prions.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Glia 2013;61:71-90; PMID:22674585; http://dx.doi.org/10.1002/glia.22350 [24] Vincenti JE, Murphy L, Grabert K, McColl BW, Cancellotti E, Freeman TC, Manson JC.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Virol 2016; 90:3003- 17; http://dx.doi.org/10.1128/JVI.02613-15 [25] Dervishi E, Lam TH, Dunn SM, Zwierzchowski G, Saleem F, Wishart DS, Ametaj BN.",Non-OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Prion 2015; 9:59-73; PMID:25695140; http://dx.doi.org/ 10.1080/19336896.2015.1019694 [26] Ladner CL, Wishart DS.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
Plos One 2014; 9:e98753; PMID:24892647; http://dx.doi.org/10.1371/journal.pone.0098753 [28] Lakowicz JR. Principles of Fluorescence Spectros- copy.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
Brit J Pharmacol 2010; 161:1219-37; http://dx.doi.org/ 10.1111/j.1476-5381.2009.00604.x [30] Pollard TD.,Non-OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Mol Biol Cell 2010; 21:4061-7; PMID:21115850; http://dx.doi.org/10.1091/mbc.E10-08-0683 [31] Santos NC, Silva AC, Castanho MARB, Martins- Silva J, Saldanha C. Evaluation of lipopolysaccha- ride aggregation by light scattering spectroscopy.Chembiochem 2003; 4:96-100; PMID:12512082; http://dx.doi.org/10.1002/cbic.200390020 [32] Micsonai A, Wien F, Kernya L, Lee YH, Goto Y, Refregiers M, Kardos J.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochemistry-Us 1991; 30:7672-80; http://dx.doi.org/10.1021/bi00245a003 [34] Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang ZW, Fletterick RJ,Cohen FE, et al.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochemistry-Us 2011; 50:7111-6; http://dx.doi.org/ 10.1021/bi200786p [36] Silva CJ, Vazquez-Fernandez E, Onisko B, Requena JR. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Virus Res 2015;207:120-6; PMID:25816779; http://dx.doi.org/10.1016/j.virusres.2015.03.008 [37] Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, CaugheyB.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Nat Methods 2007; 4:645-50; PMID:17643109;http://dx.doi.org/10.1038/nmeth1066 [38] Yang C, Lo WL, Kuo YH, Sang JC, Lee CY, Chiang YW, Chen RPY.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Acs Chem B iol 2015; 10:493-501; PMID:25375095; http://dx.doi.org/10.1021/cb500765e [39] Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, et al.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Virol 2015;89:12418-26; PMID:26423957; http://dx.doi.org/ 10.1128/JVI.02142-15 [41] Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
Plos Path2007; 3:1175-86; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
J Mol Biol 2005;346:645-59; PMID:15670611; http://dx.doi.org/10.1016/j.jmb.2004.11.068482 C. L. Ladner-Keay et al.,OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Biochemistry-Us 2011; 50:1162-73; http://dx.doi.org/10.1021/bi101435c [44] Ding HF, Nakoneczna I, Hsu HS.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"J Med Microbiol 1990; 31:95- 102; PMID:2406449; http://dx.doi.org/10.1099/ 00222615-31-2-95 [45] Neuhoff V, Stamm R, Eibl H. Clear background and highly sensitive protein staining with coomassie blue dyes in polyacrylamide Gels - a systematicanalysis.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"Nat Rev Microbiol 2009; 7:677-83; PMID:19633680; http://dx.doi.org/10.1038/nrmicro2184 [49] Muller-Loennies S, Lindner B, Brade H. Structural analysis of oligosaccharides from lipopolysaccharide(LPS) of Escherichia coli K12 strain W3100 reveals a link between inner and outer core LPS biosynthesis.",OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
J Biol Chem 2003; 278:34090-101; PMID:12819207;http://dx.doi.org/10.1074/jbc.M303985200DETOXIFIED LIPOPOLYSACCHARIDE INDUCES PRION CONVERSION 483,Non-OADS,/arxiv_data1/oa_pdf/45/1a/kprn-10-06-1254857.PMC5161299.pdf
"1, 37 –70, http://dx.doi.org/10.1080/00173134.2015.1108997 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/0a/34/sgra-56-037.PMC5161302.pdf
"(APW)Mostly tropical, but a few extending deep into the temperate zone (APW)A-,C-and warmer D-climates Abbreviations of data sources (online data bases, accessed 20 August 2015): APW, Angiosperm Phylogeny Website (Stevens 2001+); GBIF, Global Biodiversity Information Facility, www.gbif.org; CRBP, Costa Rica Biodiversity Portal, http://crbio.cr/portalCRBio; FoC, e-Flora of China (eFlora 2008); FoNA, e-Flora of North America (eFloras 2008), Tropicos, Tropicos® database (Tropicos.org).aCraigia, Tilia , not including Mortoniodendron .Eocene in situ bee pollen from Germany 65",Non-OADS,/arxiv_data1/oa_pdf/0a/34/sgra-56-037.PMC5161302.pdf
ORCID Reinhard Zetter http://orcid.org/0000-0002-0220- 6921 Michael S. Engel http://orcid.org/0000-0003-3067- 077XReferences APG III.,Non-OADS,/arxiv_data1/oa_pdf/0a/34/sgra-56-037.PMC5161302.pdf
Version 12.http://www.mobot.org/MOBOT/research/APweb/ ; accessed August 2015.,Non-OADS,/arxiv_data1/oa_pdf/0a/34/sgra-56-037.PMC5161302.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 671–672Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 671 LEttEr open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S123481 the essential role of mentors in medical  institutions Arez Mohamed Elena Antoni University College London Medical  School, University College London,  London, UKDear editor We read with great interest the papers written by Al Qahtani¹ and Banu et al.² The for - mer explored the motivation of medical students to engage in mentoring in a place  where this was a scarce phenomenon and the other analyzed how mentoring could be successfully implemented and enhance acquisition of knowledge among mentees.",Non-OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
"This usually involves organizing both educational and social activities, greatly improving  Correspondence: Arez Mohamed 91 Upsdell Avenue, London N136JJ, UKtel +44 79 6666 1937 Email arez.mohamed.11@ucl.ac.uk Journal name: Advances in Medical Education and Practice Article Designation: LetterY ear: 2016V olume: 7Running head verso: Mohamed and AntoniRunning head recto: The essential role of mentorsDOI: http://dx.doi.org/10.2147/AMEP .S123481",Non-OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 672 Mohamed and Antoni the mentees ability to integrate with peers while feeling safe  under the supervision of their medic parents.,Non-OADS,/arxiv_data1/oa_pdf/6c/05/amep-7-671.PMC5161331.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1215–1220Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1215 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S120343Heart rate variability during treatment of  breakthrough pain in patients with advanced  cancer: a pilot study Eva Katharina Masel   Patrick Huber   T obias Engler   Herbert Hans Watzke Clinical Division of Palliative Care,   Department of Internal Medicine I,  Medical University of Vienna, Vienna,  AustriaBackground: Decisions on the intensity of analgesic therapy and judgments regarding its  efficacy are difficult at the end of life, when many patients are not fully conscious and pain is  a very common symptom.",Non-OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
"4 Therefore, it can hardly be used in end-of-life care  situations, when many patients are not fully conscious and pain is a very common symptom.Correspondence: Herbert Hans Watzke   Clinical Division of Palliative Care,  Department of Internal Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria Tel +43 1 40400 44550   Fax +43 1 40400 78600   Email herbert.watzke@meduniwien.ac.atJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Masel et alRunning head recto: HRV during treatment of cancer breakthrough painDOI: http://dx.doi.org/10.2147/JPR.S120343",Non-OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1220 Masel et al 19.,Non-OADS,/arxiv_data1/oa_pdf/4e/ba/jpr-9-1215.PMC5161332.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/00/copd-11-3179.PMC5161333.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3179–3187International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3179RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11869 2 endocan and the respiratory system: a review Maria Kechagia1,2 Ioannis Papassotiriou2 Konstantinos I  Gourgoulianis1 1Respiratory Medicine Department,   University of Thessaly Medical School,   Larissa, 2Department of Clinical  Biochemistry, Aghia Sophia Children’s  Hospital, Athens, GreeceAbstract:  Endocan, formerly called endothelial cell-specific molecule 1, is an endothelial  cell-associated proteoglycan that is preferentially expressed by renal and pulmonary endothe - lium.",Non-OADS,/arxiv_data1/oa_pdf/1a/00/copd-11-3179.PMC5161333.pdf
"In humans, it is encoded by a single gene, the ESM-1  gene, Correspondence: Maria Kechagia Respiratory Medicine Department,  University of Thessaly Medical School,  Mezourlo, 41110, Larissa, Thessaly,  Greece Tel +30 697 217 6916 email maria.keh@hotmail.co m Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Kechagia et al Running head recto: Endocan and the respiratory system DOI: http://dx.doi.org/10.2147/COPD.S118692",Non-OADS,/arxiv_data1/oa_pdf/1a/00/copd-11-3179.PMC5161333.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1a/00/copd-11-3179.PMC5161333.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/00/copd-11-3179.PMC5161333.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/3b/ijn-11-6713.PMC5161334.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6713–6725International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6713OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11164 7 MicrorNa-200c delivered by solid lipid  nanoparticles enhances the effect of paclitaxel  on breast cancer stem cell Jingwen liu1 Tingting Meng1 Ming Yuan1 lijuan Wen1 Bolin cheng1 Na liu1 Xuan huang2 Yun hong3 hong Yuan1 Fuqiang hu1 1Department of Pharmaceutics,   college of Pharmaceutical sciences,   Zhejiang University, hangzhou,   2Department of Pharmacy, school of  Medicine science, Jiaxing University,   Jiaxing, 3The First affiliated hospital,   college of Medicine, Zhejiang  University, hangzhou, Zhejiang,   People’s republic of chinaBackground:  One of the major obstacles in the treatment of breast cancer is breast cancer stem  cells (BCSC) which are resistant to standard chemotherapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/69/3b/ijn-11-6713.PMC5161334.pdf
"Keywords:  breast cancer stem cells, microRNA-200c, paclitaxel, solid lipid nanoparticles,  nanostructured lipid carriers, combination therapy Introduction Breast cancer is the leading cause of cancer death among females worldwide.1 Surgery,  chemotherapy, radiotherapy, and hormonal therapy are common therapeutic options for  breast cancer patients currently; however, there still remains the issue of tumor recur - rence, metastasis, and acquisition of drug resistance.2–4 Emerging evidence suggests  that breast cancer stem cells (BCSC), which possess the properties of self-renewal and  differentiation, may play critical roles.5,6 Thus, the eradication of BCSC is an important  goal to cure breast cancer.7 One of the major obstacles toward treatment of BCSC is  their resistance to standard chemotherapeutic drugs.8,9 Therefore, increasing the drug  sensitivity is a vital step of improved treatment toward BCSC.correspondence: Fuqiang hu Department of Pharmaceutics,  college of Pharmaceutical sciences,  Zhejiang University, 866 Yuhangtang  road, hangzhou 310058,  People’s republic of china Tel/fax +86 571 8820 8441 email hufq@zju.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Delivery of microRNA and paclitaxel DOI: http://dx.doi.org/10.2147/IJN.S111647",Non-OADS,/arxiv_data1/oa_pdf/69/3b/ijn-11-6713.PMC5161334.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/3b/ijn-11-6713.PMC5161334.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/3b/ijn-11-6713.PMC5161334.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/84/ijn-11-6727.PMC5161335.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6727–6741International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6727OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12235 8 Manipulation of schwann cell migration across  the astrocyte boundary by polysialyltransferase- loaded superparamagnetic nanoparticles under  magnetic field Bing Xia* liangliang huang* lei Zhu Zhongyang liu T eng Ma shu Zhu Jinghui huang Zhuojing luo Department of Orthopaedics, Xijing  hospital, Fourth Military Medical  University, Xi’an, shaanxi, People’s  republic of china *These authors contributed equally  to this workAbstract:  Schwann cell (SC) transplantation is an attractive strategy for spinal cord injury (SCI).",Non-OADS,/arxiv_data1/oa_pdf/42/84/ijn-11-6727.PMC5161335.pdf
"Keywords:  Schwann cell, astrocyte, magnetic field, superparamagnetic iron oxide nanoparticles,  spinal cord injury, cell orientation Introduction Cell transplantation therapy is an attractive strategy for nerve repairs and functional  recovery after spinal cord injury (SCI).1 Thus far, various cell types have been used  for SCI treatment, including oligodendrocytes, Schwann cells (SCs), olfactory  ensheathing cells, and stem cells.2,3 SCs are among the most promising candidates  for transplantation, as they can form Büngner bands serving as substrates for axonal  elongation, provide multiple neurotrophic factors, and remyelinate the regenerated  and demyelinated axons, necessary for nerve regeneration and functional recovery.4,5  However, one major issue yet to be addressed is the poor integration of transplanted correspondence: Jinghui huang;  Zhuojing luo Department of Orthopaedics, Xijing  hospital, Fourth Military Medical  University, 169 changle West road,  Xi’an, shaanxi 710032, People’s  republic of china Tel/fax +86 29 8477 5285 email huangjh@fmmu.edu.c n;  zjluo@fmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xia et al Running head recto: Manipulation of SC migration across the astrocyte boundary DOI: http://dx.doi.org/10.2147/IJN.S122358",Non-OADS,/arxiv_data1/oa_pdf/42/84/ijn-11-6727.PMC5161335.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/42/84/ijn-11-6727.PMC5161335.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/84/ijn-11-6727.PMC5161335.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/20/ijwh-8-713.PMC5161336.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 713–719International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  713OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12245 9 Determinants of pelvic organ prolapse among  gynecologic patients in Bahir Dar, north West  ethiopia: a case–control study ayalnesh asresie1 eleni admassu2 T esfaye setegn2 1Hamlin Fistula center, amhara  national regional state, Bahir Dar,   ethiopia; 2Bahir Dar University,   college of Medicine and Health  sciences, school of Public Health,   reproductive Health Department,   amhara national regional state, Bahir  Dar, ethiopiaIntroduction:  Pelvic organ prolapse (POP) is a significant public health problem in developing  countries including Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/ijwh-8-713.PMC5161336.pdf
"It has socioeconomic and health consequences, affecting overall health and sexual  function.3 It has been a major gynecologic problem in developed and developing  nations.4 However, women in developing countries are affected disproportionally.5,6  In the United States, different types of POP, such as uterine prolapse, cystocele, and  rectocele, are prevalent.7 Due to the multitude of factors associated with socioeconomic  and institutional factors, the prevalence of POP has been significant in developing  countries.4,8–10correspondence: Tesfaye setegn  Department of reproductive Health,  school of Public Health, college of  Medicine and Health sciences, Bahir Dar  University, PO Box 1977, amhara national  regional state, Bahir Dar, ethiopia email tesfayesetegn@yahoo.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Asresie et al Running head recto: Determinants of pelvic organ prolapse DOI: http://dx.doi.org/10.2147/IJWH.S122459",Non-OADS,/arxiv_data1/oa_pdf/f7/20/ijwh-8-713.PMC5161336.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/ijwh-8-713.PMC5161336.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/ijwh-8-713.PMC5161336.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/2c/copd-11-3079.PMC5161337.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3079–3091International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3079OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12228 2 Major air pollutants and risk of COPD  exacerbations: a systematic review and  meta-analysis Jinhui li1,2 shengzhi sun1,2 robert Tang1,2 hong Qiu2 Qingyuan huang3 T onya g Mason2 linwei Tian1,2 1shenzhen Institute of research and  Innovation, nanshan, The University  of hong Kong, shenzhen, People’s  republic of China; 2school of Public  health, The University of hong Kong,   Pok Fu lam, hong Kong special  administrative region; 3Department  of Thoracic surgery, shanghai  Chest hospital, shanghai Jiao Tong  University, Minhang, shanghai, People’s  republic of ChinaBackground:  Short-term exposure to major air pollutants (O3, CO, NO2, SO2, PM10, and PM2.5)  has been associated with respiratory risk.",Non-OADS,/arxiv_data1/oa_pdf/ad/2c/copd-11-3079.PMC5161337.pdf
"In the course of pulmonary ventilation and gas  exchange, these pollutants could induce oxidative stress and inflammation, resulting  in airway injury and dysfunction.2 Correspondence: linwei Tian shenzhen Institute of research and  Innovation, school of Public health, The  University of hong Kong, 7 sassoon  road, Pok Fu lam, hong Kong special  administrative region, People’s republic  of China Tel +852 39176351 email linweit@hku.h k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Short-term air pollution exposure to COPD patients DOI: http://dx.doi.org/10.2147/COPD.S122282",Non-OADS,/arxiv_data1/oa_pdf/ad/2c/copd-11-3079.PMC5161337.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ad/2c/copd-11-3079.PMC5161337.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/2c/copd-11-3079.PMC5161337.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6703–6712International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6703OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12115 6 evaluation of β-cyclodextrin-modified gemini  surfactant-based delivery systems in melanoma  models Deborah Michel1 Waleed Mohammed-saeid1 heather getson1 caitlin roy1 Masoomeh Poorghorban1 Jackson M chitanda2 ronald Verrall2 Ildiko Badea1 1Drug Design and Discovery Research  Group, College of Pharmacy and  Nutrition, 2Department of chemistry,   University of saskatchewan,   saskatoon, sK, canadaAbstract:  Novel drug delivery systems are developed to improve the biological behavior of  poorly soluble drugs and to improve therapeutic outcomes.",Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
"Nanoparticle drug delivery systems have  been used for the past two decades to improve drug solubility and pharmacokinetic  profile of a series of chemotherapeutics.1 Their potential applicability is broad, given the  successes achieved to date, such as Abraxane (nanoparticle albumin bound paclitaxel),  Doxil® (liposomal doxorubicin), DaunoXome® (liposomal daunorubicin), and Marqibo®  (liposomal vincristine).2,3 In addition, nanoparticle drug delivery systems can enhance correspondence: Ildiko Badea Drug Design and Discovery Research  Group, College of Pharmacy and  Nutrition, University of saskatchewan,  107 Wiggins Road, Academic Health  Sciences Building, Room 3D01.5,  Saskatoon, SK S7N 5E5, Canada Tel +1 306 966 6349 Fax +1 306 966 6377 email ildiko.badea@usask.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Michel et al Running head recto: Evaluation of β-cyclodextrin-gemini surfactant-based delivery systems DOI: http://dx.doi.org/10.2147/IJN.S121156",Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
"Available from: http://seer.cancer.gov/statfacts/html/melan.htm l.  Accessed August 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/2f/ijn-11-6703.PMC5161338.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 473–482Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 473 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S94320 Chronic radiation-induced dermatitis: challenges  and solutions Mateusz Spałek Department of Radiotherapy I, The  Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PolandAbstract: Chronic radiation dermatitis is a late side effect of skin irradiation, which may  deteriorate patients’ quality of life.",Non-OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
"3 Acute skin toxicity usually develops within 90 days Correspondence: Mateusz Spałek Department of Radiotherapy I,   The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Warsaw, W. Roentgena 5, 02-781 Warsaw, PolandTel +48 22 604 573 442Email mateusz.spalek@coi.plJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: SpałekRunning head recto: Chronic radiation-induced dermatitisDOI: http://dx.doi.org/10.2147/CCID.S94320",Non-OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 482 Spałek,Non-OADS,/arxiv_data1/oa_pdf/67/23/ccid-9-473.PMC5161339.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/91/b0/ijn-11-6609.PMC5161340.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6609–6619International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6609OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12272 6 Biophysical evaluation of aminoclay as an effective  protectant for protein stabilization during  freeze-drying and storage Jae geun song sang hoon lee hyo-Kyung han college of Pharmacy, Dongguk  University, goyang, south KoreaAbstract:  This study aimed to evaluate aminoclay (3-aminopropyl-functionalized magnesium  phyllosilicate) as an effective protectant for the stabilization of protein formulation in freeze- drying.",Non-OADS,/arxiv_data1/oa_pdf/91/b0/ijn-11-6609.PMC5161340.pdf
"One of the major barriers is the structural alteration of proteins due to the  chemical and/or physical instabilities, resulting in activity loss and immunogenicity  issues.1–3 Although there have been many attempts to overcome these issues, pro - tein stabilization is still a big challenge in the manufacturing process and storage of  protein drugs because of the complexity of protein structures and diverse instability  mechanisms.4,5 Therefore, the development of stable formulations that can avoid  the biological activity loss and potential immunogenic effect of physically and/or  chemically altered protein molecules is critical to promote the commercialization of  therapeutic proteins.correspondence: hyo-Kyung han college of Pharmacy, Dongguk  University, Dongguk-ro-32,   Ilsan-Donggu, goyang, south Korea Tel +82 31 961 5217 Fax +82 31 961 5206 email hkhan@dongguk.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Song et al Running head recto: Biophysical evaluation of aminoclay as an effective protectant DOI: http://dx.doi.org/10.2147/IJN.S122726",Non-OADS,/arxiv_data1/oa_pdf/91/b0/ijn-11-6609.PMC5161340.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/91/b0/ijn-11-6609.PMC5161340.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/b0/ijn-11-6609.PMC5161340.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/f7/dddt-10-3959.PMC5161341.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3959–3968Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3959Hypo THesisopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S12001 4 Dose-dependent effects of cisplatin on the  severity of testicular injury in sprague Dawley  rats: reactive oxygen species and endoplasmic  reticulum stress Kiran Kumar soni1 Hye Kyung Kim2 Bo Ram Choi1 Keshab Kumar Karna1 Jae Hyung you1 Jai seong Cha1 yu seob shin1 sung Won Lee3 Chul young Kim4 Jong Kwan park1 1Department of Urology, institute  for Medical sciences, Chonbuk  National University Medical school  –  Biomedical Research and institute  and Clinical Trial Center for Medical  Devices, Chonbuk National University  Hospital, Jeonju, 2College of pharmacy,   Kyungsung University, Busan,   3Department of Urology, samsung  Medical Center, samsung Biomedical  Research institute, sungkyunkwan  University Medical school, seoul,   4College of pharmacy, Hanyang  University, Ansan, Republic of KoreaAbstract:  Cisplatin (CIS) is used in the treatment of cancer, but its nonspecific systemic  actions lead to toxic effects on other parts of the body.",Non-OADS,/arxiv_data1/oa_pdf/92/f7/dddt-10-3959.PMC5161341.pdf
"Keywords:  cisplatin, testicular toxicity, oxidative stress, StAR protein, CatSper, endoplasmic  reticulum stress Introduction Cis-diamminedichloroplatinum (II), cisplatin, or cisplatinum (CIS) is an important  antineoplastic drug used to treat solid neoplasms, including head, neck, lung, colorectal,  hematologic, ovarian, and testicular cancer.1 It was approved for use in cancer patients  in 1978 by the US Food and Drug Administration.2 CIS contains the peculiar atomic  configuration of platinum at its core, creating a divalent, inorganic, water-soluble  complex.3 Although CIS has a chemotherapeutic effect, it has serious side effects on vital  organs.4–6 However, the mechanisms of CIS-induced nephrotoxicity, hepatotoxicity,  and testicular toxicity remain poorly understood.7 CIS causes a gradual decrease in renal  function that is characterized by significant increases in serum blood urea nitrogen (BUN)  levels.8 It also increases the red blood cell (RBC) count, hematocrit (Hct), and hemoglobin  (Hb) levels within a short period of time.9 Animals administered CIS develop severe Correspondence: Jong Kwan park Department of Urology, institute for  Medical sciences, Chonbuk National  University Medical school – Biomedical  Research and institute and Clinical  Trial Center for Medical Devices,  Chonbuk National University Hospital,  20, Geonji-Ro, Deokjin-Gu, Jeonju 54909,  Republic of Korea Tel +82 63 250 1510 Fax +82 63 250 1564 email rain@chonbuk.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Hypothesis Y ear: 2016 Volume: 10 Running head verso: Soni et al Running head recto: Dose-dependent effects of cisplatin DOI: http://dx.doi.org/10.2147/DDDT.S120014",Non-OADS,/arxiv_data1/oa_pdf/92/f7/dddt-10-3959.PMC5161341.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/92/f7/dddt-10-3959.PMC5161341.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/f7/dddt-10-3959.PMC5161341.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/73/ndt-12-3191.PMC5161389.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3191–3194Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3191LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12567 7 Neuroprotection and acidosis induced by cortical  spreading depression Kenneth K Kwong Suk-tak Chan Department of radiology, MGH/MIT/ HMS Athinoula A. Martinos Center  for Biomedical Imaging, Massachusetts  General Hospital, Boston, MA, USADear editor We read with interest the article “Cortical spreading depression produces a  neuroprotective effect activating mitochondrial uncoupling protein-5” published  in Neuropsychiatr Dis Treat  by Viggiano et al.1 The authors showed that cerebral  spreading depression (CSD) triggered uncoupling protein-5 (UCP-5),1 which had been  reported to exert a long-term effect upon neuron protection.2 The result is another  piece in CSD literature on modifying gene expressions to provide neuroprotection to  subsequent ischemic episodes.3,4 An unmentioned but additional factor for neuroprotection in CSD could be  acidosis.",Non-OADS,/arxiv_data1/oa_pdf/43/73/ndt-12-3191.PMC5161389.pdf
"1984;4(1):17–27.Correspondence: Kenneth K Kwong Athinoula A. Martinos Center for  Biomedical Imaging, Building 149,  13th Street, Mail Code 149-2301,  Charlestown, MA 02129, USA email kwong@nmr.mgh.harvard.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Kwong and Chan Running head recto: Neuroprotection and acidosis induced by cortical spreading depression DOI: http://dx.doi.org/10.2147/NDT.S125677",Non-OADS,/arxiv_data1/oa_pdf/43/73/ndt-12-3191.PMC5161389.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/43/73/ndt-12-3191.PMC5161389.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/73/ndt-12-3191.PMC5161389.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/55/opth-10-2489.PMC5161390.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2489–2496Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2489Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10800 2 Visual, aberrometric, photic phenomena, and  patient satisfaction after myopic wavefront-guided  lasiK using a high-resolution aberrometer sarah Moussa alois K Dexl eva M Krall eva M arlt günther grabner Josef ruckhofer Department of Ophthalmology,   Paracelsus Medical University  salzburg, salzburg, austriaPurpose:  The purpose of this study was to evaluate the visual, refractive, and aberrometric  outcomes as well as the level of patient satisfaction and photic phenomena after myopic laser  in situ keratomileusis (LASIK) surgery using wavefront-guided (WFG) ablations based on  measurements obtained with a high-resolution aberrometer.",Non-OADS,/arxiv_data1/oa_pdf/77/55/opth-10-2489.PMC5161390.pdf
"Keywords:  LASIK, patient satisfaction, Wave-front guided LASIK, high resolution aberrom - eter, photic phenomena, glare Introduction The use of accurate static references for centration, the improvement of accuracy of  wavefront aberration measurements, and the refinement of ablation profiles are techno - logical advances that have led the corneal refractive surgery to a high level of efficacy,  predictability, and accuracy.1–3 Specifically, these advances have allowed surgeons to  overcome some limitations concerning the characterization of ocular aberrations and  therefore to obtain improved outcomes using wavefront-guided (WFG) ablation pro - files, even in the more complex cases.2,4–6 There is a variety of studies confirming the  safety and efficacy of WFG laser in situ keratomileusis (LASIK) for the correction of  spherocylindrical refractive errors with the latest laser platforms as well as the ability  of these treatments to minimize the induction of higher order aberrations (HOAs) and  reduce the level of some preexisting HOAs.1–3,5–15Correspondence: sarah Moussa Department of Ophthalmology,  Paracelsus Medical University salzburg,  Müllner hauptstraße 48, 5020 salzburg,  austria Tel +43 662 4 4825 8371 Fax +43 662 4482 3703 email s.moussa@salk.at Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Moussa et al Running head recto: WFG LASIK surgery for the correction of myopia DOI: http://dx.doi.org/10.2147/OPTH.S108002",Non-OADS,/arxiv_data1/oa_pdf/77/55/opth-10-2489.PMC5161390.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/77/55/opth-10-2489.PMC5161390.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/55/opth-10-2489.PMC5161390.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/05/ott-9-7537.PMC5161391.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7537–7544OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7537Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11650 8 The benefit of using bladder sub-volume  equivalent uniform dose constraints in prostate  intensity-modulated radiotherapy planning Jian Zhu1–3 antoine simon3–5 Pascal haigron3–5 Caroline Lafond4–6 Oscar acosta4,5 huazhong shu1,3 Joel castelli4–6 Baosheng li1–3 renaud De crevoisier3–6 1Laboratory of Image Science and  T echnology, southeast University,   nanjing, Jiangsu, 2Department of  radiation Oncology, shandong  cancer hospital & institute,   Jinan, 3centre de recherche en  Information Biomédicale Sino- français, Nanjing, People’s Republic  of China; 4institut national de la  sante et de la recherche Medicale,   U1099, 5Laboratory of Signal and  image Processing ( lTsi), University  of Rennes 1, 6Department of  radiotherapy, centre eugène  Marquis,  rennes, FranceBackground:  To assess the benefits of bladder wall sub-volume equivalent uniform dose (EUD)  constraints in prostate cancer intensity-modulated radiotherapy (IMRT) planning.",Non-OADS,/arxiv_data1/oa_pdf/67/05/ott-9-7537.PMC5161391.pdf
"In 1999, it  was extended to gEUD to describe doses on normal tissues which is more compre - hensive than a single dose–volume threshold for a unified description compared to  the nonuniform dose distribution.1 Furthermore, since EUD can be used to describe  the biological dose–volume characteristics of normal tissues by setting different  parameters, it may also be used as biological constraint for IMRT optimization to correspondence: Jian Zhu Laboratory of Image Science and  Technology, southeast University,  sipailou 2#, nanjing, Jiangsu Province,  210096, People’s Republic of China Tel/fax +86 531 6762 7907 email zhujian.cn@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: Benefit of bladder sub-volume EUD in prostate IMRT DOI: http://dx.doi.org/10.2147/OTT.S116508",Non-OADS,/arxiv_data1/oa_pdf/67/05/ott-9-7537.PMC5161391.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/67/05/ott-9-7537.PMC5161391.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/05/ott-9-7537.PMC5161391.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/67/ott-9-7521.PMC5161392.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7521–7526OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7521Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12085 4 β-elemene treatment of glioblastoma: a single- center retrospective study chunxiao Ma Wei Zhou Zhaoyue Yan Mingqi Qu Xingyao Bu Department of n eurosurgery,   henan Provincial People’s  hospital, Zhengzhou,   People’s republic of chinaAbstract:  Glioblastoma (GBM) is the most common primary malignancy in the central nervous  system.",Non-OADS,/arxiv_data1/oa_pdf/a7/67/ott-9-7521.PMC5161392.pdf
"In this study, we retrospectively ana - lyzed the use of ELE in patients with newly diagnosed GBM and also assessed  the survival benefit of ELE.correspondence: chunxiao Ma Department of neurosurgery,  henan Provincial People’s hospital,  7 Weiwu road, Zhengzhou 450003,  People’s republic of china Tel +86 371 6558 0014 email machunxiao148@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma et al Running head recto: β-Elemene treatment in patients with glioblastoma DOI: http://dx.doi.org/10.2147/OTT.S120854",Non-OADS,/arxiv_data1/oa_pdf/a7/67/ott-9-7521.PMC5161392.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a7/67/ott-9-7521.PMC5161392.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/67/ott-9-7521.PMC5161392.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/04/ott-9-7527.PMC5161393.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7527–7535OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7527Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11267 0 a pilot study employing hepatic intra-arterial  irinotecan injection of drug-eluting beads as  salvage therapy in liver metastatic colorectal  cancer patients without extrahepatic involvement:  the first southern Italy experience girolamo ranieri,1 artor  niccoli asabella,2 corinna  altini,2 Vito Fazio,1  luciana caporusso,1  ilaria Marech,1 gianluca  Vinciarelli,1 Francesco  Macina,1 Dario de ceglia,1  Margherita Fanelli,2 Michele  ammendola,3,4 giuseppe  rubini,2 cosmo Damiano  gadaleta1 1Diagnostic and interventional  radiology Unit with integrated  section of Translational Medical  Oncology, national cancer research  centre, istituto T umori “ giovanni  Paolo ii”, 2nuclear Medicine Unit,   University of Bari “ aldo Moro”, Bari,   3Department of Medical and surgery  science, clinical surgery Unit, “Magna  graecia” Medical school, catanzaro,   4surgery Unit, national cancer  research centre, istituto Tumori  “giovanni Paolo ii”, Bari, italyBackground:  The main aim of this prospective study was to evaluate the efficacy of drug-eluting  beads with irinotecan (DEBIRI) for liver metastases from colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ott-9-7527.PMC5161393.pdf
"Keywords:  colorectal cancer, liver metastases, transarterial chemoembolization, DEBIRI Background CRC is the third most common cancer worldwide.1 Up to 70% of its metastases occur  in the liver, and LM represent a predominant cause (50%) of death in these patients.2  Without any treatment, the median OS after detection of LM is ~9 months, depending correspondence: girolamo ranieri Diagnostic and interventional radiology  Unit with integrated section of  Translational Medical Oncology, national  cancer research centre, istituto Tumori  “giovanni Paolo ii”, Viale Orazio  Flacco 65, 70124 Bari, italy Tel +39 324 805 0022 email giroran@tiscali.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ranieri et al Running head recto: DEBIRI as salvage therapy in liver metastatic CRC DOI: http://dx.doi.org/10.2147/OTT.S112670",Non-OADS,/arxiv_data1/oa_pdf/12/04/ott-9-7527.PMC5161393.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ott-9-7527.PMC5161393.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/04/ott-9-7527.PMC5161393.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/27/ott-9-7515.PMC5161394.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7515–7520OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7515Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11522 1 correlation between epidermal growth factor  receptor tyrosine kinase inhibitor efficacy and  circulating tumor cell levels in patients with  advanced non-small cell lung cancer Wenjie he1 Wenhui li1 Bo Jiang1 li chang1 congguo Jin2 changlin T u1 Yunfen li1 1Department of cadre’s Medical  Oncology, Yunnan T umor hospital,   The Third affiliated hospital  of Kunming Medical University,   2Department of Oncology research  institution, Kunming, People’s  republic of chinaObjective:  The aim of this study was to investigate the correlation between the efficacy of  epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and circulating tumor  cell (CTC) levels in patients with advanced non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/a3/27/ott-9-7515.PMC5161394.pdf
"Most patients die of recurrence of lung cancer and  distant metastasis.3correspondence: Wenhui li Department of cadre’s Medical  Oncology, Yunnan Tumor hospital,  The Third Affiliated Hospital of  Kunming Medical University, Kun  Zhou road no 687, Kunming 650118,  People’s republic of china Tel/fax +86 871 818 5656 2592 email wenhuilidc@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: Advanced non-small cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S115221",Non-OADS,/arxiv_data1/oa_pdf/a3/27/ott-9-7515.PMC5161394.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/27/ott-9-7515.PMC5161394.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/27/ott-9-7515.PMC5161394.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/b4/ndt-12-3161.PMC5161395.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3161–3173Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3161OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12177 9 Treadmill exercise promotes neuroprotection  against cerebral ischemia–reperfusion injury via  downregulation of pro-inflammatory mediators Ying Zhang1,* richard Y cao2,* Xinling Jia3,* Qing li1 lei Qiao1 guofeng Yan4 Jian Yang1 1Department of rehabilitation,   2laboratory of immunology, shanghai  Xuhui central hospital, shanghai  clinical research center, chinese  academy of sciences, 3school of  life sciences, shanghai University,   4school of Medicine, shanghai Jiao  Tong University, shanghai, People’s  republic of china *These authors contributed equally  to this workBackground:  Stroke is one of the major causes of morbidity and mortality worldwide, which is  associated with serious physical deficits that affect daily living and quality of life and produces  immense public health and economic burdens.",Non-OADS,/arxiv_data1/oa_pdf/6e/b4/ndt-12-3161.PMC5161395.pdf
"But the clinical trial of NXY-059, a free-radical-trapping agent, failed to show  neuroprotective effects in patients with acute ischemic stroke.4 Dietary supplement of correspondence: Jian Yang Department of rehabilitation, shanghai  Xuhui central hospital, shanghai  clinical research center, chinese  academy of sciences, 966 Middle  huaihai road, shanghai 200031,  People’s republic of china Tel +86 133 6180 1366 Fax +86 21 5404 0689 email jyang@scrc.ac.c n  richard Y cao laboratory of immunology, shanghai  Xuhui central hospital, shanghai  clinical research center, chinese  academy of sciences, 966 Middle  huaihai road, shanghai 200031,  People’s republic of china Tel +86 21 3127 0810 ext 62146 Fax +86 21 5403 3969 email rycao@scrc.ac.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhang et al Running head recto: Exercise prevents ischemic brain injury DOI: http://dx.doi.org/10.2147/NDT.S121779",Non-OADS,/arxiv_data1/oa_pdf/6e/b4/ndt-12-3161.PMC5161395.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6e/b4/ndt-12-3161.PMC5161395.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/b4/ndt-12-3161.PMC5161395.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/9f/opth-10-2469.PMC5161396.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2469–2474Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2469Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10522 2 Oxygen permeability of the pigmented material  used in cosmetic daily disposable contact lenses stephen galas lenora l Copper Johnson & Johnson Vision Care inc.,   Jacksonville, Fl, UsaPurpose:  To evaluate the individual contributions of pigment colorant and packing solution  containing polyvinyl pyrrolidone (PVP) on the oxygen permeability (Dk) of a cosmetic printed  etafilcon A daily disposable contact lens packaged with PVP.",Non-OADS,/arxiv_data1/oa_pdf/50/9f/opth-10-2469.PMC5161396.pdf
"Correspondence: lenora l Copper Johnson & Johnson Vision Care inc.,  7500 Centurion Parkway, suite 100,  Jacksonville, Fl32256, Usa email lcopper2@its.jnj.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Galas and Copper Running head recto: Oxygen permeability of the pigmented material DOI: http://dx.doi.org/10.2147/OPTH.S105222",Non-OADS,/arxiv_data1/oa_pdf/50/9f/opth-10-2469.PMC5161396.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/50/9f/opth-10-2469.PMC5161396.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/9f/opth-10-2469.PMC5161396.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 491–496Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress 491 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S101880Results of a venous thromboembolism  prophylaxis program for hospitalized patients Luiz Francisco Cardoso Daniella Vianna C Krokoscz Edison Ferreira de Paiva   Ilka Spinola Furtado   Jorge Mattar Jr   Marcia Martiniano de   Souza e Sá   Antonio Carlos Onofre   de Lira Sírio Libanês Hospital, São Paulo,   BrazilIntroduction: Venous thromboembolism (VTE) is the leading cause of preventable death in  hospitalized patients.",Non-OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"4Correspondence: Luiz Francisco Cardoso Sírio Libanês Hospital, Rua Dona Adma Jafet, 91, Bela Vista, São Paulo CEP 01308-050, Brazil Tel +55 11 3394 5886 Email luiz.cardoso@hsl.org.brJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: Cardoso et alRunning head recto: Venous thromboembolism prophylaxis program for hospitalized patientsDOI: http://dx.doi.org/10.2147/VHRM.S101880",Non-OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 496 Cardoso et al Conclusion The implementation of a VTE prophylaxis program tar - geting adults admitted to a large hospital that employed  a multiple-strategy approach achieved high rates of risk assessment within the first 24 hours after admission, improved the adequacy of prophylaxis in high-risk patients, and reduced the rate of VTE events, according to the dis-charge records.",Non-OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
Available from: http://apps.who.int/classifications/icd10/browse/2016/en.,OADS,/arxiv_data1/oa_pdf/80/d1/vhrm-12-491.PMC5161397.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/72/opth-10-2485.PMC5161398.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2485–2488Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2485Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11780 1 Practice patterns of ophthalmologists  administering intravitreal injections in  europe: a longitudinal survey Kui huang1 Marla B sultan2 Duo Zhou3 Charles s Tressler4 Jingping Mo1 1epidemiology, Worldwide safety and  regulatory, 2Clinical sciences, global  innovative Products Business, 3Clinical  statistics, global established Pharma  Business, 4safety surveillance and  risk Management, Worldwide safety  and regulatory, Pfizer inc, new Y ork,   nY, UsaPurpose:  This study was performed to understand the practice patterns of ophthalmologists  administering intravitreal (IVT) injections in Europe after the procedure became routine.",Non-OADS,/arxiv_data1/oa_pdf/32/72/opth-10-2485.PMC5161398.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/32/72/opth-10-2485.PMC5161398.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/72/opth-10-2485.PMC5161398.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 481–490Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  481 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S58149Omega-3 carboxylic acids monotherapy and  combination with statins in the management of  dyslipidemia Lane B Benes1 Nikhil S Bassi2 Michael H Davidson1 1Department of Medicine, Section of  Cardiology, 2Department of Medicine,   University of Chicago, Chicago,    IL, USAAbstract:  The 2013 American College of Cardiology/American Heart Association guidelines  on cholesterol management placed greater emphasis on statin therapy given the well-established  benefits in primary and secondary prevention of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
"Moreover, from a clinical standpoint, Correspondence: Michael H Davidson The University of Chicago Medicine, Section of Cardiology, 5841 S. Maryland Avenue, MC 6080, Chicago, IL 60637, USATel +1 773 702 1717Fax +1 773 834 7300Email mdavidso@bsd.uchicago.eduJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: Benes et alRunning head recto: Omega-3 carboxylic acids in the management of dyslipidemiaDOI: http://dx.doi.org/10.2147/VHRM.S58149",Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
The ongoing Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia (STRENGTH) will help determine the effects of OM3-CA on cardiovascular event rates ( http://clinicaltrials.gov/show/NCT02104817) .,Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 490 Benes et al 62.,Non-OADS,/arxiv_data1/oa_pdf/b8/ff/vhrm-12-481.PMC5161399.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 179–189The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 179 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S122030 Advances in the management of erythropoietic  protoporphyria – role of afamelanotide Ashley M Lane1 Jerome T McKay2 Herbert L Bonkovsky1 1Department of Internal Medicine,   Section on Gastroenterology;   2Department of Microbiology and  Immunology, Wake Forest University  School of Medicine, Winston-Salem,  NC, USAAbstract: Erythropoietic protoporphyria (EPP) and the phenotypically similar disease X-linked  protoporphyria (XLPP) are inherited cutaneous porphyrias characterized clinically by acute  non-blistering photosensitivity, intolerance to sunlight, and significantly reduced quality of life.",Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
"2,4,7Correspondence: Herbert L Bonkovsky Wake Forest University School of Medicine, Nutrition Building, E-112; 1 Medical Center Blvd, Winston-Salem, NC 27157, USATel +1 336 713 7341Fax +1 336 713 7322Email hbonkovsky@me.comJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Lane et alRunning head recto: Afamelanotide for EPPDOI: http://dx.doi.org/10.2147/TACG.S122030",Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Available from: https://www.ncbi.nlm.nih.gov/books/NBK100826/.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 189 Afamelanotide for EPP 36.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
2010; Available at: http://www.clinuvel.com.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Available at: http://www.ema.europa.eu.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Available at: http://www.clinuvel.com.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Available at: http://www.clinuvel.com.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
Available at: http://www.clinuvel.com.,Non-OADS,/arxiv_data1/oa_pdf/e6/6f/tacg-9-179.PMC5161401.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/95/ndt-12-3175.PMC5161402.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3175–3181Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3175OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12427 7 The impact of residual symptoms on relapse and  quality of life among Thai depressive patients Thanita hiranyatheb1 Daochompu Nakawiro1 Tinakon Wongpakaran2 Nahathai Wongpakaran2 Putipong Bookkamana3 Manee Pinyopornpanish2 Nattha saisavoey4 Kamonporn Wannarit4 sirina satthapisit5 sitthinant Tanchakvaranont6 1Department of Psychiatry, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok,   2Department of Psychiatry, Faculty of  Medicine, 3Department of statistics,   Faculty of science, chiang Mai  University, chiang Mai, 4Department  of Psychiatry, Faculty of Medicine,   siriraj hospital, Mahidol University,   Bangkok, 5Department of Psychiatry  Khon Kaen hospital, Khon Kaen,   6Department of Psychiatry, Queen  savang Vadhana Memorial hospital,   chonburi, ThailandPurpose:  Residual symptoms of depressive disorder are major predictors of relapse of  depression and lower quality of life.",Non-OADS,/arxiv_data1/oa_pdf/1c/95/ndt-12-3175.PMC5161402.pdf
"Also, clinicians need to be aware of those symptoms that are usually underrecognized  as symptoms of depression and need to be ruled out for causes from medical condi - tion, such as fatigue, lack of energy, and a diminished ability to think and concentrate correspondence: Thanita hiranyatheb Department of Psychiatry, Faculty of  Medicine, ramathibodi hospital, Mahidol  University, 270 rama Vi road, Payathai,  ratchatewi, Bangkok 10400, Thailand Tel +66 2 201 1929 Fax +66 2 354 7299 email thanita.hin@mahidol.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hiranyatheb et al Running head recto: Residual symptoms of depression on relapse and quality of life DOI: http://dx.doi.org/10.2147/NDT.S124277",Non-OADS,/arxiv_data1/oa_pdf/1c/95/ndt-12-3175.PMC5161402.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1c/95/ndt-12-3175.PMC5161402.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/ndt-12-3175.PMC5161402.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/cc/ott-9-7481.PMC5161403.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7481–7492OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7481Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12265 3 isoorientin induces apoptosis, decreases  invasiveness, and downregulates V egF secretion by  activating aMPK signaling in pancreatic cancer cells Tingting Ye1 Jiadong su1 chaohao huang1 Dinglai Yu1 shengjie Dai1 Xince huang1 Bicheng chen1,2 Mengtao Zhou1 1Department of surgery, The First  affiliated hospital, Wenzhou Medical  University, 2Zhejiang Provincial T op  Key Discipline in surgery, Wenzhou  Key laboratory of surgery, Wenzhou,   Zhejiang Province, People’s republic  of chinaAbstract:  Isoorientin (or homoorientin) is a flavone, which is a chemical flavonoid-like  compound, and a 6-C-glucoside of luteolin.",Non-OADS,/arxiv_data1/oa_pdf/29/cc/ott-9-7481.PMC5161403.pdf
"With many biological activities and therapeutic effects, including  anti-inflammatory, antidiabetic, antioxidant, proapoptotic, and autophagy-inducing correspondence: Mengtao Zhou;   Bicheng chen Department of surgery, The First  Affiliated Hospital, Wenzhou Medical  University, 2 FuXue lane, Wenzhou  325000, Zhejiang Province, People’s  republic of china Tel +86 577 5557 9220 Fax +86 577 8806 9555 email zmt0417@hotmail.co m;   chenbicheng@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y e et al Running head recto: Anti-pancreatic cancer effects of isoorientin DOI: http://dx.doi.org/10.2147/OTT.S122653",Non-OADS,/arxiv_data1/oa_pdf/29/cc/ott-9-7481.PMC5161403.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/cc/ott-9-7481.PMC5161403.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/cc/ott-9-7481.PMC5161403.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/46/ndt-12-3183.PMC5161404.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3183–3190Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3183OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12054 0 associations between the mismatch-negativity  component and symptom severity in children and  adolescents with attention deficit/hyperactivity  disorder Kazuhiko Yamamuro1 T oyosaku Ota1 Junzo iida2 Y oko Nakanishi1 Naoko Kishimoto1 T oshifumi Kishimoto1 1Department of Psychiatry, 2Faculty  of Nursing, Nara Medical University  school of Medicine, Kashihara, JapanAim:  Cognitive impairment is an important predictor of functional outcome in patients with  attention deficit/hyperactivity disorder (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/37/46/ndt-12-3183.PMC5161404.pdf
"These deficits are similar to those reported for patients with  frontal lobe lesions.1,2 Indeed, several neuroimaging studies have reported that deficits  in inhibitory control are associated with structural and functional disorganization with  respect to the connectivity between the basal ganglia and the prefrontal cortex (PFC)  in individuals with ADHD.3,4correspondence: Kazuhiko Yamamuro Department of Psychiatry, Nara Medical  University school of Medicine, 840 shijo- cho, Kashihara, Nara 634 8522, Japan Tel +81 74 422 3051 Fax +81 74 422 3854 email muro@naramed-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Y amamuro et al Running head recto: Association between MMN and severity of ADHD DOI: http://dx.doi.org/10.2147/NDT.S120540",Non-OADS,/arxiv_data1/oa_pdf/37/46/ndt-12-3183.PMC5161404.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/37/46/ndt-12-3183.PMC5161404.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/46/ndt-12-3183.PMC5161404.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diffusion magnetic resonance imaging MetabolomicsTIA 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/48/main.PMC5161417.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.010 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/48/main.PMC5161417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/48/main.PMC5161417.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Autophagy Neurodegenerative disease CancerClinical trials Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/2c/01/main.PMC5161418.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.034 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/01/main.PMC5161418.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/01/main.PMC5161418.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Interleukin 10miR-146bMacrophageCRISPR/Cas9Colitis 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/main.PMC5161420.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.041 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/main.PMC5161420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/main.PMC5161420.pdf
XPPAUT 7.0(http://www.math.pitt.edu/~bard/xpp/xpp.html ) was used to perform the simulation analyses.,OADS,/arxiv_data1/oa_pdf/f8/f9/main.PMC5161420.pdf
http://dx.doi.org/10.1002/eji.200838905 .,Non-OADS,/arxiv_data1/oa_pdf/f8/f9/main.PMC5161420.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Indoleamine 2,3-dioxygenaseAngiogenesisLung metastasis Oxygen-induced retinopathy Interferon-gammaInterleukin 6Inﬂammation Tryptophan 1.",Non-OADS,/arxiv_data1/oa_pdf/36/9b/main.PMC5161421.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.013 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/36/9b/main.PMC5161421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/9b/main.PMC5161421.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Reciprocal translocationBreakpoint Single nucleotide polymorphism Preimplantation genetic diagnosis 1.,Non-OADS,/arxiv_data1/oa_pdf/09/48/main.PMC5161423.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.007 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/48/main.PMC5161423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/48/main.PMC5161423.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Flap endonuclease 1 (FEN1)DNA replication and repair Breast cancer Chemotherapeutic drugSmall molecular inhibitor 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/37/main.PMC5161424.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.012 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/37/main.PMC5161424.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/37/main.PMC5161424.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/13/ott-9-7149.PMC5161425.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7149–7159OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7149Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11942 8 BRAF inhibitors and radiotherapy for melanoma  brain metastases: potential advantages and  disadvantages of combination therapy Mudit Chowdhary1,2 Kirtesh R Patel1 Hasan H Danish1 David H Lawson3 Mohammad K Khan1 1Department of Radiation Oncology,   winship Cancer institute, emory  University, Atlanta, GA, 2Department  of Radiation Oncology, Rush  University Medical Center, Chicago,   iL, 3Department of Hematology  and Medical Oncology, winship  Cancer institute, emory University,   Atlanta, GA, USAAbstract:  Melanoma is an aggressive malignancy that frequently spreads to the brain,  resulting in rapid deterioration in both quality and quantity of life.",Non-OADS,/arxiv_data1/oa_pdf/e4/13/ott-9-7149.PMC5161425.pdf
"They  applied this graded partitioning analysis (GPA) to a multi-institution database with  4,259 BM patients to develop disease-specific prognostic criteria.8 For MBM patients,  only Karnofsky performance status (KPS) and the number of intracranial metastases Correspondence: Mohammad K Khan Department of Radiation Oncology,  winship Cancer institute, emory  University, 1365 Clifton Road Northeast,  Room A1312, Atlanta, GA 30322, USA Tel +1 404 778 3763 Fax +1 404 778 4139 email drkhurram2000@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Chowdhary et al Running head recto: Radiation and BRAF inhibitor for melanoma brain metastases DOI: http://dx.doi.org/10.2147/OTT.S119428",Non-OADS,/arxiv_data1/oa_pdf/e4/13/ott-9-7149.PMC5161425.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/13/ott-9-7149.PMC5161425.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/13/ott-9-7149.PMC5161425.pdf
The shipboard ADCP was processed using the CODAS software package developed at the University of Hawaii(http://currents.soest.hawaii.e du/docs/adcp_doc/index.html).,OADS,/arxiv_data1/oa_pdf/92/15/1601610.PMC5161426.pdf
"J. Bohlander, T. Scambos, Antarctic Coastlines and Grounding Line Derived from MODIS Mosaic of Antarctica (MOA) (National Snow and Ice Data Center, 2007); http://nsidc.org/ data/atlas/news/antarctic_coastlines.html.",OADS,/arxiv_data1/oa_pdf/92/15/1601610.PMC5161426.pdf
"T. Scambos, B. Raup, J. Bohlander, Images of Antarctic Ice Shelves, Version 1 (National Snow and Ice Data Center, 2001); http://dx.doi.org/10.7265/N5NC5Z4N.",OADS,/arxiv_data1/oa_pdf/92/15/1601610.PMC5161426.pdf
Data are available from the Australian Antarctic Data Centre (https://data.aad.gov.au/).,OADS,/arxiv_data1/oa_pdf/92/15/1601610.PMC5161426.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601039/DC1 Supplementary Text table S1.,Non-OADS,/arxiv_data1/oa_pdf/d5/92/1601039.PMC5161427.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601742/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/02/f7/1601742.PMC5161428.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601470/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/82/bd/1601470.PMC5161429.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601838/DC1Simulation details fig.,Non-OADS,/arxiv_data1/oa_pdf/50/5b/1601838.PMC5161430.pdf
(2016) observed signi ﬁcant shifts in RBC populations following ironEBioMedicine 14 (2016) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.11.011 .,OADS,/arxiv_data1/oa_pdf/09/d1/main.PMC5161432.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.036 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/09/d1/main.PMC5161432.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/d1/main.PMC5161432.pdf
http://dx.doi.org/10.1016/S0140-6736(03)13779-8 .,OADS,/arxiv_data1/oa_pdf/09/d1/main.PMC5161432.pdf
5:4446. http://dx.doi.org/10.1038/ncomms5446 .,Non-OADS,/arxiv_data1/oa_pdf/09/d1/main.PMC5161432.pdf
because these data were lacking.EBioMedicine 14 (2016) 7 –8 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.11.003 .,OADS,/arxiv_data1/oa_pdf/77/b3/main.PMC5161433.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.030 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/77/b3/main.PMC5161433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/b3/main.PMC5161433.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DihydroartemisininDrug conjugates Cell cycle ApoptosisMetastasisOvarian cancer 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/9e/main.PMC5161434.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.026 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/9e/main.PMC5161434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/9e/main.PMC5161434.pdf
Gut http://dx.doi.org/10.1136/ gutjnl-2015-310514 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/9a/9e/main.PMC5161434.pdf
The knowledge gap that demands an adequately powered trial is the safety of SLDPQ in children with acute uncomplicated malaria whenEBioMedicine 14 (2016) 5 –6 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.10.032 .,Non-OADS,/arxiv_data1/oa_pdf/04/e1/main.PMC5161435.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.018 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/main.PMC5161435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/e1/main.PMC5161435.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Wet age related macular degenerationAAV.sFLT-1Gene therapy Clinical trial 1.,Non-OADS,/arxiv_data1/oa_pdf/44/5e/main.PMC5161436.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.016 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/5e/main.PMC5161436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/5e/main.PMC5161436.pdf
"Use of cobra venom factor (CVF) resulted in decreased ef ﬁcacy of immunization.EBioMedicine 14 (2016) 11 –12 DOIs of original article: http://dx.doi.org/10.1016/j.ebiom.2016.05.015 ,http:// dx.doi.org/10.1016/j.ebiom.2016.11.022 .",Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC5161437.pdf
"Hence, the lack of enhancement effect in http://dx.doi.org/10.1016/j.ebiom.2016.11.023 2352-3964/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC5161437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC5161437.pdf
"TRUCKs have been shown preclinically to enhance antitu- mor activity and modify tumor microenvironment, but clinical experi- ence with TRUCKs is currently limited.EBioMedicine 14 (2016) 1 –2 http://dx.doi.org/10.1016/j.ebiom.2016.11.037 2352-3964/© 2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/15/2a/main.PMC5161438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/2a/main.PMC5161438.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ageing BiomarkersDrug repurposingClinical trials Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.020 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1377/hlthaff.25.2.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1101/gad.1588507 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
Na- ture:1 –20http://dx.doi.org/10.1038/nature16932 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1021/ ja043277y .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.cmet.2016.05.,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.cell.2014.12.020 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
Bonekey Rep. 1:96. http://dx.doi.org/10.1038/bonekey.,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/ j.cardiores.2006.10.002 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
1:1 –9.http://dx.doi.org/10.1093/gerona/glu241 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
Aging (Albany NY) 8:1 –22.http://dx.doi.org/10.18632/ aging.101020 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/ 10.1371/journal.pone.0045166 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/ 10.1093/bib/bbr013 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1017/S1462399409001197 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
Aging Cell 15:67 –76.http://dx.doi.org/10.1111/acel.12410 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1172/JCI40671 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1111/acel.12489 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1038/sj.onc.1209982 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1371/journal.pone.0152486 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
"http://dx.doi.org/10.1016/j.cell.2013.11.037 .30 V. Mallikarjun, J.",OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1098/rstl.1825.0026 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
14:45 –56.http://dx.doi.org/10.1089/rej.2010.1085 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1038/nature08221 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1038/nm.4054 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1074/jbc.M110.120295 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1093/gerona/glw126 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.nbt.2012.11.018 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.trsl.2013.11.,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1038/ 366461a0 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.711 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1111/acel.12097 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.cell.2013.05.039 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3944-09.2010 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
82:39 –49.http://dx.doi.org/10.1016/j.exger.2016.05.010 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.mad.2011.08.001 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1017/ S0029665114000147 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1111/acel.12194 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.bcp.2009.12.021 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1128/MCB.01868-08 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1111/acel.12075 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.18632/aging.100968 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.exger.2014.12.002 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1093/gerona/glv170 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-14-2814 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1096/fj.10-161497 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
11:742. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.arr.2016.08.004 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1016/j.cmet.2015.11.011 .,OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
http://dx.doi.org/10.1038/nature09076 .,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
Elife 4:1 –16.http://dx.doi.org/10.7554/eLife.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/main.PMC5161440.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ZikaFlavivirusMouseAnimalModelTestis Orchitis SteroidTreatmentInterferon 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.0172352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
http://dx.doi.org/10.1001/jamaophthalmol.2016.0267 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
Nature http://dx.doi.org/10.1038/nature20556 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
Lancet Infect.Dis.http://dx.doi.org/10.1016/S1473-3099(16)30006-8 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
"27, October 2016. http://who.int/ emergencies/zika-virus/situation-report/27-october-2016/en/ (Accessed 30 October 2016).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/main.PMC5161441.pdf
"We showed that many antibodies required complement factors for invasion inhibitory activity, and we demonstrated the importance of this mechanism for naturally acquired and vaccine induced human and rabbit antibodies against speci ﬁc merozoite proteins including theEBioMedicine 14 (2016) 9 –10 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.05.015 .",Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
Data was presented showing a reduced level of inhibition mediated by sera from MSP1-42 vaccinated malaria-naïve human subjects in C3/ C4 supplemented serum compared to C3/ C4 http://dx.doi.org/10.1016/j.ebiom.2016.11.022 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1093/femsre/fuw001 .,OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1016/j.immuni.2015.02.012 .,OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.4049/jimmunol.1501581 .,Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1371/ journal.pone.0004708 .,Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1371/journal.ppat.1004855 .,Non-OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
http://dx.doi.org/10.1128/IAI.69.6.3853- 3859.2001 .10 M.J. Boyle et al.,OADS,/arxiv_data1/oa_pdf/0b/32/main.PMC5161442.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CPT1AExpressionPrognosisBiomarkerAML 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/73/main.PMC5161445.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.11.025 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/ec/73/main.PMC5161445.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/73/main.PMC5161445.pdf
"All clinical, cytogenetic and molecular information as well as microarray data of these patients can be publicly downloaded at the Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/ geo,GSE6891 (Verhaak et al., 2009 )).",OADS,/arxiv_data1/oa_pdf/ec/73/main.PMC5161445.pdf
"6, 698–703 doi:10.1093/fampra/cmw054 Advance Access publication 13 July 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/cmw054.PMC5161487.pdf
2014.  http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.,OADS,/arxiv_data1/oa_pdf/ee/9a/cmw054.PMC5161487.pdf
"Maastricht University  2015, p. 186. https://cris.maastrichtuniversity.nl/portal/files/573394/guid- 48083a29-ac17-4f7c-8f1a-2b6ae680715b-ASSET2.0 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/cmw054.PMC5161487.pdf
"Santos,1,2 Rita Nascimento,1,2Eduarda Guerreiro,1,2Anna C. Michell,4Annebel M. van De Vrugt,5,6,7 Gisela Machado-Oliveira,1,2Guilherme Ferreira,8Ibrahim Domian,5,6and Jose ´Braganc ¸a1,2,3,* 1Regenerative Medicine Program, Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139 Faro, Portugal 2Centre for Biomedical Research - CBMR, University of Algarve, Campus of Gambelas, Building 8, Room 2.22, 8005-139 Faro, Portugal 3ABC - Algarve Biomedical Centre, 8005-139 Faro, Portugal 4Division of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK 5Cardiovascular Research Center, Massachusetts General Hospital, Charles River Plaza/CPZN 3200, 185 Cambridge Street, Boston, MA 02114-2790, USA 6Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA 7Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands 8DSM Biotechnology Center, Alexander Fleminglaan 1, 2613 AX Delft, the Netherlands *Correspondence: jebraganca@ualg.pt http://dx.doi.org/10.1016/j.stemcr.2016.10.002 SUMMARY The transcriptional regulator CITED2 is essential for heart development.",Non-OADS,/arxiv_data1/oa_pdf/db/b6/main.PMC5161512.pdf
1037 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/b6/main.PMC5161512.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/db/b6/main.PMC5161512.pdf
"http://dx.doi.org/10.1016/j.stemcr.2016.10.004 SUMMARY In fragile X syndrome (FXS), CGG repeat expansion greater than 200 triplets is believed to trigger FMR1 gene silencing and disease eti- ology.",Non-OADS,/arxiv_data1/oa_pdf/64/a5/main.PMC5161530.pdf
1059 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/a5/main.PMC5161530.pdf
"ACCESSION NUMBERS Exome sequencing data have been deposited at the EuropeanGenome-Phenome Archive (EGA, https://ega-archive.org ), under accession number EGAS00001001737.",OADS,/arxiv_data1/oa_pdf/64/a5/main.PMC5161530.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/64/a5/main.PMC5161530.pdf
"Stem Cell Reports Article In Vitro Models of GJB2 -Related Hearing Loss Recapitulate Ca2+T ransients via a Gap Junction Characteristic of Developing Cochlea Ichiro Fukunaga,1,2Ayumi Fujimoto,1Kaori Hatakeyama,1Toru Aoki,1Atena Nishikawa,1Tetsuo Noda,3,4 Osamu Minowa,3,4Nagomi Kurebayashi,5Katsuhisa Ikeda,1and Kazusaku Kamiya1,* 1Department of Otorhinolaryngology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan 2Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan 3Department of Cell Biology, Japanese Foundation for Cancer Research, Cancer Institute, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan 4Team for Advanced Development and Evaluation of Human Disease Models, RIKEN BioResource Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan 5Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japa n *Correspondence: kkamiya@juntendo.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.10.005 SUMMARY Mutation of the Gap Junction Beta 2 gene ( GJB2 ) encoding connexin 26 (CX26) is the most frequent cause of hereditary deafness world- wide and accounts for up to 50% of non-syndromic sensorineural hearing loss cases in some populations.",Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC5161531.pdf
There are more than 100 known forms of non-syn- dromic deafness associated with identiﬁed genetic loci (available at http://hereditaryhearingloss.org ).,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC5161531.pdf
1023 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC5161531.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, one table, and six movies and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC5161531.pdf
"Stem Cell Reports Article Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas Maria V. Bogachek,1Jung M. Park,1James P. De Andrade,1Allison W. Lorenzen,1Mikhail V. Kulak,1 Jeffrey R. White,1Vivian W. Gu,1Vincent T. Wu,1and Ronald J. Weigel1,* 1Department of Surgery, University of Iowa, 200 Hawkins Drive, 1516 JCP, Iowa City, IA 52242, USA *Correspondence: ronald-weigel@uiowa.edu http://dx.doi.org/10.1016/j.stemcr.2016.11.001 SUMMARY Many solid cancers have an expanded CD44+/hi/CD24/C0/lowcancer stem cell (CSC) population, which are relatively chemoresistant and drive recurrence and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/9b/42/main.PMC5161532.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/42/main.PMC5161532.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/main.PMC5161532.pdf
"Cancers (Basel) 8.http://dx.doi.org/10.3390/can- cers8030034 .Patel, G.K., Yee, C.L., Terunuma, A., Telford, W.G., Voong, N., Yuspa, S.H., and Vogel, J.C. (2012).",Non-OADS,/arxiv_data1/oa_pdf/9b/42/main.PMC5161532.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.10.008 SUMMARY Embryonic stem cells (ESCs) are fast proliferating cells capable of differentiating into all somatic cell types.,OADS,/arxiv_data1/oa_pdf/9d/7e/main.PMC5161534.pdf
1087 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/main.PMC5161534.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/main.PMC5161534.pdf
"The probability distribution function for  the serial interval is where In this calculation, we assume that the infectious period in humans is exponentially  distributed with mean 4 days,29 and mosquito lifespan is exponentially distributed with  mean varying over 1–2 weeks ( http://www.dengue.gov.sg/subject.asp?id=12 ;17).",Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
We obtain the annual routine  immunization coverage among children aged 12–23 months between 1997 and 2015 from  the WHO/UNICEF immunization estimates ( http://apps.who.int/immunization_monitoring/ globalsummary/estimates?c=AGO ).,Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
We obtain the  annual routine immunization coverage among children aged 12–23 months  between 2003 and 2015 from the WHO/UNICEF immunization estimates  (http://apps.who.int/immunization_monitoring/globalsummary/estimates?,Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
2016 published online June 8. http://www.nejm.org/doi/10.1056/NEJMp1606997 .,OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
2016  http://www.cidrap.umn.edu/news-perspective/2016/06/who-plans-stretch-vaccine-yellow-fever- persists-africa .,Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
2013 http://www.path.org/publications/detail.php?i=2285 .,Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
2016. http://www.afro.who.int/en/clusters-a-programmes/dpc/epidemic-a-pandemic-alert-Wu et al.,Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
Reuters; 2016.  published online July 6. http://af.reuters.com/article/topNews/idAFKCN0ZM0EV 27.,OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
"Washington DC, USA:  2005. http://www.paho.org/hq/index.php?option=com_docmanWu et al.",Non-OADS,/arxiv_data1/oa_pdf/19/2a/nihms830973.PMC5161610.pdf
"The approach used here was to use head-related impulse response measurements measured for a binaural manikin available from the CIPIC HRTF database (http://interface.cipic.ucdavis.edu/sound/hrtf.html) downloaded from the Music and Audio Research Laboratory, at New Y ork University (http://marl.",OADS,/arxiv_data1/oa_pdf/a6/25/aud-38-e13.PMC5161636.pdf
"Stem Cell Reports Report Histone H3 Lysine 9 Acetylation Obstructs ATM Activation and Promotes Ionizing Radiation Sensitivity in Normal Stem Cells Barbara Meyer,1Maria Rita Fabbrizi,1Suyash Raj,1Cheri L. Zobel,1Dennis E. Hallahan,1,2 and Girdhar G. Sharma1,2,* 1Cancer Biology Division, Department of Radiation Oncology, Washington University School of Medicine, 4511 Forest Park, Saint Louis, MO 63108, USA 2Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO 63108, USA *Correspondence: sharma@wustl.edu http://dx.doi.org/10.1016/j.stemcr.2016.11.004 SUMMARY Dynamic spatiotemporal modiﬁcation of chromatin around DNA damage is vital for efﬁcient DNA repair.",Non-OADS,/arxiv_data1/oa_pdf/31/7f/main.PMC5161741.pdf
1013 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/7f/main.PMC5161741.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.11.004 .,Non-OADS,/arxiv_data1/oa_pdf/31/7f/main.PMC5161741.pdf
"Stem Cell Reports Article Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcomeafter Spinal Cord Injury Dearbhaile Dooley,1,2Evi Lemmens,1Tim Vangansewinkel,1Debbie Le Blon,2Chloe ´Hoornaert,2 Peter Ponsaerts,2,3and Sven Hendrix1,3,* 1Department of Morphology, Biomedical Research Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium 2Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Wilrijk, 2610 Antwerp, Belgium 3Co-senior author *Correspondence: sven.hendrix@uhasselt.be http://dx.doi.org/10.1016/j.stemcr.2016.11.005 SUMMARY The therapeutic effects of mesenchymal stem cell (MSC) transplantation following spinal cord injury (SCI) to date have been limited.",Non-OADS,/arxiv_data1/oa_pdf/1b/0e/main.PMC5161742.pdf
1099 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/0e/main.PMC5161742.pdf
http://dx.doi.org/10.1002/term.2188 .,Non-OADS,/arxiv_data1/oa_pdf/1b/0e/main.PMC5161742.pdf
"http://dx.doi.org/10.1016/j.stemcr.2016.11.007 SUMMARY The Drosophila testis has been fundamental to understanding how stem cells interact with their endogenous microenvironment, or niche, to control organ growth in vivo.",OADS,/arxiv_data1/oa_pdf/eb/6b/main.PMC5161748.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/6b/main.PMC5161748.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/eb/6b/main.PMC5161748.pdf
"Stem Cell Reports Article Myoﬁbroblasts Derived from Hepatic Progenitor Cells Create the T umor Microenvironment Sayaka Sekiya,1,3Shizuka Miura,1,3Kanae Matsuda-Ito,1,3and Atsushi Suzuki1,2,* 1Division of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-858 2, Japan 2Core Research for Evolutional Science and Technology, The Japan Agency for Medical Research and Development, 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan 3Co-ﬁrst author *Correspondence: suzukicks@bioreg.kyushu-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.11.002 SUMMARY Hepatic progenitor cells (HPCs) appear in response to several types of chronic injury in the human and rodent liver that often develop into liver ﬁbrosis, cirrhosis, and primary liver cancers.",OADS,/arxiv_data1/oa_pdf/3a/93/main.PMC5161752.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/93/main.PMC5161752.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.,Non-OADS,/arxiv_data1/oa_pdf/3a/93/main.PMC5161752.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Lysosome-associated protein transmembrane-4 β Y Meng et al 6365 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/95/2f/onc2016189a.PMC5161753.pdf
The authors also acknowledge theEREG expression and methylation data across different indications generated by the TCGA Research Network: http://cancergenome.nih.gov.,OADS,/arxiv_data1/oa_pdf/3c/c6/onc2016170a.PMC5161754.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Activation of EGFR in CRC through EREG demethylation XQ u et al 6415 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/3c/c6/onc2016170a.PMC5161754.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/81/15/main.PMC5161776.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.007 500,OADS,/arxiv_data1/oa_pdf/81/15/main.PMC5161776.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/f4/main.PMC5161778.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.10.009 502,OADS,/arxiv_data1/oa_pdf/6f/f4/main.PMC5161778.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4c/91/main.PMC5161779.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.10.005 497,OADS,/arxiv_data1/oa_pdf/4c/91/main.PMC5161779.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33299 - http://dx.doi.org/10.3402/jchimp.v6.33299 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1c/3a/JCHIMP-6-33299.PMC5161782.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33299 - http://dx.doi.org/10.3402/jchimp.v6.33299",Non-OADS,/arxiv_data1/oa_pdf/1c/3a/JCHIMP-6-33299.PMC5161782.pdf
"of patients 11 37.9 18 62.1 29 100 Age Range 54 /C176 52 /C181 Mean 68 69 68 Sex Male 8 72.7 10 55.6 18 62.1 Female 3 27.3 8 44.4 11 37.9 Race Caucasian 11 100.0 13 72.2 24 82.8 African American 0 0.0 5 27.8 5 17.2Others 0 0.0 0 0.0 Smoking status Current 4 36.4 5 27.8 9 31.0 Past (quit /C216 months) 7 63.6 13 72.2 20 69.0 Never 0 0 0 PPI use 3 27.3 2 11.1 5 17.2 Inhaler use 6 54.5 10 55.6 16 55.2 Right lung Total 5 45.5 8 44.4 13 44.8 Upper 3 27.3 4 22.2Middle 2 18.2 0 0.0Lower 0 0.0 4 22.2 Left lung Total 6 54.5 9 50.0 15 51.7 Upper 2 18.2 1 5.6Lower 1 9.1 8 44.4Squamous cell carcinoma of the lung Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33299 - http://dx.doi.org/10.3402/jchimp.v6.33299 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1c/3a/JCHIMP-6-33299.PMC5161782.pdf
Biomed Res Int 2013; 2013: 157838. doi: http://dx.doi.org/10.1155/2013/157838.William Krimsky et al.,OADS,/arxiv_data1/oa_pdf/1c/3a/JCHIMP-6-33299.PMC5161782.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33299 - http://dx.doi.org/10.3402/jchimp.v6.33299",Non-OADS,/arxiv_data1/oa_pdf/1c/3a/JCHIMP-6-33299.PMC5161782.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32960 - http://dx.doi.org/10.3402/jchimp.v6.32960 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32960 - http://dx.doi.org/10.3402/jchimp.v6.32960",Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
BMJ Case Rep2014; 2014. doi: http://dx.doi.org/10.1136/bcr-2013-203055 2.,Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/10.3205/0001655.,Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/10.1016/j.rcl.2015.06.004 6.,OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/10.5001/omj.2016.45 7.,Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
Lancet 2009; 373(9680): 2054. doi: http://dx.doi.org/10.1016/ S0140-6736(09)61031-X 10.,Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/ 10.1038/nrgastro.2010.189 11.,OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
doi: http://dx.doi.org/10.1016/j.ijscr.2016.09.015 13.,OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
"1956; 103: 423/C1424.Abdominal pain Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32960 - http://dx.doi.org/10.3402/jchimp.v6.32960 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/34/JCHIMP-6-32960.PMC5161783.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33114 - http://dx.doi.org/10.3402/jchimp.v6.33114 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33114 - http://dx.doi.org/10.3402/jchimp.v6.33114",Non-OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
World J Surg Oncol 2010; 8: 68. doi:http://dx.doi.org/10.1186/1477-7819-8-68 3.,Non-OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
doi: http://dx.doi.org/10.1016/j.jare.2013.01.005 4.,OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
Front Immunol 2013; 4: 89. doi: http://dx.doi.org/10.3389/ﬁmmu.2013.00089 5.,Non-OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
"482 /C1508.Non-necrotizing colonic granuloma by schistosomiasis Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33114 - http://dx.doi.org/10.3402/jchimp.v6.33114 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/10/66/JCHIMP-6-33114.PMC5161784.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33215 - http://dx.doi.org/10.3402/jchimp.v6.33215 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33215 - http://dx.doi.org/10.3402/jchimp.v6.33215",Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
"The morphologic features are interpreted as consistent with Mucorales (H&E stain, 400 /C29original magniﬁcation).Acute ischemia and mucormycosis endocarditis Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33215 - http://dx.doi.org/10.3402/jchimp.v6.33215 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
doi: http://dx.doi.org/10.1007/s11046-013- 9715-3 4.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
doi: http://dx.doi.org/10.1016/j.euje.2003.09.001 5.,OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33215 - http://dx.doi.org/10.3402/jchimp.v6.33215",Non-OADS,/arxiv_data1/oa_pdf/29/3a/JCHIMP-6-33215.PMC5161785.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"Relationship between day and time of admission and mortality Admission time Mortality Survive Total Cumulative mortality Weekdays Daytime 13 43 56 0.2321 Night-time 9 58 67 0.1343Late-night 13 42 55 0.2363After-hour(Night-time /C27Late-night)22 100 122 0.1803 Weekends 10 94 104 0.0961Effects of time and day of admission on patients admitted to ICU Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"However, we postulate that the data presented in this study provide interesting insights on the timing of admission to ICU and its relationship withpatients’ outcome.Effects of time and day of admission on patients admitted to ICU Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"6 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33478 - http://dx.doi.org/10.3402/jchimp.v6.33478",Non-OADS,/arxiv_data1/oa_pdf/89/84/JCHIMP-6-33478.PMC5161786.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32683 - http://dx.doi.org/10.3402/jchimp.v6.32683 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/76/e5/JCHIMP-6-32683.PMC5161787.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32683 - http://dx.doi.org/10.3402/jchimp.v6.32683",Non-OADS,/arxiv_data1/oa_pdf/76/e5/JCHIMP-6-32683.PMC5161787.pdf
"348No /C147Cardiogenic shock /C147Ventricular support /C147Cardiac biopsy with eosinophilsClozapine-associated cardiac dysfunction Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32683 - http://dx.doi.org/10.3402/jchimp.v6.32683 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/76/e5/JCHIMP-6-32683.PMC5161787.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32952 - http://dx.doi.org/10.3402/jchimp.v6.32952 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f2/96/JCHIMP-6-32952.PMC5161788.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32952 - http://dx.doi.org/10.3402/jchimp.v6.32952",Non-OADS,/arxiv_data1/oa_pdf/f2/96/JCHIMP-6-32952.PMC5161788.pdf
"Repeat ECG after second emergency department visit.Falsely elevated troponin Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32952 - http://dx.doi.org/10.3402/jchimp.v6.32952 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f2/96/JCHIMP-6-32952.PMC5161788.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32952 - http://dx.doi.org/10.3402/jchimp.v6.32952",Non-OADS,/arxiv_data1/oa_pdf/f2/96/JCHIMP-6-32952.PMC5161788.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0 /), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 34107 - http://dx.doi.org/10.3402/jchimp.v6.34107 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/6b/JCHIMP-6-34107.PMC5161789.pdf
"Ferguson and Richard Alweis 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 34107 - http://dx.doi.org/10.3402/jchimp.v6.34107",Non-OADS,/arxiv_data1/oa_pdf/ce/6b/JCHIMP-6-34107.PMC5161789.pdf
J Community Hosp Intern Med Perspect 2011; 1(1): 10. doi: http://dx.doi.org/10.3402/jchimp.v1i0.,Non-OADS,/arxiv_data1/oa_pdf/ce/6b/JCHIMP-6-34107.PMC5161789.pdf
J Community Hosp Intern Med Perspect 2011; 1: 6350. doi: http://dx.doi.org/10.3402/jchimp.v1i1.6350Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ce/6b/JCHIMP-6-34107.PMC5161789.pdf
"JCHIMP peer reviewers 2016 Brian Aboff Robert Ferguson Phillip Mackowiak Manzoor Rather Khalid Abusaada Laurel Fick Srinivasa Madhavan Sofiya Rehman Carlos Acuna Kevin Fleming Naba Mainali Namita RuhelaAmesh Adalja Yacov Fogelman Srikrishna Malayala Mohsen SaadatAmitesh Agarwal Scott Forman Mohammad Malik Sanah SadiqManyoo Agarwal Paul Foster Jayaprakash Manda Yazan SamhouriHassan Alkawam Joseph Fuscaldo Henry Meilman Fardad SarabchiAhmed Al-khazraji Ibrahim Ghobrial Marita Mike Prabin Sharma Richard Alweis Sunil Goyal Hmu Minn Ankita Shashidhar Priya Angi Gaurav Gulati Robabeh(Ruby)Mohammadzadeh Chirag ShethNobuhiro Ariyoshi Shanu Gupta Mahsa Mohebtash Mansur ShomaliDonna Astiz Hafeez Hassan Virk Harsha Moole Nazia SiddiquiRaja Ayash Farnaz Houshmand Nargiz Muganlinskaya Peter SloaneHooman Bakhshi Duosha Hu Marc Mugmon David SmithSandeep Banga Reza Imani Swaroopa Nalamalapu Jeffrey StroupTalha Bashir Syung Min Jung Salik Nazir Bishnu Subedi Prashanthi Baskaran Alan Kaell Binh Nguyen Daniel Summers Ewelina Biskup Yugandhar Kandimalla James Nguyen Thein SweYvonne Braver Paras Karmacharya Fnu Nutan Kshitij ThakurWayne Campbell Joel Katz Vikram Oke Joel ThekekaraYuanning Cao Maryam Keshtkarjahromi Abdillahi Omar Linda ThomasLucien Cardinal Ramesh Khurana Ali Ozhand Michael TofanoIssam Cheikh Victor Kolade Venkataraman Palabindala Nitin TrivediMalek Cheikh Kiran K Kommaraju Phil Panzarella Liubou Uslar Chester Choi Robert Kornberg Kinnari Parikh Hakim Uqdah Dobbin Chow Mahesh Krishnamurthy Jimmy Pham Yue WangFrancis Christian Claudia Kroker-Bode Amareshwar Podugu David WeismanJohn Cmar Sapna Kuehl Richard PomerantZ David WidlusRicardo Conti Amit Kulkarni Dilli Poudel Radhika VijStefan David Alexandre Lacasse Khalid Qazi Frederick WilliamsJanaki Deepak Ankush Lahoti Nazia Qazi Neil VyasZhijun Du May Lee Celeste Quianzon Manajyoti Yadav Emmanuel Elueze John Logan Shweta Ramsahai Jessica Young Vamsi Emani Richard Loynd Ashish RanaJCHIMP /C1an idea whose time has come Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 34107 - http://dx.doi.org/10.3402/jchimp.v6.34107 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/6b/JCHIMP-6-34107.PMC5161789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"Reviewed bymentor, not by CCC second reviewerCCC for formative feedback Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1056/NEJMsr 1200117 2.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
Available from: https://www.acgme.org/acgmeweb/Portals/0/ACGMEClinical CompetencyCommitteeGuidebook.pdf [cited 21 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.3109/0142159X.2012.652239 4.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.4300/JGME-07003043 5.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.3109/ 0142159X.2011.5658286.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1097/ACM.0000000000000736 9.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.3102/ 0034654307313795 11.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1097/ ACM.0000000000000879 13.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
Acad Med 2015; 90(9): 1182. doi: http://dx.doi.org/10.1097/ACM.0000000000000818 15.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.4300/JGME-D-14-00 738.1 16.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
J Grad Med Educ 2014; 6(1): 1/C1 6. doi: http://dx.doi.org/10.4300/JGME-D-13-00445.1 17.,OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1111/j.1365- 2923.2008.03230.x 18.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"Anonymous survey results of participants, mentors, and residents regarding the fairness, transparency, and prioritization of learning of the assessment system QuestionaMentors and CCC members Residents Please characterize your feelings on the fairness of the overall system of assessment of competence in this internal medicine program4.80 4.04 Please characterize your feelings on the transparency of the overall system of assessment of competence in this internal medicine program4.00 4.16 Please characterize how well the program prioritizes your (resident) learning in its assessment systemb4.70 4.20 aScale: 1 /C30not at all (fair, transparent, learner-centered), 5 /C30very (fair, transparent, learner-centered);bresident survey question stem read ‘prioritized your learning’, CCC member survey read ‘prioritized-resident learning’.CCC for formative feedback Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1097/ACM.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
doi: http://dx.doi.org/10.1097/ACM.0000000000000725 22.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"6 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33533 - http://dx.doi.org/10.3402/jchimp.v6.33533",Non-OADS,/arxiv_data1/oa_pdf/0b/00/JCHIMP-6-33533.PMC5161790.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33358 - http://dx.doi.org/10.3402/jchimp.v6.33358 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c1/6d/JCHIMP-6-33358.PMC5161791.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33358 - http://dx.doi.org/10.3402/jchimp.v6.33358",Non-OADS,/arxiv_data1/oa_pdf/c1/6d/JCHIMP-6-33358.PMC5161791.pdf
"*p/C300.01; [95% CI].Use of pocket-sized ultrasound devices Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33358 - http://dx.doi.org/10.3402/jchimp.v6.33358 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c1/6d/JCHIMP-6-33358.PMC5161791.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33358 - http://dx.doi.org/10.3402/jchimp.v6.33358",Non-OADS,/arxiv_data1/oa_pdf/c1/6d/JCHIMP-6-33358.PMC5161791.pdf
"J Hosp Med 2012; 7: 537 /C143.Use of pocket-sized ultrasound devices Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33358 - http://dx.doi.org/10.3402/jchimp.v6.33358 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c1/6d/JCHIMP-6-33358.PMC5161791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0 /), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33540 - http://dx.doi.org/10.3402/jchimp.v6.33540 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/57/JCHIMP-6-33540.PMC5161792.pdf
"During expiration, axial non-contrast CT (center) showing thin crescent tracheal lumen and (right) both main stem bronchi (arrows).Ghaly Kerolus and Ossama Ikladios 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33540 - http://dx.doi.org/10.3402/jchimp.v6.33540",Non-OADS,/arxiv_data1/oa_pdf/11/57/JCHIMP-6-33540.PMC5161792.pdf
"Chest 2007; 132: 609 /C116.Tracheomalacia and recurrent exacerbations of COPD Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33540 - http://dx.doi.org/10.3402/jchimp.v6.33540 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/57/JCHIMP-6-33540.PMC5161792.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33095 - http://dx.doi.org/10.3402/jchimp.v6.33095 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a4/bd/JCHIMP-6-33095.PMC5161795.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33095 - http://dx.doi.org/10.3402/jchimp.v6.33095",Non-OADS,/arxiv_data1/oa_pdf/a4/bd/JCHIMP-6-33095.PMC5161795.pdf
"Stage CD4 /C27count Autoimmunity I High ( /C21500) Initial presentation of some autoimmune diseases II Normal/low (200/C1499)Immune complex formation, vasculitis III Low ( B200) CD8 /C27cell predominant rheumatologic illnesses IV High ( /C21500) Resurgence of once quiescent diseaseDermatomyositis and HIV Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33095 - http://dx.doi.org/10.3402/jchimp.v6.33095 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a4/bd/JCHIMP-6-33095.PMC5161795.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33095 - http://dx.doi.org/10.3402/jchimp.v6.33095",Non-OADS,/arxiv_data1/oa_pdf/a4/bd/JCHIMP-6-33095.PMC5161795.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32310 - http://dx.doi.org/10.3402/jchimp.v6.32310 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/c4/JCHIMP-6-32310.PMC5161797.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32310 - http://dx.doi.org/10.3402/jchimp.v6.32310",Non-OADS,/arxiv_data1/oa_pdf/c7/c4/JCHIMP-6-32310.PMC5161797.pdf
"Hemolytic anemia workup Lab indices Value LDH 2,244 U/L Direct bilirubin 14.1 mg/dLHaptoglobin B7 mg/dL Reticulocyte count 153 K/ULReticulocyte percentage 8.1%INR 1.2 PTT 28 sec Fibrinogen 250 mg/dLHIT panel NegativeADAMTS13 56% HIT, heparin induced thromobocytopenia.Refractory thrombotic thrombocytopenic purpura Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32310 - http://dx.doi.org/10.3402/jchimp.v6.32310 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/c4/JCHIMP-6-32310.PMC5161797.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32310 - http://dx.doi.org/10.3402/jchimp.v6.32310",Non-OADS,/arxiv_data1/oa_pdf/c7/c4/JCHIMP-6-32310.PMC5161797.pdf
"Eur J Med Res 2008; 13: 481 /C12.Refractory thrombotic thrombocytopenic purpura Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32310 - http://dx.doi.org/10.3402/jchimp.v6.32310 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/c4/JCHIMP-6-32310.PMC5161797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32976 - http://dx.doi.org/10.3402/jchimp.v6.32976 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/de/02/JCHIMP-6-32976.PMC5161798.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32976 - http://dx.doi.org/10.3402/jchimp.v6.32976",Non-OADS,/arxiv_data1/oa_pdf/de/02/JCHIMP-6-32976.PMC5161798.pdf
"Clin Nephrol 2005; 64: 155 /C18.A rare case of lamotrigine-induced AIN Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32976 - http://dx.doi.org/10.3402/jchimp.v6.32976 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/de/02/JCHIMP-6-32976.PMC5161798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33674 - http://dx.doi.org/10.3402/jchimp.v6.33674 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/c4/JCHIMP-6-33674.PMC5161799.pdf
"This simplistic ﬁgure does not differentiate true posi- tive from false positives or true negatives from false negatives.Lucien Cardinal 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33674 - http://dx.doi.org/10.3402/jchimp.v6.33674",Non-OADS,/arxiv_data1/oa_pdf/4a/c4/JCHIMP-6-33674.PMC5161799.pdf
"In the above case, the positive predictive value has dropped to66% (40/60 /C29100) compared with 80% in (a) due to a speciﬁcity of 60% (30/50 /C29100).Diagnostic testing Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33674 - http://dx.doi.org/10.3402/jchimp.v6.33674 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/c4/JCHIMP-6-33674.PMC5161799.pdf
"However, testing large numbers of persons to identify a rare disease is inefﬁcient and may be prohibitive in terms of cost and other harms.Lucien Cardinal 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33674 - http://dx.doi.org/10.3402/jchimp.v6.33674",Non-OADS,/arxiv_data1/oa_pdf/4a/c4/JCHIMP-6-33674.PMC5161799.pdf
"Numbers in the illustration are rounded to the closest digit.Diagnostic testing Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33674 - http://dx.doi.org/10.3402/jchimp.v6.33674 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/c4/JCHIMP-6-33674.PMC5161799.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33776 - http://dx.doi.org/10.3402/jchimp.v6.33776 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fa/d1/JCHIMP-6-33776.PMC5161801.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33361 - http://dx.doi.org/10.3402/jchimp.v6.33361 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/93/bd/JCHIMP-6-33361.PMC5161802.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33361 - http://dx.doi.org/10.3402/jchimp.v6.33361",Non-OADS,/arxiv_data1/oa_pdf/93/bd/JCHIMP-6-33361.PMC5161802.pdf
"Axial view of CT abdomen showing punctate retro- peritoneal air around left kidney.Spontaneous pneumomediastinum Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33361 - http://dx.doi.org/10.3402/jchimp.v6.33361 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/93/bd/JCHIMP-6-33361.PMC5161802.pdf
doi: http://dx.doi.org/10.1503/cmaj.100099Thein Swe et al.,OADS,/arxiv_data1/oa_pdf/93/bd/JCHIMP-6-33361.PMC5161802.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33361 - http://dx.doi.org/10.3402/jchimp.v6.33361",Non-OADS,/arxiv_data1/oa_pdf/93/bd/JCHIMP-6-33361.PMC5161802.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33383 - http://dx.doi.org/10.3402/jchimp.v6.33383 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/a7/JCHIMP-6-33383.PMC5161803.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33383 - http://dx.doi.org/10.3402/jchimp.v6.33383",Non-OADS,/arxiv_data1/oa_pdf/25/a7/JCHIMP-6-33383.PMC5161803.pdf
"Clin Gastroenterol Hepatol 2011; 9(9): 727 /C138.Cryptococcemia in an HIV negative patient Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33383 - http://dx.doi.org/10.3402/jchimp.v6.33383 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/a7/JCHIMP-6-33383.PMC5161803.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33383 - http://dx.doi.org/10.3402/jchimp.v6.33383",Non-OADS,/arxiv_data1/oa_pdf/25/a7/JCHIMP-6-33383.PMC5161803.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33342 - http://dx.doi.org/10.3402/jchimp.v6.33342 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c4/d0/JCHIMP-6-33342.PMC5161805.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33342 - http://dx.doi.org/10.3402/jchimp.v6.33342",Non-OADS,/arxiv_data1/oa_pdf/c4/d0/JCHIMP-6-33342.PMC5161805.pdf
"Vieira CL, Baldaia C, Fatela N, Ramalho F, Cardoso C. Case of acute hepatitis E with concomitant signs of autoimmunity.World J Hepatol 2013; 5(3): 152 /C15.Rare cause of autoimmune hepatitis Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 33342 - http://dx.doi.org/10.3402/jchimp.v6.33342 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c4/d0/JCHIMP-6-33342.PMC5161805.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5161806.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.09.001 Introduction Simultaneous bilateral cataract surgery, now more accu- rately referred to as immediately sequential bilateral cataract surgery (ISBCS) - to clearly differentiate it from delayed sequential bilateral cataract surgery [DSBCS],1is still a con- troversial topic in the ophthalmic world and has to come a long way to become a routine procedure.",Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5161806.pdf
Accessed July 2014.http://one.aao.org/summary-benchmark-detail cataract-in-adult-eye- summary-benchmark—october-2.,Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5161806.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/37/main.PMC5161807.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.11.001 Introduction Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/6b/37/main.PMC5161807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/f1/main.PMC5161808.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.10.006 Introduction Laser in situ keratomileusis (LASIK) is a commonly per- formed refractive surgery of refractive errors.,Non-OADS,/arxiv_data1/oa_pdf/8a/f1/main.PMC5161808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/eb/main.PMC5161809.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.10.007 Introduction Haemodialysis (HD) is the unique treatment modality for end stage chronic renal failure patients until the possible renal transplantation.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/main.PMC5161809.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/fd/main.PMC5161810.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.10.004 Introduction A variety of lasers are used in Ophthalmology for diagnos- tic and therapeutic purposes.,Non-OADS,/arxiv_data1/oa_pdf/8a/fd/main.PMC5161810.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/b7/main.PMC5161811.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.11.004 Peer review under responsibility of Saudi Ophthalmological Society, King Saud University Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.com www.sciencedirect.comReceived 23 February 2016; received in revised form 26 October 2016; accepted 1 November 2016; available online 10 November 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/b7/main.PMC5161811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/18/main.PMC5161812.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.10.001 Introduction Postoperative vitreous hemorrhage after vitrectomy for complications of diabetic retinopathy commonly occurs withan incidence of 12–63%.1–4Patients with postoperative vitre- ous hemorrhage suffer a delay in visual recovery while in some patients, this can result in loss of vision and need for reoperation.",Non-OADS,/arxiv_data1/oa_pdf/c0/18/main.PMC5161812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/35/main.PMC5161813.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.07.004 Introduction Exotropia is an eye condition where the two eyes are not aligned along the same axes, but instead the axes diverge.Intermittent exotropia (IXT) is an exodeviation intermittently controlled by fusional mechanisms and spontaneously breaks down into a manifest exotropia.",Non-OADS,/arxiv_data1/oa_pdf/7c/35/main.PMC5161813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/dc/main.PMC5161814.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.11.003 Introduction Doubling of the optic disc is rare and is seen as true dou- bling or pseudodoubling.,Non-OADS,/arxiv_data1/oa_pdf/92/dc/main.PMC5161814.pdf
This is an open access art icle under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/fb/main.PMC5161815.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.10.005 The Institute of Dacryology, L.V.",OADS,/arxiv_data1/oa_pdf/e3/fb/main.PMC5161815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/f2/main.PMC5161816.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.10.002 Introduction Submacular haemorrhages (SMH) are associated with a variety of conditions including age-related macular degener- ation (AMD), retinal artery macroaneuyrsm (RAM), oculartrauma, pathological myopia and presumed ocular histoplas- mosis syndrome (POHS).",Non-OADS,/arxiv_data1/oa_pdf/66/f2/main.PMC5161816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/79/main.PMC5161817.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.11.005 Introduction Membranoproliferative glomerulonephritis type II (MPGNII), also known as dense deposit disease, is an inflam- mation of the glomerulus and one of the major causes ofnephrotic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/1e/79/main.PMC5161817.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.10.008 Introduction Aflibercept (INN, USAN) is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet maculardegeneration under the trade name Eylea.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.org/10.1210/ en.2008-0325 .,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
"http://dx.doi.org/10.1016/j.ophtha.2013.08.011 , Epub 2013 Sep 29.",OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
"http://dx.doi.org/10.3341/kjo.2013.27.6.425 , Epub 2013 Nov 15.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.org/10.1136/ bjophthalmol-2013-303344.Epub2013 Jun 13 .,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
http://dx.doi.org/10.3928/ 23258160-20130313-04 .232 S. Abou-Ltaif,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/main.PMC5161818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/7f/main.PMC5161819.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.11.002 Introduction Visual axis opacification after cataract surgery can be a disturbing experience for the patient.,Non-OADS,/arxiv_data1/oa_pdf/dc/7f/main.PMC5161819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/58/main.PMC5161821.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.10.003 Introduction For a clear vision in a healthy cornea, the number of endothelial cells covering the back surface of the corneashould be sufficient.",Non-OADS,/arxiv_data1/oa_pdf/21/58/main.PMC5161821.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/47/sfv107.PMC5162403.pdf
"In addition to insti- tutional registration and electronic medical record, we veri ﬁed all patients ’vital status using the Social Security Death Index Registry ( http://www.genealogybank.com/gbnk/ssdi/ ).",Non-OADS,/arxiv_data1/oa_pdf/28/47/sfv107.PMC5162403.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/75/31/sfw037.PMC5162404.pdf
"To conclude, compared with historical data, the standardised and home-focused pre-dialysis programme GUIDE, with its home visit, seems to successfully increase the number of patients that choose and receive home dialysis.Supplementary data Supplementary data are available online at http://ndt.oxfordjour- nals.org.",Non-OADS,/arxiv_data1/oa_pdf/75/31/sfw037.PMC5162404.pdf
"https://www.renine.nl/ static?id=prev_years&var=dg&style=line&render=png (17 June 2015, date last accessed) 2.",Non-OADS,/arxiv_data1/oa_pdf/75/31/sfw037.PMC5162404.pdf
"http://www.gezondenieren.nl/over-ons/voor-professionals/#main-nav (17 June 2015, date last accessed) 20.",Non-OADS,/arxiv_data1/oa_pdf/75/31/sfw037.PMC5162404.pdf
https://www.renine.nl/page?,Non-OADS,/arxiv_data1/oa_pdf/75/31/sfw037.PMC5162404.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/0c/sfw057.PMC5162405.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d1/sfw064.PMC5162406.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/99/sfw069.PMC5162407.pdf
"http://data.worldbank.org/indicator/SH.XPD.PUBL.ZS (9 March 2015, date last accessed) 4.",Non-OADS,/arxiv_data1/oa_pdf/1a/99/sfw069.PMC5162407.pdf
"Abraham G, Varughese S, Thandavan T et al.CKD in South Asia – an update .https://www.era-edta.org/newsletter_ndt_southasia_ update.html (11 April 2016, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/1a/99/sfw069.PMC5162407.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
doi:https://secure.cihi.ca/free_products/2011_CORR_Annua_ Report_EN.pdf 3 .,OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/15021846 (2 April 2016, date last accessed) 5.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
http://WWW.HEALTH-LITERACY.EU 18.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/ 15311167 (2 April 2016, date last accessed) 19.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/12132978 (2 April 2016, date last accessed) 22.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
Prog Transplant 2009; 19: 25 –34.http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/ 7865918 (2 April 2016, date last accessed) 38.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"Adv Ren Replace Ther 1997; 4: 46 –54.http://www.ncbi.nlm.nih.gov/pubmed/8996620 (2 April 2016, date last accessed) 48.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/10083108 (2 April 2016, date last accessed) 49.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/10372057 (2 April 2016, date last accessed)CLINICAL KIDNEY JOURNAL865 Health literacy and medication adherence |",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/sfw076.PMC5162408.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/sfw078.PMC5162409.pdf
Supplementary data Supplementary data is available online at http://ndt.oxfordjour- nals.org.,OADS,/arxiv_data1/oa_pdf/71/5d/sfw078.PMC5162409.pdf
"http://www.european-renal-best-practice.org/ content/ebpg-european-best-practice-guidelines- documents (9 October 2015, date last accessed) 16.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/sfw078.PMC5162409.pdf
"http://www.agence-biomedecine.fr/ annexes/bilan2013/donnees/sommaire-organes.htm (20 June 2016, date last accessed) 19.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/sfw078.PMC5162409.pdf
"Rapport REIN 2013. http://www.agence-biomedecine.fr/Le- programme-REIN (20 June 2016, date last accessed) 21.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/sfw078.PMC5162409.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/3b/42/sfw084.PMC5162410.pdf
"2016. http://data.worldbank.org/ country/nigeria (14 July 2016, date last accessed) 13.",Non-OADS,/arxiv_data1/oa_pdf/3b/42/sfw084.PMC5162410.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/0a/sfw085.PMC5162411.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/9e/e6/sfw087.PMC5162412.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/fc/sfw090.PMC5162413.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/24/d0/sfw091.PMC5162414.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/sfw093.PMC5162415.pdf
"http://www.ncbi.nlm.nih.gov/books/NBK100238/ (1 February 2016, date last accessed) 7.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/sfw093.PMC5162415.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/sfw094.PMC5162416.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/5a/sfw096.PMC5162417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/2d/sfw104.PMC5162418.pdf
"http://www.unaids.org/sites/default/ ﬁles/media_asset/AIDS-by-the-numbers-2016_en.pdf .1 2 1 1 Geneva 27, Switzerland, 2016 2.",Non-OADS,/arxiv_data1/oa_pdf/ef/2d/sfw104.PMC5162418.pdf
https://aidsinfo.nih.gov/ guidelines/html/1/adult-and-adolescent-arv-guidelines/44/ arv-dosing-for-renal-or-hepatic-insuf ﬁciency 72.,Non-OADS,/arxiv_data1/oa_pdf/ef/2d/sfw104.PMC5162418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/8c/sfw109.PMC5162419.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/f0/sfw114.PMC5162420.pdf
"Keywords:  Minimally invasive surgical procedures; Decompression; Discectomy; Fusion; Surgical wound infections Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/7f/asj-10-1000.PMC5164988.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 22, 2016; Revised Apr 16, 2016; Accepted May 7, 2016 Corresponding author: Arvind Gopalrao Kulkarni Mumbai Spine Scoliosis & Disc Replacement Centre, Bombay Hospital  and Medical Research Centre, Mumbai 400020 India Tel: +91-9892875490, Fax: +91-22-22080871, E-mail: drarvindspines@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1000-1006  •  https://doi.org/10.4184/asj.2016.10.6.1000 Asian Spine Journal Introduction Surgical site infections (SSIs) are dreaded complications  of spinal surgery with reported rates ranging from 0.09%  to 16% [1-18].",Non-OADS,/arxiv_data1/oa_pdf/03/7f/asj-10-1000.PMC5164988.pdf
"Keywords:  Stretch myelopathy; Multilevel cervical myelopathy; Cervical pedicle screws; Kyphosis correction; Partial facetectomies Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/6e/asj-10-1007.PMC5164989.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 24, 2016; Revised Apr 9, 2016; Accepted Apr 9, 2016 Corresponding author: Bidre Upendra Jain Institute of Spine care And Research ( JISAR), Bhagwan Mahaveer Jain Hospital,  Vasanth Nagar, Bangalore 560052, India Tel: +91-9686803495, Fax: +91-8022261153, E-mail: upibn75@gmail.com   ASJClinical Study Asian Spine J 2016;10(6):1007-1017  •  https://doi.org/10.4184/asj.2016.10.6.1007 Asian Spine Journal Introduction The stretch component of the cervical cord seems a likely contributing factor to cervical myelopathy [1-5] apart  from non-mechanical factors like ischemia, apoptosis  and inflammation [3,4].",Non-OADS,/arxiv_data1/oa_pdf/ca/6e/asj-10-1007.PMC5164989.pdf
"Keywords:  Infection surgical site; Fusion spinal; Prophylaxis antibiotic Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/e5/asj-10-1018.PMC5164990.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 3, 2016; Revised May 10, 2016; Accepted Jun 4, 2016 Corresponding author: Chandrasekaran Marimuthu Spine Unit, Department of orthopaedics, Mahatma Gandhi Medical College and Research Institute,  Pillayarkuppam, Pondicherry, India 607402  Tel:+91-944-3398534, Fax: +91-413-2615457, E-mail: chandruortho@yahoo.com    ASJClinical Study Asian Spine J 2016;10(6):1018-1022  •  https://doi.org/10.4184/asj.2016.10.6.1018 Asian Spine Journal Introduction Antimicrobial prophylaxis in surgical practice has become  a universally accepted protocol for minimizing postopera - tive complications related to infections [1-3].",Non-OADS,/arxiv_data1/oa_pdf/b8/e5/asj-10-1018.PMC5164990.pdf
"Keywords:  Adult spinal deformity; Lateral lumbar interbody fusion; Anterior lumbar interbody fusion; Sagittal balance; Lumbar lordosis Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/2a/asj-10-1023.PMC5164991.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 27, 2016; Revised May 18, 2016; Accepted May 19, 2016 Corresponding author: Se-Jun Park Department of Orthopedic Surgery, Spine Center, Samsung Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-1583, Fax: +82-2-3410-0061, E-mail: sejunos@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1023-1032  •  https://doi.org/10.4184/asj.2016.10.6.1023 Asian Spine Journal Introduction The traditional method of correcting adult spinal defor - mity (ASD) is a posterior-only surgery.",Non-OADS,/arxiv_data1/oa_pdf/13/2a/asj-10-1023.PMC5164991.pdf
"Keywords:  Cervical Spondylosis; Spine; Degenerative disease; Osteophyte; Herniated disc Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/db/asj-10-1033.PMC5164992.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 20, 2016; Revised Apr 8, 2016; Accepted May 6, 2016 Corresponding author: Deepak Kumar Jha Department of Neurosurgery, Institute of Human Behavior and Allied Sciences, Delhi 110095, India   Tel: +91-9868527900, Fax: +91-1122114066, E-mail: jhadeepak2@rediffmail.com    ASJClinical Study Asian Spine J 2016;10(6):1033-1041  •  https://doi.org/10.4184/asj.2016.10.6.1033 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/a5/db/asj-10-1033.PMC5164992.pdf
"Keywords: Surgical wound infection; Instrumentation; Biomarkers; Lymphopenia; Leukocytes Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/3e/asj-10-1042.PMC5164993.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 22, 2016; Revised Apr 23, 2016; Accepted May 10, 2016 Corresponding author: Eiichiro Iwata Department of Orthopedic Surgery, Nara Medical University, 840 Shijo-cho, Kashiharashi, Nara 634-8522, Japan Tel: +81-744-29-8873, Fax: +81-744-29-4902, E-mail: iwata@naramed-u.ac.jp    ASJClinical Study Asian Spine J 2016;10(6):1042-1046  •  https://doi.org/10.4184/asj.2016.10.6.1042 Asian Spine Journal Introduction Surgical site infection (SSI) remains one of the most serious problems after spinal instrumentation surgery [1-3].",Non-OADS,/arxiv_data1/oa_pdf/e3/3e/asj-10-1042.PMC5164993.pdf
"Keywords:  Pancoast syndrome; Tumor resection; Chemotherapy; Radiation therapy Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/0c/asj-10-1047.PMC5164994.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 24, 2016; Revised May 6, 2016; Accepted May 28, 2016 Corresponding author: Fahed Zairi Department of Neurosurgery, Lille University Hospital, CHRU de Lille, 59000 Lille, France  Tel: +33-666546169, Fax: +33-320446623, E-mail: fahed.zairi@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1047-1057  •  https://doi.org/10.4184/asj.2016.10.6.1047 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/2e/0c/asj-10-1047.PMC5164994.pdf
"Keywords: Decompression; Surgery; Reduction; Neurology  Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/af/asj-10-1058.PMC5164995.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 26, 2016; Revised Apr 2, 2016; Accepted Apr 8, 2016 Corresponding author: Shardul Madhav Soman  Department of Orthopaedics, Government Spine Institute, Ahmedabad, Gujarat 380016, India  Tel: +91-89-80844549, Fax: +91-79-22683421, E-mail: somanshardul@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1058-1064  •  https://doi.org/10.4184/asj.2016.10.6.1058 Asian Spine Journal Introduction Spondyloptosis is a condition in which there is complete  slippage of one vertebral body over the corpus of the ad - jacent one.",Non-OADS,/arxiv_data1/oa_pdf/b8/af/asj-10-1058.PMC5164995.pdf
"Keywords:  Burkholderia pseudomallei ; Melioidosis; Tuberculosis; Spondylitis; Non-caseating granuloma; Antibiotics Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/asj-10-1065.PMC5164996.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 22, 2016; Revised May 4, 2016; Accepted May 14, 2016 Corresponding author: Justin Arockiaraj Spinal Disorders Surgery Unit, Department of Orthopaedics, Christian Medical College & Hospital,  Vellore, Tamil Nadu 632004, India  Tel: +91-416-2282020, Fax: +91-416-2232054, E-mail: svjustin.arockiaraj@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1065-1071  •  https://doi.org/10.4184/asj.2016.10.6.1065 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/4b/23/asj-10-1065.PMC5164996.pdf
"Keywords:  Spine; Hematoma; Fibrosis; Drainage; Back pain Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/db/asj-10-1072.PMC5164997.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 4, 2016; Revised May 23, 2016; Accepted May 24, 2016 Corresponding author: Kadir Kotil Department of Neurosurgery, Istanbul Arel University, Tepekent, Istanbul, Turkey Tel: +90-216-360-12-26, Fax: +90-216-302-03-91, E-mail: kadirkotil@gmail.com  ASJClinical Study Asian Spine J 2016;10(6):1072-1078  •  https://doi.org/10.4184/asj.2016.10.6.1072 Asian Spine Journal Introduction Postoperative epidural hematomas (EH) have been re - ported as “very frequent” when radiologic investigation of  the postoperative lumbar spine is performed [1].",Non-OADS,/arxiv_data1/oa_pdf/8d/db/asj-10-1072.PMC5164997.pdf
"Keywords:  Neurilemmoma; Cauda equina; Surgery Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/ca/asj-10-1079.PMC5164998.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 1, 2016; Revised May 26, 2016; Accepted May 27, 2016 Corresponding author: Kengo Fujii  Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba,  1-1-1 Tennodai, Tsukuba 305-8575, Japan  Tel: +81-29-853-3219, Fax: +81-29-853-3162, E-mail: kengox15feb@tsukuba-seikei.jp ASJClinical Study Asian Spine J 2016;10(6):1079-1084  •  https://doi.org/10.4184/asj.2016.10.6.1079 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/00/ca/asj-10-1079.PMC5164998.pdf
"Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/a7/asj-10-1085.PMC5164999.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 12, 2016; Revised Apr 20, 2016; Accepted May 6, 2016 Corresponding author: Masao Koda  Department of Orthopedic Surgery, Chiba University Graduate School of Medicine 1-8-1 Inohana, Chuo-Ku, Chiba 2608670, Japan Tel: +81-43-226-2961, Fax: +81-43-224-5124, E-mail: masaokod@gmail.com ASJClinical Study Asian Spine J 2016;10(6):1085-1090  •  https://doi.org/10.4184/asj.2016.10.6.1085 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/0a/a7/asj-10-1085.PMC5164999.pdf
"Keywords:  Lumbar spine; Degenerative; Transforaminal interbody fusion; Bone morphogenic protein; TLIF BMP Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/7f/asj-10-1091.PMC5165000.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 18, 2016; Revised Apr 20, 2016; Accepted May 7, 2016 Corresponding author: Wai-Mun Yue Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, 169608 Singapore  Tel: +65-6321-4603, Fax: +65-6224-8100, E-mail: yuewm@singnet.com.sg ASJClinical Study Asian Spine J 2016;10(6):1091-1099  •  https://doi.org/10.4184/asj.2016.10.6.1091 Asian Spine Journal Introduction Fusion of the lumbar spine is the surgical treatment of  choice for a number of spinal disorders, including degen - erative, traumatic, and neoplastic disorders.",Non-OADS,/arxiv_data1/oa_pdf/a6/7f/asj-10-1091.PMC5165000.pdf
"Keywords:  Spinal fusion; Stand-alone implants; Degenerative intervertebral disks; Treatment outcome  Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/33/asj-10-1100.PMC5165001.pdf
"Box 80215, Jeddah 21589, Saudi Arabia  Tel: +966-12-6408346, Fax: +966-12-6408469, E-mail: sbaeesa@kau.edu.sa    ASJClinical Study Asian Spine J 2016;10(6):1100-1105  •  https://doi.org/10.4184/asj.2016.10.6.1100 Asian Spine Journal Introduction Posterior lumbar interbody fusion (PLIF) creates in - tervertebral fusion using a posterior approach [1].",Non-OADS,/arxiv_data1/oa_pdf/6d/33/asj-10-1100.PMC5165001.pdf
"Keywords:  Spinal tuberculosis; Decompression; Fusion; Kyphosis Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/80/asj-10-1106.PMC5165002.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 3, 2016; Revised Apr 19, 2016; Accepted May 17, 2016 Corresponding author: Shaival Dalal B.J Medical College and Civil Hospital, Ahmedabad, Gujarat  380016, India Tel: +91-9904915211, E-mail: shaival_dalal@yahoo.co.in    ASJClinical Study Asian Spine J 2016;10(6):1106-1114  •  https://doi.org/10.4184/asj.2016.10.6.1106 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/03/80/asj-10-1106.PMC5165002.pdf
Available from: http://www.who.int/tb/ publications/global_report.,Non-OADS,/arxiv_data1/oa_pdf/03/80/asj-10-1106.PMC5165002.pdf
"Keywords:  Lumbar; Prolapsed disc; Slipped disc; Sciatica; Magnetic resonance imaging; Correlation study; Intraoperative Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/b6/asj-10-1115.PMC5165003.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Dec 30, 2015; Revised May 1, 2016; Accepted May 6, 2016 Corresponding author: Shumayou Dutta Bharati Vidyapeeth Deemed Hospital and Medical College, Pune Satara Road, Pune, Maharashtra 411043, India Tel: 91-020-24373226, Fax: +91-020-24373222, E-mail: shumayou@hotmail.com    ASJClinical Study Asian Spine J 2016;10(6):1115-1121  •  https://doi.org/10.4184/asj.2016.10.6.1115 Asian Spine Journal Introduction Lumbar disc prolapse is a common cause of back and leg  pain affecting today’s working population and is a major   cause of sickness absenteeism, creating a substantial socio-economic burden [1,2].",Non-OADS,/arxiv_data1/oa_pdf/15/b6/asj-10-1115.PMC5165003.pdf
"Oxycodone (51.9%) and fentanyl (50.8%) were the most frequently prescribed opioids; most patients  Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0f/asj-10-1122.PMC5165004.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Oct 27, 2016; Revised Nov 18, 2016; Accepted Nov 18, 2016 Corresponding author: Chun-Kun Park Department of Neurosurgery, Good Doctor Teun Teun Hospital, 775 Gyeongsu-Daero Dongan-gu, Anyang 14041, Korea Tel: +82-31-8086-8357, Fax: +82-2-534-4799, E-mail: ckpmd@catholic.ac.kr    ASJClinical Study Asian Spine J 2016;10(6):1122-1131  •  https://doi.org/10.4184/asj.2016.10.6.1122 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/05/0f/asj-10-1122.PMC5165004.pdf
Available from: https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/05/0f/asj-10-1122.PMC5165004.pdf
Available from: https://www.fpm.ac.uk/faculty-of- pain-medicine/opioids-aware.,Non-OADS,/arxiv_data1/oa_pdf/05/0f/asj-10-1122.PMC5165004.pdf
"Keywords:  Disc degeneration; Ligamentum flavum thickness; Lumbar spine; Facet orientation Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/7c/asj-10-1132.PMC5165005.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 24, 2016; Revised May 23, 2016; Accepted Jun 8, 2016 Corresponding author: Masashi Miyazaki Department of Orthopaedic Surgery, Oita University Faculty of Medicine,  1-1 Idaigaoka, Hsama-machi, Yufu, 879-5593, Japan Tel: +81-97-586-5872, Fax: +81-97-586-6647, E-mail: masashim@med.oita-u.ac.jp ASJClinical Study Asian Spine J 2016;10(6):1132-1140  •  https://doi.org/10.4184/asj.2016.10.6.1132 Asian Spine Journal Introduction Posterior spinal structures, including ligamentum flavum (LF) thickness, play a major role in lumbar spinal canal  stenosis (LSCS) pathogenesis [1-3].",Non-OADS,/arxiv_data1/oa_pdf/f4/7c/asj-10-1132.PMC5165005.pdf
"Keywords:  Vertebral artery; High-riding vertebral artery; Pedicle; X-ray computed tomography; C2 screw Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/44/asj-10-1141.PMC5165006.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 18, 2016; Revised Apr 23, 2016; Accepted May 8, 2016 Corresponding author: Thamrong Lertudomphonwanit Department of Orthopedics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University,  270 Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand Tel: +66-2-2011589, Fax: +66-2-6520306, E-mail: thamrong.lert@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1141-1148  •  https://doi.org/10.4184/asj.2016.10.6.1141 Asian Spine Journal Introduction Posterior atlantoaxial transarticular screw fixation and segmental screw fixation of the C1 lateral mass and C2  pedicle are acceptable methods used to stabilize the atlan - toaxial joint [1].",Non-OADS,/arxiv_data1/oa_pdf/af/44/asj-10-1141.PMC5165006.pdf
"Keywords:  Posterolateral lumbar fusion; Demineralized bone matrix; Hydroxyapatites Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/22/asj-10-1149.PMC5165007.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 7, 2016; Revised Apr 13, 2016; Accepted Apr 27, 2016 Corresponding author: Jemin Yi Department of Orthopaedic Surgery, Kangwon National University Hospital,  156 Baengnyeong-ro, Chuncheon 24289, Korea Tel: +82-33-258-9209, Fax: +82-33-258-2149, E-mail: firekimdo@gmail.com    ASJClinical Study Asian Spine J 2016;10(6):1149-1156  •  https://doi.org/10.4184/asj.2016.10.6.1149 Asian Spine Journal Introduction Posterolateral lumbar fusion (PLF) is a commonly used  surgical intervention to treat degenerative spinal disor - ders [1].",Non-OADS,/arxiv_data1/oa_pdf/65/22/asj-10-1149.PMC5165007.pdf
"Keywords:  Kyphosis; Severe; Radiological; Sign; Baltalimani Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/32/asj-10-1157.PMC5165008.pdf
"55500 Carsamba, Samsun, Turkey Tel: +90-36-2833-4121 Fax: +90-21-2323-7082, E-mail: yunatici@hotmail.com    ASJClinical Study Asian Spine J 2016;10(6):1157-1162  •  https://doi.org/10.4184/asj.2016.10.6.1157 Asian Spine Journal Introduction Angular kyphosis is a localized spinal deformity with a  sharp angulation.",Non-OADS,/arxiv_data1/oa_pdf/43/32/asj-10-1157.PMC5165008.pdf
"Keywords:  Scoliosis; Long-term adverse effects; Treatment Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/68/asj-10-1163.PMC5165009.pdf
"23, D-55457 Gensingen, Germany Tel: +49-6727-894040, Fax: +49-6727-8940429, E-mail: hr.weiss@skoliose-dr-weiss.com    ASJReview Article Asian Spine J 2016;10(6):1163-1169  •  https://doi.org/10.4184/asj.2016.10.6.1163 Asian Spine Journal Introduction Scoliosis is a three-dimensional deformity of the spine  and trunk; it includes lateral deviation, rotation, and a  disturbed sagittal profile [1-4].",Non-OADS,/arxiv_data1/oa_pdf/90/68/asj-10-1163.PMC5165009.pdf
"Keywords:  Adolescent; Exercise; Humans; Kyphosis; Scoliosis; Braces Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/99/asj-10-1170.PMC5165010.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 18, 2016; Revised  Mar 30, 2016; Accepted  Apr 3, 2016 Corresponding author: Josette Bettany-Saltikov School of Health and Social Care, University of Teesside, Borough Road, Middlesbrough, TS1 3BA, United Kingdom  Tel: +44-01642-342981, Fax: +44-01642-344124, E-mail: j.b.saltikov@tees.ac.uk    ASJReview Article Asian Spine J 2016;10(6):1170-1194  •  https://doi.org/10.4184/asj.2016.10.6.1170 Asian Spine Journal",Non-OADS,/arxiv_data1/oa_pdf/64/99/asj-10-1170.PMC5165010.pdf
Available from: http://www.cochrane- handbook.org.,OADS,/arxiv_data1/oa_pdf/64/99/asj-10-1170.PMC5165010.pdf
"Keywords:  Spinal cord stimulation; Failed back surgery syndrome; Low back pain; Pain management Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/f3/asj-10-1195.PMC5165011.pdf
"Prof. Lotha 26; 76-200 Słupsk, Poland Tel: +48-663-534-485, E-mail: p.waszak@gumed.edu.pl    ASJReview Article Asian Spine J 2016;10(6):1195-1204  •  https://doi.org/10.4184/asj.2016.10.6.1195 Asian Spine Journal Introduction Failed back surgery syndrome (FBSS) is a chronic pain  condition that features persistent or recurring low back  pain after one or more spinal surgeries [1].",Non-OADS,/arxiv_data1/oa_pdf/6e/f3/asj-10-1195.PMC5165011.pdf
"Keywords:  RNA interference; p75; Viability; Notochordal cells Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/ca/asj-10-985.PMC5165012.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Aug 4, 2016; Revised Aug 11, 2016; Accepted Aug 13, 2016 Corresponding author: Jong-Beom Park Department of Orthopaedic Surgery, Uijeongbu St. Mary’s Hospital, College of Medicine,  The Catholic University of Korea, 271 Cheonbo-ro, Uijeongbu 11765, Korea Tel: +82-31-820-3578, Fax: +82-3-1847-3671, E-mail: spinepjb@catholic.ac.kr    ASJBasic Study Asian Spine J 2016;10(6):985-992  •  https://doi.org/10.4184/asj.2016.10.6.985 Asian Spine Journal Introduction Nerve growth factor (NGF) is a member of the neuro - trophin family.",Non-OADS,/arxiv_data1/oa_pdf/db/ca/asj-10-985.PMC5165012.pdf
"Keywords:  Cross-link; Spinous process; Biomechanics; Spinal fusion; Pedicle screw-rod Copyright Ⓒ 2016 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/asj-10-993.PMC5165013.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 1, 2016; Revised Apr 5, 2016; Accepted Apr 8, 2016 Corresponding author: Yasuhiro Nakajima Department of Neurosurgery, Inazawa Municipal Hospital, 100 Numa, Nazuka-cho, Inazawa City, Aichi 492-8510, Japan Tel: +81-587-32-2111, Fax: +81-587-32-2151, E-mail: y-nakajima@city.inazawa.aichi.jp ASJBasic Study Asian Spine J 2016;10(6):993-999  •  https://doi.org/10.4184/asj.2016.10.6.993 Asian Spine Journal Introduction The mechanical strength provided by instrumentation is very important for the clinical success of spinal fusion.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/asj-10-993.PMC5165013.pdf
"1 While much of the evidence focuses on single health behaviours, there is increasing appreciation that these behaviours are not inde- http://dx.doi.org/10.1016/j.ssmph.2016.10.011 Received in revised form 8 October 2016; Accepted 20 October 2016⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"physical activity: http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-strateg-phys-act-guidelines#apaadult ; diet http://www.eatforhealth.gov.au/guidelines/australian-guide-healthy-eating ; alcohol intake http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/guide-adult ), USA (physical activity http://health.gov/paguidelines/pdf/paguide.pdf; diet http://health.gov/dietaryguidelines/2015/guidelines/ ; alcohol intake http://health.gov/dietaryguidelines/ 2015/guidelines/appendix-9/ and smoking http://smokefree.gov/); DoH (2003, 2005, 2011, 2013a, 2013b) .SSM - Population Health 2 (2016) 824–833 2352-8273/ © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Acknowledgements The study was supported by the funding from the Public Health Research Consortium (PHRC) http://phrc.lshtm.ac.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.ssmph.2016.10.011 .,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Health Education Research , 19(3), 261– 271. http://dx.doi.org/10.1093/her/cyg040 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Australian and New Zealand Journal of Public Health ,37(2), 118– 123. http://dx.doi.org/10.1111/1753-6405.12028 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Longitudinal and Life Course Studies ,3(1), 5 –17.http://dx.doi.org/10.14301/llcs.v3i1.159 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"PLoS One ,7(5), e36345 .http://dx.doi.org/10.1371/journal.pone.0036345.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Relating latent class analysis results to variables not included in the analysis .〈https://www.statmodel.com/download/relatinglca.pdf 〉.,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Journal of Prevention Intervention in the Community ,38(3), 213– 228. http://dx.doi.org/10.1080/10852352.2010.486299 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"BMC Public Health , 2011(11), 692〈http://www.biomedcentral.com/1471-2458/11/692 〉.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive medicine ,46(3), 203– 208. http://dx.doi.org/10.1016/j.ypmed.2007.08.005 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Available at: 〈https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ ﬁle/213740/dh_128145.pdf 〉.H.,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Available at: 〈https://www.gov.uk/government/policies/reducing-harmful-drinking 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
UK Chief Medical O ﬃcers' alcohol guidelines review summary of the proposed new guidelines .〈https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ ﬁle/489795/summary.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"BMJ ,328(7444), 861. http://dx.doi.org/10.1136/ bmj.38034.702836.55 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Psychology of Sport and Exercise ,11(6), 522– 535. http://dx.doi.org/10.1016/j.psychsport.2010.05.001 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Heterogeneity of alcohol, tobacco, and other substance use behaviors in U.S. college students: A latent class analysis.Addictive Behaviors, 53,8 0 –85.http://dx.doi.org/10.1016/j.addbeh.2015.10.010 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Journal of Public Health .http://dx.doi.org/ 10.1093/pubmed/fdv061 .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1542/peds.2008-2251 .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Policy Politics ,37(4), 463– 479. http://dx.doi.org/10.1332/030557309X445618 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive medicine ,67, 141– 146. http://dx.doi.org/10.1016/j.ypmed.2014.07.007 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Retrieved from 〈https://www.understandingsociety.ac.uk/research/publications/ ﬁndings/2012 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"American Journal of Public Health ,94(2), 279– 285. http://dx.doi.org/10.2105/AJPH.94.2.279 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/ 10.1371/journal.pmed.0050012 .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Retrieved from 〈http://phrc.lshtm.ac.uk/papers/ PHRC_002_Final_Report.pdf 〉 Knies, G.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Journal of Advanced Nursing .http://dx.doi.org/ 10.1111/jan.12981.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"European Journal Public Health ,11.http://dx.doi.org/10.1093/eurpub/ 11.3.294 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"BMC Public Health ,10, 1–13.http://dx.doi.org/10.1186/1471-2458-10-330 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1016/S0140-6736(12)61228-8 .,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive Medicine ,65, 148– 152. http://dx.doi.org/10.1016/j.ypmed.2014.05.023 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1016/j.ypmed.2016.03.003 .,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"International Journal of Public Health ,59(1),117– 121. http://dx.doi.org/10.1007/s00038-013-0523-9 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive medicine ,84, 1–5.http://dx.doi.org/10.1016/j.ypmed.2015.12.009 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive Medicine ,81, 16–41.http://dx.doi.org/10.1016/j.ypmed.2015.07.003 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"BMC Public Health ,15(1), 1–9.http://dx.doi.org/10.1186/s12889-015-2015-8 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Structural Equation Modeling: A Multidisciplinary Journal , 14(4), 535– 569. http://dx.doi.org/10.1080/10705510701575396 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
〈http://www.ons.gov.uk/ons/dcp171776_361923.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Statistical bulletin: Families and Households: 2015 .〈http://www.ons.gov.uk/peoplepopulationandcommunity/ birthsdeathsandmarriages/families/bulletins/familiesandhouseholds/2015-11- 05#families 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Public Health Nutrition ,12(02), 267– 283. http://dx.doi.org/10.1017/S1368980008002589 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Health Promotion Practice ,10(4), 505– 516. http://dx.doi.org/10.1177/1524839909341025.",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive Med, 44, 124– 128. http://dx.doi.org/10.1016/j.ypmed.2006.10.006 .",OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"Preventive medicine ,46(3), 181– 188. http://dx.doi.org/10.1016/j.ypmed.2008.02.001 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1001/jama.2010.297 .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"BMC Medical Research methodology ,10(1), 1 –8.http://dx.doi.org/10.1186/1471-2288-10-84 .",Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1111/j.1360-0443.2005.01193.x .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
http://dx.doi.org/10.1017/S0033291711000249 .,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
From 〈http://www.who.int/healthy_settings/en/ 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
Retrieved from 〈http://www.who.int/nmh/publications/ncd-status-report-2014/en/〉 .H.,OADS,/arxiv_data1/oa_pdf/05/b3/main.PMC5165044.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/6c/rjw198.PMC5165050.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d1/ca/rjw213.PMC5165051.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 34299 - http://dx.doi.org/10.3402/jev.v5.34299 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 34299 - http://dx.doi.org/10.3402/jev.v5.34299",OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"Hill La Trobe University, Australia 35 min Lecture 10 The lipid content of EVs Edit I. Buzas Semmelweis University, Hungary 18 minQuiz 2 Biogenesis, cargo and uptake of EVs 15 questions Week 3: Collection and processing of cell culture media and body fluids prior to isolation of EVs Lecture 11 Cell culture media Cecilia La ¨ sser University of Gothenburg, Sweden 13 min Lecture 12 Blood plasma and serum Kenneth W. Witwer Johns Hopkins University, United States 15 minLecture 13 Breast milk Esther Nolte-‘t Hoen Utrecht University, The Netherlands 8 minLecture 14 Urine Lesley Cheng La Trobe University, Australia 25 minLecture 15 Cerebrospinal fluid Julie A. Saugstad Oregon Health & Science University, United States15 min Quiz 3 Collection and processing of cell culture media and body fluids prior to isolation of EVs 18 questions Week 4: Methods for isolating EVs Lecture 16 Differential ultracentrifugation /C1Part 1 Cecilia La ¨ sser University of Gothenburg, Sweden 15 min Lecture 17 Differential ultracentrifugation /C1Part 2 Cecilia La ¨ sser University of Gothenburg, Sweden 16 min Lecture 18 Density gradient Su Chul Jang University of Gothenburg, Sweden 12 minLecture 19 Size exclusion chromatography Rienk Nieuwland Academic Medical Center, The Netherlands14 min Lecture 20 Kit-based precipitation An Hendrix Ghent University, Belgium 12 min Lecture 21 Summary of isolation methods for EVs Cecilia La ¨ sser University of Gothenburg, Sweden 6 min Quiz 4 Methods for isolating extracellular vesicles 11 questions Week 5: Techniques for characterisation and quantification of EVs Lecture 22 Electron microscopy /C1Part 1 Johanna Ho ¨o¨ g University of Gothenburg, Sweden 9 min Lecture 23 Electron microscopy /C1Part 2 Johanna Ho ¨o¨ g University of Gothenburg, Sweden 14 min Lecture 24 Electron microscopy /C1Part 3 Johanna Ho ¨o¨ g University of Gothenburg, Sweden 6 min Lecture 25 Cryo-TEM Alain Brisson University of Bordeaux, France 14 minLecture 26 Atomic-force microscopy Shivani Sharma University of California, United States 19 minLecture 27 Flow cytometry Marca H. Wauben Utrecht University, The Netherlands 25 minLecture 28 Nanoparticle tracking analysis Chris Gardiner University College London, UK 17 minQuiz 5 Techniques for characterisation and quantification of EVs 18 questions Cryo-TEM, cryo-transmission electron microscopy; EVs, extracellular vesicles.ISEV launches the first massive open online course on EVs Citation: Journal of Extracellular Vesicles 2016, 5: 34299 - http://dx.doi.org/10.3402/jev.v5.34299 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"2014;3:24641,doi: http://dx.doi.org/10.3402/jev.v3.24641 11.",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.20360 12.",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"2014;3:24215,doi: http://dx.doi.org/10.3402/jev.v3.24215 13.",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"2014;3:26913, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 34299 - http://dx.doi.org/10.3402/jev.v5.34299",OADS,/arxiv_data1/oa_pdf/ef/49/JEV-5-34299.PMC5165052.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/6d/rjw206.PMC5165059.pdf
1/7 http://ejgo.orgABSTRACT Objective:  To determine whether less invasive endometrial (EM) aspiration biopsy is  adequately accurate for evaluating treatment outcomes compared to the dilatation and  curettage (D&C) biopsy in early-stage endometrial cancer (EC) patients treated with high  dose oral progestin and levonorgestrel intrauterine system (LNG-IUS).,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
"2017 Jan;28(1):e1 https://doi.org/10.3802/jgo.2017.28.e1 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  May 25, 2016 Revised:  Jun 20, 2016 Accepted:  Jul 19, 2016 Correspondence to Seok Ju Seong Department of Obstetrics and Gynecology,  CHA Gangnam Medical Center, CHA  University, 566 Nonhyeon-ro, Gangnam-gu,  Seoul 06135, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
"ORCID Da Hee Kim http://orcid.org/0000-0001-6737-5219 Seok Ju Seong http://orcid.org/0000-0003-3820-3412 Mi Kyoung Kim http://orcid.org/0000-0002-9520-2339Da Hee Kim,1 Seok Ju Seong,1 Mi Kyoung Kim,1 Hyo Sook Bae,1 Mi-La Kim,1   Bo Seong Yun,1 Yong Wook Jung,1 Jeong Yun Shim2 1Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea 2Department of Pathology, CHA Gangnam Medical Center, CHA University, Seoul, KoreaDilatation and curettage is more  accurate than endometrial aspiration  biopsy in early-stage endometrial  cancer patients treated with high  dose oral progestin and levonorgestrel  intrauterine system",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
2/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment Hyo Sook Bae http://orcid.org/0000-0001-8829-6480 Mi-La Kim http://orcid.org/0000-0003-1011-5664 Bo Seong Yun http://orcid.org/0000-0003-4352-1693 Yong Wook Jung http://orcid.org/0000-0003-2098-8143 Jeong Yun Shim http://orcid.org/0000-0001-9367-2233 Conflict of Interest No potential conflict of interest relevant to this  article was reported.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
"Of the seven samples diagnosed as normal by  using D&C biopsy, three samples also had normal results in the EM aspiration biopsy and  3/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment Fig.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
"For patients who are contraindicated to receive oral  progestin or those with complaints of systemic side effects, LNG-IUS, which works locally  4/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment Table 1.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
5/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
PUBMED  | CROSSREF 6/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
PUBMED  | CROSSREF 7/7 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e1D&C in endometrial cancer after progestin treatment,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jgo-28-e1.PMC5165062.pdf
1/22 http://ejgo.orgABSTRACT Clinical practice guidelines for gynecologic cancers have been developed by many  organizations.,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"2017 Jan;28(1):e12 https://doi.org/10.3802/jgo.2017.28.e12 pISSN 2005-0380·eISSN 2005-0399 Practice Guideline Received:  Oct 7, 2016 Accepted:  Oct 16, 2016 Correspondence to Taek Sang Lee Department of Obstetrics and Gynecology,  Seoul Metropolitan Government Seoul  National University Borame Medical  Center, Seoul National University College of  Medicine, 20 Boramae-ro 5-gil, Dongjak-gu,  Seoul 07061, Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"ORCID Shin-Wha Lee http://orcid.org/0000-0002-5088-1905 Taek Sang Lee http://orcid.org/0000-0001-8119-5601 Jae Hong No http://orcid.org/0000-0002-2389-6757 Dong Choon Park http://orcid.org/0000-0001-9485-4987 Jae Man Bae http://orcid.org/0000-0001-7453-1443 Seok Ju Seong http://orcid.org/0000-0003-3820-3412 Keun Ho Lee http://orcid.org/0000-0001-9005-7796 Yoo Kyung Lee http://orcid.org/0000-0002-0621-8030Shin-Wha Lee,1 Taek Sang Lee,2 Dae Gy Hong,3 Jae Hong No,4 Dong Choon Park,5  Jae Man Bae,6 Seok Ju Seong,7 So-Jin Shin,8 Woong Ju,9 Keun Ho Lee,10   Yoo Kyung Lee,11 Hanbyoul Cho,12 Chulmin Lee,13 Jiheum Paek,14 Hyun-Jung Kim,15  Jeong-Won Lee,16 Jae-Weon Kim,17 Duk-Soo Bae16 1 Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea 2 Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University  Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea 3 Department of Obstetrics and Gynecology, Kyungpook National University Medical Center, Kyungpook  National University School of Medicine, Daegu, Korea 4 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National  University College of Medicine, Seongnam, Korea 5 Department of Obstetrics and Gynecology, St. Vincent’s Hospital, College of Medicine, The Catholic  University of Korea, Suwon, Korea 6Department of Obstetrics and Gynecology, Hanyang University Medical Center, Seoul, Korea 7Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea 8Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea 9Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea 10 Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic  University of Korea, Seoul, Korea 11 Department of Obstetrics and Gynecology, Cheil General Hospital & Women’s Healthcare Center, Dankook  University College of Medicine, Seoul, Korea 12 Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of  Medicine, Seoul, Korea 13Department of Obstetrics and Gynecology, Sanggye Paik Hospital, Inje University, Seoul, Korea 14Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea 15Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea 16 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea 17Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, KoreaPractice guidelines for management  of uterine corpus cancer in Korea:  a Korean Society of Gynecologic  Oncology Consensus Statement",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
Jiheum Paek http://orcid.org/0000-0003-3964-5925 Jeong-Won Lee http://orcid.org/0000-0002-6945-0398 Jae-Weon Kim http://orcid.org/0000-0003-1835-9436 Funding All costs related to the consensus conference  were covered from the Korean Society of  Gynecologic Oncology (KSGO) central funds.,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"In doing so, they: 1) considered the rapidly advancing developments  in precision medicines and analyzed and applied the results of up-to-date clinical trials,  including target therapies; 2) accepted and included the recently revised World Health  2/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
The histopathological classification recommended by the Gynecological Pathology Study  Group of the KSP was used as the histopathological classification of these guidelines on  3/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea Table 1.,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"However, pelvic lymphadenectomy  may be omitted in patients who are predicted to have a very low risk of lymph node  4/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
Our  5/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
6/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"Well-known clinicopathologic prognostic factors predicting  recurrence are FIGO stage, tumor grade, histologic type (endometrioid vs. serous and  7/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
8/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
9/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"Other toxic events (grade ≥3) that occurred more  often with TAP were neutropenia, thrombocytopenia, nausea, vomiting, diarrhea, and  10/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
11/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
4) Treatment for metastasis and recurrence (1) Management for locally recurred uterine sarcoma Management for locally recurred uterine sarcoma is determined by the presence or absence  12/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
13/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
"•  If the lesion of papillary serous adenocarcinoma/clear cell carcinoma/carcinosarcoma  is limited to the endometrium, no adjuvant treatment or chemotherapy or pelvic RT is  14/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea",Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
The authors would  like to thank Enago ( http://www.enago.co.kr ) for medical writing assistance and English  language review.,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
15/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 16/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 17/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 18/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 19/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 20/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 21/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
PUBMED  | CROSSREF 22/22 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e12Practice guidelines for uterine corpus cancer in Korea,Non-OADS,/arxiv_data1/oa_pdf/61/e6/jgo-28-e12.PMC5165063.pdf
1/13 http://ejgo.orgABSTRACT Objective:  To evaluate the efficacy and toxicity of paclitaxel plus carboplatin (TC)-based  concurrent chemoradiotherapy (CCRT) followed by consolidation chemotherapy in the  International Federation of Gynecology and Obstetrics (FIGO) stage IIIB/IVA cervical cancer  patients.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
"2017 Jan;28(1):e15 https://doi.org/10.3802/jgo.2017.28.e15 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Aug 30, 2016 Revised:  Oct 5, 2016 Accepted:  Nov 10, 2016 Correspondence to Seiji Mabuchi Department of Obstetrics and Gynecology,  Osaka University, Graduate School of Medicine,  2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.",Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
"ORCID Seiji Mabuchi http://orcid.org/0000-0003-1803-1166 Fumiaki Isohashi http://orcid.org/0000-0001-6342-4693 Mika Okazawa http://orcid.org/0000-0002-6439-856X Fuminori Kitada http://orcid.org/0000-0001-7387-0814 Shintaro Maruoka http://orcid.org/0000-0002-0239-7107Seiji Mabuchi,1 Fumiaki Isohashi,2 Mika Okazawa,1 Fuminori Kitada,3   Shintaro Maruoka,4 Kazuhiko Ogawa,2 Tadashi Kimura1 1Department of Obstetrics and Gynecology, Osaka University, Graduate School of Medicine, Osaka, Japan 2Department of Radiation Oncology, Osaka University, Graduate School of Medicine, Osaka, Japan 3Department of Obstetrics and Gynecology, Suita Tokusyukai Hospital, Osaka, Japan 4Department of Radiology, Suita Tokusyukai Hospital, Osaka, JapanChemoradiotherapy followed by  consolidation chemotherapy involving  paclitaxel and carboplatin and in FIGO  stage IIIB/IVA cervical cancer patients",Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
Kazuhiko Ogawa http://orcid.org/0000-0001-8872-7690 Tadashi Kimura http://orcid.org/0000-0002-4391-6866 Funding This study was supported in part by Grant- in-aid for General Scientific Research No.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
2/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
Chemotherapies 1) Concurrent chemotherapy Chemotherapy consisting of paclitaxel (35 mg/m2) and carboplatin (area under the curve  3/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
4/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer A Time (mo)0.6 0.4 0.2 0 12 24 36 48Progression-free survival0.81.0B CEBRT + brachytherapy Radiotherapy Chemotherapy Weekly TC × /five.LP Triweekly TC × /three.LP Concurrent chemotherapy  Maintenance chemotherapy Time (mo)0.6 0.4 0.2 0 12 24 36 48Overall survival0.81.0 Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
Twenty-four patients had tumors that displayed squamous cell carcinoma  5/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
6/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer Table 1.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
"Grade 3–4 late toxicities occurred in 6 patients (20.0%):  a vesicovaginal fistula in one patient, rectal bleeding in 3 patients, and hydronephrosis in  7/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer Table 2.",Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
The  8/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer A B TC-CCRT RTCCRTTC-CCRT RTCCRT Time (mo)0.6 0.4 0.2 0 12 24 36 48Progression-free survival0.81.0 Time (mo)0.6 0.4 0.2 0 12 24 36 48Overall survival0.81.0 Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
[ 15] investigated the  feasibility of combining weekly paclitaxel (60 mg/m2) and weekly carboplatin (AUC: 2) with  9/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer Table 4.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
10/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT01755845.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT01414608.,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
11/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
PUBMED  | CROSSREF 12/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
PUBMED  | CROSSREF 13/13 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e15TC-based CCRT for cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/93/c4/jgo-28-e15.PMC5165064.pdf
"1/2 http://ejgo.org► See the article “Fertility preserving treatment with hysteroscopic resection followed by progestin  therapy in young women with early endometrial cancer” in volume 28, e2.",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/jgo-28-e16.PMC5165065.pdf
"2017 Jan;28(1):e16 https://doi.org/10.3802/jgo.2017.28.e16 pISSN 2005-0380·eISSN 2005-0399 Editorial Received:  Nov 13, 2016 Accepted:  Nov 14, 2016 Correspondence to Jeong-Yeol Park Department of Obstetrics and Gynecology,  University of Ulsan College of Medicine,  Asan Medical Center, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/jgo-28-e16.PMC5165065.pdf
"ORCID Jeong-Yeol Park http://orcid.org/0000-0003-2475-7123 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Jeong-Yeol Park  Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center,  Seoul, KoreaHysteroscopy in fertility-sparing  management for early endometrial  cancer: a double-edged sword",Non-OADS,/arxiv_data1/oa_pdf/3e/d6/jgo-28-e16.PMC5165065.pdf
PUBMED  | CROSSREF 2/2 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e16Hysteroscopy in fertility-sparing management for endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/3e/d6/jgo-28-e16.PMC5165065.pdf
"1/2 http://ejgo.org► See the article “Genetic screening in young women diagnosed with endometrial cancer” in volume  28, e4.",Non-OADS,/arxiv_data1/oa_pdf/e3/73/jgo-28-e17.PMC5165066.pdf
"2017 Jan;28(1):e17 https://doi.org/10.3802/jgo.2017.28.e17 pISSN 2005-0380·eISSN 2005-0399 Editorial Received:  Nov 13, 2016 Accepted:  Nov 14, 2016 Correspondence to Min Kyu Kim Department of Obstetrics and Gynecology,  Samsung Changwon Hospital, Sungkyunkwan  University School of Medicine, 158 Paryong-ro,  Masanhoiwon-gu, Changwon 51353, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e3/73/jgo-28-e17.PMC5165066.pdf
"ORCID Min Kyu Kim http://orcid.org/0000-0002-1937-3611 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Min Kyu Kim Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School  of Medicine, Changwon, KoreaThe gate-keeping role of surgeons  with regard to endometrial cancers in  Lynch syndrome",Non-OADS,/arxiv_data1/oa_pdf/e3/73/jgo-28-e17.PMC5165066.pdf
PUBMED  | CROSSREF 2/2 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e17Surgeons’ role in endometrial cancer about Lynch syndrome,Non-OADS,/arxiv_data1/oa_pdf/e3/73/jgo-28-e17.PMC5165066.pdf
1/12 http://ejgo.orgABSTRACT Objective:  To report our 15-year institutional experience of fertility-sparing treatment  in young patients with early endometrial cancer (EC) treated by combined hysteroscopic  resection and progestin therapy.,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"2017 Jan;28(1):e2 https://doi.org/10.3802/jgo.2017.28.e2 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Jun 3, 2016 Revised:  Jul 22, 2016 Accepted:  Jul 22, 2016 Correspondence to Stefano Greggi Gynecologic Oncology Surgery, National  Cancer Institute of Naples-IRCCS “Fondazione  G. Pascale”, Via M. Semmola, Naples 80131, Italy.",Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"ORCID Francesca Falcone http://orcid.org/0000-0002-3729-2321 Giuseppe Laurelli http://orcid.org/0000-0001-6739-3687 Simona Losito http://orcid.org/0000-0001-9045-0328 Marilena Di Napoli http://orcid.org/0000-0003-4516-7341 Vincenza Granata http://orcid.org/0000-0002-6601-3221 Stefano Greggi http://orcid.org/0000-0001-5601-5111 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Francesca Falcone,1,2 Giuseppe Laurelli,1 Simona Losito,3 Marilena Di Napoli,4  Vincenza Granata,5 Stefano Greggi1 1  Gynecologic Oncology Surgery, National Cancer Institute of Naples-IRCCS “Fondazione G. Pascale”,  Naples, Italy 2Department of Woman, Child, and General and Specialized Surgery, Second University of Naples, Naples, Italy 3Surgical Pathology Unit, National Cancer Institute of Naples-IRCCS “Fondazione G. Pascale”, Naples, Italy 4 Division of Medical Oncology, Department of Uro-Gynaecological Oncology, National Cancer Institute of  Naples-IRCCS “Fondazione G. Pascale”, Naples, Italy 5Radiology Unit, National Cancer Institute of Naples-IRCCS “Fondazione G. Pascale”, Naples, ItalyFertility preserving treatment with  hysteroscopic resection followed by  progestin therapy in young women  with early endometrial cancer",Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
2/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
3/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment Table 1.,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"The remaining four patients, who did not  4/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment",Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
5/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment Table 2.,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"In a recent meta-analysis,  although preoperative hysteroscopy resulted in a significantly increase of positive peritoneal  6/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment Table 4.",Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
The 96.3% complete regression rate observed in our G1 patients suggests that the addition  7/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
8/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment Table 5.,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"In our series, 11 out of 15 patients attempting  9/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment",Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
PUBMED  | CROSSREF 10/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf  22.,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
PUBMED  | CROSSREF 11/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
PUBMED  | CROSSREF 12/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e2Endometrial cancer conservative treatment,Non-OADS,/arxiv_data1/oa_pdf/53/0a/jgo-28-e2.PMC5165067.pdf
"1/2 http://ejgo.org► See the article “Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific  survival in patients with ovarian cancer” in volume 28, e7.",Non-OADS,/arxiv_data1/oa_pdf/65/2a/jgo-28-e21.PMC5165068.pdf
"2017 Jan;28(1):e21 https://doi.org/10.3802/jgo.2017.28.e21 pISSN 2005-0380·eISSN 2005-0399 Editorial Received:  Nov 29, 2016 Accepted:  Nov 29, 2016 Correspondence to Sokbom Kang Center for Uterine Cancer, National Cancer  Center, 323 Ilsan-ro, Ilsandong-gu, Goyang  10408, Korea.",Non-OADS,/arxiv_data1/oa_pdf/65/2a/jgo-28-e21.PMC5165068.pdf
"ORCID Sokbom Kang http://orcid.org/0000-0002-8428-9555 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Sokbom Kang Center for Uterine Cancer, National Cancer Center, Goyang, KoreaDo we need a better marker for  successful ovarian cancer surgery?",Non-OADS,/arxiv_data1/oa_pdf/65/2a/jgo-28-e21.PMC5165068.pdf
PUBMED  | CROSSREF 2/2 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e21A better marker for successful ovarian cancer surgery,Non-OADS,/arxiv_data1/oa_pdf/65/2a/jgo-28-e21.PMC5165068.pdf
1/4 http://ejgo.orgThe 4th International Workshop of the Asian Society of Gynecologic Oncology (ASGO) was  held in the Sendai International Center on 12 November 2016.,Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
"2017 Jan;28(1):e24 https://doi.org/10.3802/jgo.2017.28.e24 pISSN 2005-0380·eISSN 2005-0399 Meeting Report Received:  Nov 30, 2016 Accepted:  Dec 1, 2016 Correspondence to Masafumi Toyoshima Department of Obstetrics and Gynecology,  Tohoku University School of Medicine,   1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi  980-8574, Japan.",Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
"ORCID Yusuke Shibuya http://orcid.org/0000-0001-9295-4108 Masafumi Toyoshima http://orcid.org/0000-0001-8199-9917 Conflict of Interest No potential conflicts of interest relevant to  this article was reported.Yusuke Shibuya, Masafumi Toyoshima, Nobuo Yaegashi Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, JapanASGO 4th International Workshop on  Gynecologic Oncology",Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
2/4 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e24ASGO 4th International Workshop Table 1.,Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
3/4 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e24ASGO 4th International Workshop,Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
"Affiliations of the speakers •  Takahide Arimoto, Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan •  Tadao Takano, Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan •  Ryo Kitagawa, Department of Gynecology and Obstetrics, Tohoku Medical and Pharmaceutical University, Sendai, Japan • Chunling Chen, Department of Obstetrics and Gynecology, Beijing Jadecare Medical Hospital, Beijing, China •  Nao Suzuki, Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kanagawa, Japan •  Toyomi Satoh, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan •  Sarikapan Wilailak, Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand • Hidemichi Watari, Department of Gynecology, Hokkaido University, Hokkaido, Japan 4/4 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e24ASGO 4th International Workshop",Non-OADS,/arxiv_data1/oa_pdf/de/8f/jgo-28-e24.PMC5165069.pdf
"1/5 http://ejgo.orgUterine carcinosarcoma (UCS) is a relatively rare tumor in gynecologic malignancy that  comprises less than 5% of uterine cancers, but it often shows an aggressive phenotype that  has contributed to 30% of uterine cancer deaths [ 1].",Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
"2017 Jan;28(1):e25 https://doi.org/10.3802/jgo.2017.28.e25 pISSN 2005-0380·eISSN 2005-0399 Correspondence Received:  Sep 9, 2016 Revised:  Oct 20, 2016 Accepted:  Dec 1, 2016 Correspondence to Kosei Hasegawa Department of Gynecologic Oncology,  Saitama Medical University International  Medical Center, 1397-1 Yamane, Hidaka,  Saitama 350-1298, Japan.",Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
"ORCID Tadaaki Nishikawa http://orcid.org/0000-0003-2606-4208 Kosei Hasegawa http://orcid.org/0000-0002-1903-7001 Akira Yabuno http://orcid.org/0000-0002-1221-0609 Hiroyuki Yoshida http://orcid.org/0000-0002-0618-3800 Masanori Yasuda http://orcid.org/0000-0002-0769-360X Eito Kozawa http://orcid.org/0000-0002-4260-4668Tadaaki Nishikawa,1 Kosei Hasegawa,1 Akira Yabuno,1 Hiroyuki Yoshida,1   Masanori Yasuda,2 Eito Kozawa,3 Keiichi Fujiwara1 1Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama,  Japan 2Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan 3Department of Diagnostic Radiology, Saitama Medical University International Medical Center, Saitama,  JapanPazopanib as a second line treatment  for uterine and ovarian carcinosarcoma:  a single institutional study",Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
Keiichi Fujiwara http://orcid.org/ 0000-0002-7388-0243 Conflict of Interest No potential conflict of interest relevant to this  article was reported.who were responsive to pazopanib as a second or third line chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
2/5 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e25Pazopanib for uterine and ovarian carcinosarcoma Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
"However, existing chemotherapy for CS shows limited  3/5 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e25Pazopanib for uterine and ovarian carcinosarcoma A B C D Fig.",Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
PUBMED  | CROSSREF 4/5 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e25Pazopanib for uterine and ovarian carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
Available from: https://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#uterine .,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
PUBMED  | CROSSREF 5/5 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e25Pazopanib for uterine and ovarian carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/ad/db/jgo-28-e25.PMC5165070.pdf
1/8 http://ejgo.orgABSTRACT Objective:  Most BRCA1/2  carriers do not undergo risk-reducing salpingo-oophorectomy  (RRSO) by the recommended age.,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
"2017 Jan;28(1):e3 https://doi.org/10.3802/jgo.2017.28.e3 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Jul 4, 2016 Revised:  Jul 26, 2016 Accepted:  Jul 26, 2016 Correspondence to Shin-Wha Lee Department of Obstetrics and Gynecology,  Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
"ORCID Young-Jae Lee http://orcid.org/0000-0001-6557-2454 Shin-Wha Lee http://orcid.org/0000-0002-5088-1905 Kyung-Hae Jung http://orcid.org/0000-0002-1580-7224 Jong-Won Lee http://orcid.org/0000-0001-7875-1603 Yong-Man Kim http://orcid.org/0000-0003-3225-5748 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Young-Jae Lee,1 Shin-Wha Lee,1 Kyu-Rae Kim,2 Kyung-Hae Jung,3 Jong-Won Lee,4  Yong-Man Kim1 1 Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea 2Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 3Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 4Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaPathologic findings at risk-reducing  salpingo-oophorectomy (RRSO) in  germline BRCA  mutation carriers with  breast cancer: significance of bilateral  RRSO at the optimal age in germline  BRCA  mutation carriers",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
2/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
"In the BRCA2  mutation  group, precursor lesions were only detected in patients who were older than 40 when they  3/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers Table 1.",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
"In BRCA1/2  mutation carriers with breast cancer history,  4/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers Table 3.",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
"Eight patients were found to have occult cancer from 2010 to 2014, and only one  5/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
6/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
CROSSREF 7/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
PUBMED  | CROSSREF 8/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e3Pathologic findings in BRCA mutation carriers,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/jgo-28-e3.PMC5165071.pdf
1/11 http://ejgo.orgABSTRACT Objective:  To evaluate the importance of Lynch syndrome associated risk screening in the  patients aged less than 50 years affected from endometrial cancer.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
"2017 Jan;28(1):e4 https://doi.org/10.3802/jgo.2017.28.e4 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Jun 1, 2016 Revised:  Aug 1, 2016 Accepted:  Aug 4, 2016 Correspondence to Basilio Pecorino Division of Gynecology and Obstetrics,  Maternal and Child Department, Cannizzaro  Hospital, Via Messina 829, Catania 95126, Italy.",Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
"ORCID Basilio Pecorino http://orcid.org/0000-0001-6987-4193 Cinzia Rubino http://orcid.org/0000-0002-8107-9069 Vito Fabio Guardalà http://orcid.org/0000-0002-2433-7308 Antonio Galia http://orcid.org/0000-0002-2659-3487 Paolo Scollo http://orcid.org/0000-0001-6275-7488 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Basilio Pecorino,1 Cinzia Rubino,2 Vito Fabio Guardalà,1 Antonio Galia,3   Paolo Scollo1 1Division of Gynecology and Obstetrics, Maternal and Child Department, Cannizzaro Hospital, Catania, Italy 2Division of Gynecology and Obstetrics, Magati Hospital, Scandiano AUSL Reggio Emilia, Scandiano, Italy 3Department of Pathology, Cannizzaro Hospital, Catania, ItalyGenetic screening in young women  diagnosed with endometrial cancer",Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
2/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
3/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
MLH1  4/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer B A Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
"In our cohort, only 33% (3/9) of MSI-H/L patients fulfill the Amsterdam criteria, while the  remaining 67% (6/9) of patients do not have family cancer risk or previous cancers related to  5/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer Immunohistochemistry MLH/one.LP Molecular analysis MLH/one.LP negative A BUnstable StablePositive Negative Dubious/five.LP; /seven.LP/one.LP% /three.LP/three.LP; /eight.LP/one.LP%/seven.LP; /one.LP/seven.LP%/one.LP; /two.LP% /two.LP; /two.LP/nine.LP% Fig.",Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
Patient was treated  6/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer A B  CBAT/two.LP/five.LP A/one.LP/one.LP A/one.LP/zero.LP B/one.LP C/five.LP A/one.LP A/five.LP B/six.LP C/six.LP B/one.LP A/seven.LP B/one.LP/one.LP C/two.LPBAT/two.LP/six.LP NR/two.LP/seven.LP BAT/two.LP/five.LP BAT/two.LP/six.LP NR/two.LP/seven.LP BAT/two.LP/five.LP BAT/two.LP/six.LP NR/two.LP/seven.LP Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
A great  7/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
8/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
9/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
Available from: http://www.medscape.com/viewarticle/842496  8.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
PUBMED  | CROSSREF 10/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp  19.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp  20.,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
PUBMED  | CROSSREF 11/11 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e4Genetic screening in endometrial cancer,Non-OADS,/arxiv_data1/oa_pdf/53/5e/jgo-28-e4.PMC5165072.pdf
1/8 http://ejgo.orgABSTRACT The Surgery Treatment Modality Committee of the Korean Gynecologic Oncologic Group  (KGOG) has determined to develop a surgical manual to facilitate clinical trials and to improve  communication between investigators by standardizing and precisely describing operating  procedures.,Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"2017 Jan;28(1):e5 https://doi.org/10.3802/jgo.2017.28.e5 pISSN 2005-0380·eISSN 2005-0399 Surgical Manual Received:  Jul 26, 2016 Accepted:  Aug 5, 2016 Correspondence to Ju-Won Roh Department of Obstetrics and Gynecology,  Dongguk University Ilsan Hospital, Dongguk  University College of Medicine, 27 Dongguk-ro,  Ilsandong-gu, Goyang 10326, Korea.",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"ORCID Maria Lee http://orcid.org/0000-0002-8017-3176 Yun Hwan Kim http://orcid.org/0000-0001-9498-2938 Kwang Beom Lee http://orcid.org/0000-0003-4634-176X Shin-Wha Lee http://orcid.org/0000-0002-5088-1905 Seung-Hyuk Shim http://orcid.org/0000-0001-8043-2257 Yong-Jung Song http://orcid.org/0000-0002-6103-2466 Ju-Won Roh http://orcid.org/0000-0002-2449-8742Maria Lee,1 Chel Hun Choi,2 Yi Kyeong Chun,3 Yun Hwan Kim,4 Kwang Beom Lee,5  Shin-Wha Lee,6 Seung-Hyuk Shim,7 Yong-Jung Song,8 Ju-Won Roh,9   Suk-Joon Chang,10 Jong-Min Lee11 1Department of Obstetrics and Gynaecology, Seoul National University College of Medicine, Seoul, Korea 2 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea 3 Department of Pathology, Cheil General Hospital & Women’s Healthcare Center, Dankook University  College of Medicine, Seoul, Korea 4 Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans  University School of Medicine, Seoul, Korea 5 Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Gachon University  College of Medicine, Incheon, Korea 6 Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea 7 Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University  School of Medicine, Seoul, Korea 8 Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National  University School of Medicine, Yangsan, Korea 9 Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Dongguk University College  of Medicine, Goyang, Korea 10Departments of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea 11 Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Kyung Hee  University School of Medicine, Seoul, KoreaSurgical manual of the Korean  Gynecologic Oncology Group:  classification of hysterectomy and  lymphadenectomy",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"However, several limitations, including inconsistencies in terminology, drawbacks  associated with a uterocentric concept, exclusion of nerve-sparing and fertility-preserving  techniques, and difficulties adapting the guidelines to advances in vaginal, laparoscopic, or  2/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy Suk-Joon Chang http://orcid.org/0000-0002-0558-0038 Jong-Min Lee http://orcid.org/0000-0002-0562-5443 Conflict of Interest No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
3/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy Table 1.,Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
4/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy,Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"5/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy □CIN 1(milddysplasia) □CIN 2(moderatedysplasia)□CIN 3(severedysplasia&CIS) □Squamouscellcarcinoma□Adenocarcinoma □Adenosquamouscellcarcinoma      Operationrecordformforcervicalcancer       Generalinformation PatientID Name Operationdate Operator Assistant FIGOstaging □Ia1□Ia2□Ib1□Ib2□IIa1□IIa2□IIb□IIIa□IIIb□IVa□IVb Preoperativehistologicdiagno sis       □Neuroendocrinecarcinoma□Others( ) Diseasestatus □Primarydisease □Afterneoadjuvantchemotherapy □Afterchemoradiation □Recu rrentdisease □Others( ) Preoperativetumormarker □SCC-Ag( )□CA-125( )□CEA( ) Anesthesia □General□Spinal □Epidural □Local □Others Patient'sposition □Supine□Lithotomy□Others Approach Laparotomy □Lower midline incision□Extendedlowermidlineincision □Pfannenstiel’sincision □Maylardincision □Others( ) Minimally invasive surgery □Laparoscopic □Portnumbers( ) □Robo tic □Portnumbers( ) Conversion□No □Yes from( )to( ) Reas on □Bleeding □Adhesion □Organ injury □Otherorganinvasion□Others( ) Operationtype:Hysterect omy(KGOG classification) □Conization □LLETZ (LEEP) □Coldknifeconizatio n □Trachelectomy(cervicectomy) □TypeA(T) Minimumresectionofparacerv ix(simpletrachelectomy; simplecervicectomy) □TypeB(T) Transectio noftheparacerv ixattheureter(radicaltrachelectomy; radicalcervicectomy)□TypeA Minimumresectionofparacerv ix (extrafascial hysterectomy) □TypeB Transectionoftheparacervixattheureter (modified radical hysterectomy)   PelvicLN/Level1 □RtLNS□RtLND□LtLNS□LtLND CommoniliacLN/Level2 □RtLNS□RtLND□LtLNS□LtLND Para-aorticLN(infra-IMA)/Level3□LNS□LND    Para-aorticLN(infra-rena l)/Level4□LNS□LND           □Hysterect omy       □Right □Left □TypeC1 Transectio nofparacerv ixatthejunctionwiththeinternaliliacvascularsystem withnervepreservation (nerve-sparingradicalhysterectomy) □Right □Left □TypeC2 Transectio nofparacerv ixatthejunctionwiththeinternaliliacvascularsystem without nervepreservation (conventionalradicalhysterectomy) □Right □Left □TypeD1 Resectio noftheentireparacerv ixalongwiththeinternaliliacvessels □Bladder □Rectum □ Inferiorglutealvessel □Internalpudendalvessel □Obturatorvessel □Others( ) □TypeD2 Resectio noftheentireparacerv ix,withtheinternaliliacvesselsandadjacentfascialor muscular structure   (specifysite: ) □Aborted (specifythereason: ) □Others ( ) Operationtype:Lymphadenectomy(KGOGclassification) □None           □Debulking (specifysite: ) □Others ( ) Combinedprocedures Oophorectomy □Right □Left □Bilateral Salpingectomy □Right □Left □Bilateral Ovariancystectomy □Right □Left □Bilateral Ovariantransposition □Right □Left □Bilateral □Otheroperation1 (surgeon: )(procedure: ) □Otheroperation2 (surgeon: )(procedure: ) Intraoperativefindings Frozenbiopsy Ascites Adhesion□No □No □No□Yes □Yes □Yes(specify, ifyes: ) ( mL) (specify, ifyes: ) Suspiciousinvasiontoadjacentorgan □No □Yes □Vagina ( ) □Paracerv ix ( ) □Vesicouterineligament      ( )   □Uterosacralligament ( )        Lymphnodeenlargement □No □Yes (specify,ifyes: ) Nervepreservationprocedure □No □Yes identify nerve,ifyes □ Superiorhypogastricplexus □Righthypogastricnerve□Lefthypogastricnerve □Rightpelvicplexus □Leftpelvicplexus □Rightbladderbranch □Leftbladderbranch Specimenexaminationduringsurgery Sizeofprimarytumor ( cmoflargestdiameter) Rightparacerv ix width ( cm)length ( cm) Leftparacervix width ( cm)length ( cm) Vaginallength ( cm) Anti-adhesiveused □No □Yes ( ) Intraoperativeinjury □Ureter (specify, ifyes: ) □Vessel (specify, ifyes: ) □Nerve (specify, ifyes: ) □Others (specify, ifyes: ) Estimatedbloodloss ( mL) Transfusion □No □Yes (p-RBC pint, Pltconc pint, FFP pint, WB pint) Drain     Gauzecount □No Location □Checked□Yes □LLQ□RLQ□LUQ□RUQ□Others( ) □Notchecked Woundclosure    Peritoneum Fascia Subcutaneous Skin□No □No □No □No□Yes □Yes □Yes □Yes  Remarks       Fig.",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"6/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy          Pathologicreportformforcervicalcancer(excision)       Operation: □Coldknifeconizatio n □Loopelectrosurgicalexcisionprocedure (LEEP) □Other(specify)     Tumorsite:uterinecervix □Leftsuperiorquadrant(12to3o’clock), □Leftinferiorquadrant(3to6o’clock) □Rightinferiorquadrant(6to9o’clock) □Rightsuperiorquadrant(9to12o’clock) □Other(specify)     Histologictype:□Microinvasive(T1a1,T1a2)□Invasive □Squamouscellcarcinoma □Adenocarcinoma □Endocervical,usualtype □Mucinous  (gastric/intestinal/signet-ringcell) □Villoglandular □Endometrioid □Clearcell □Serous □Other(specify) □Other(specify)     Histologicgrade: □Keratinizing□Non-keratinizing □G1□G2□G3□Cannotbeassessed□Notapplicab le     Tumorsize: □Microinvasive Depth: mm   Horizontalextent: mm □Invasive Greatestdimension: cm   Additio naldimensions(optional): × cm Depth: mm        Margin:   (1)EndocervicalMargin: □Notinvolved: mm freefrom margin(specify location,  ifpossible) □Involvedbyinvasivecarcinoma/HSIL/LSIL/AIS(specifylocation, ifpossible) (2)ExocervicalMargin: □Notinvolved: mm freefrom margin(specify location,  ifpossible) □Involvedbyinvasivecarcinoma/HSIL/LSIL/AIS(specifylocation, ifpossible) (3)DeepMargin: □Notinvolved: mm freefrom margin(specify location,  ifpossible) □Involvedbyinvasivecarcinoma/HSIL/LSIL/AIS(specifylocation, ifpossible)     Vascular/lymphaticinvasion: □Absent □Present □Indeterminate Fig.",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
"ACKNOWLEDGMENTS For a clearer understanding of this KGOG classification of hysterectomy and  lymphadenectomy, a medical animation was produced by the HealthBreeze Corp. and is  available on the KGOG website (http://goo.gl/aSuRo1).",Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
PUBMED  | CROSSREF 7/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy,Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
PUBMED  | CROSSREF 8/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e5Classification of hysterectomy and lymphadenectomy,Non-OADS,/arxiv_data1/oa_pdf/89/62/jgo-28-e5.PMC5165073.pdf
1/8 http://ejgo.orgABSTRACT The Surgery Treatment Modality Committee of the Korean Gynecologic Oncology Group  has determined to develop a surgical manual to facilitate clinical trials and to improve  communication between investigators by standardizing and precisely describing operating  procedures.,Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"2017 Jan;28(1):e6 https://doi.org/10.3802/jgo.2017.28.e6 pISSN 2005-0380·eISSN 2005-0399 Surgical Manual Received:  Aug 16, 2016 Accepted:  Aug 16, 2016 Correspondence to Sang Wun Kim Division of Gynecologic Oncology, Department  of Obstetrics and Gynecology, Women’s  Cancer Center, Yonsei Cancer Center, Institute  of Women’s Life Medical Science, Severance  Hospital, Yonsei University College of  Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul  03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"ORCID Seob Jeon http://orcid.org/0000-0001-5230-1997 Sung Jong Lee http://orcid.org/0000-0002-6077-2649 Myong Cheol Lim http://orcid.org/0000-0001-8964-7158 Taejong Song http://orcid.org/0000-0003-0288-1254 Jaeman Bae http://orcid.org/0000-0001-7453-1443 Kidong Kim http://orcid.org/0000-0001-9254-6024 Jung-Yun Lee http://orcid.org/0000-0001-7948-1350Seob Jeon,1 Sung Jong Lee,2 Myong Cheol Lim,3 Taejong Song,4 Jaeman Bae,5  Kidong Kim,6 Jung-Yun Lee,7 Sang Wun Kim,7 Suk-Joon Chang,8 Jong-Min Lee9 1 Department of Obstetrics and Gynecology, Soonchunhyang University Cheonan Hospital, Soonchunhyang  University College of Medicine, Cheonan, Korea 2 Department of Obstetrics and Gynecology, St. Vincent’s Hospital, College of Medicine, The Catholic  University of Korea, Suwon, Korea 3 Center for Uterine Cancer and Gynecologic Cancer Branch, Research Institute and Hospital, National  Cancer Center, Goyang, Korea 4 Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School  of Medicine, Seoul, Korea 5 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hanyang University College  of Medicine, Seoul, Korea 6 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National  University College of Medicine, Seongnam, Korea 7 Women’s Cancer Center, Yonsei Cancer Center, Department of Obstetrics and Gynecology, Severance  Hospital, Yonsei University College of Medicine, Seoul, Korea 8 Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Ajou University School of  Medicine, Suwon, Korea 9 Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Kyung Hee  University School of Medicine, Seoul, KoreaSurgical manual of the Korean  Gynecologic Oncology Group: ovarian,  tubal, and peritoneal cancers",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"Sang Wun Kim http://orcid.org/0000-0002-8342-8701 Suk-Joon Chang http://orcid.org/0000-0002-0558-0038 Jong-Min Lee http://orcid.org/0000-0002-0562-5443 Funding This work was supported in part by the grant  (NCC1310311 and NCC1610070) of the National  Cancer Center, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"Pelvic and para-aortic lymph node should be systematically  2/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"3/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers Table 1.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"4/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers Table 2.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"5/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers       Operationrecordformforovarian,tubal,andperitonealcancers       Generalinformation   PatientID Name Operationdate Operator Assistant FIGOstaging □IA□IB□IC1□IC2□IC3□IIA□IIB□IIIA1(i)□IIIA1(ii)□IIIA2□IIIB□IIIC□IVA□IVB   Primarysite □Ovary □Fallopiantube □Peritoneum □Unknown   Diseasestatus □Primarydisease □Afterneoadjuvantchemotherapy □Re-staging □Recurrentdisease □Others( )   Preoperativetumormarker □CA-125( )□CA-19-9( )□HE-4( )□CEA( )□Others( )   Anesthesia □General□Spinal □Epidural □Local □Others   Patient'sposition □Supine □Lithotomy□Others   Approach Laparotomy □Midlineincisionfromxiphoidprocesstosymphysispubis □Lowermidlineincision □Pfannenstiel'sincision□Maylardincision□Others ( )   Minimally invasive surgery □Laparoscopic□Portnumbers( ) □Robo tic □Portnumbers( ) Conversion□No □Yesfrom ( )to( ) Reas on □Bleeding □Adhesion □Organ injury □Otherorganinvasion□Others ( )   Operation     Fertilitypreservation□No □Yes  Hysterectomy□No □Yes    □TypeA □TypeB □TypeC          Salpingo-oophorectomy,Left                           □No                             □Biopsy                      □Yes Right □No □Biopsy □Yes Peritonectomy        □No                           □Yes                          □Biopsy Pelvic □Leftsidewall□Rightsidewall□Bladderserosa□Cul-de-sac Abdominal□Left □Right Diaphragmatic       □Left                          □Right Omentectomy           □No                              □Yes □Biopsy □Infracolic □Total Bowelresection□No □Yes(specify,ifyes: ) Prophylactic stomy□No □Yes(specify,ifyes: ) Permanentstomy□No □Yes(specify,ifyes: ) Splenectomy           □No                           □Yes Otherorganresection □No □Yes(specify,ifyes: ) Video-assistedthoraci csurgery □No □Yes(specify,ifyes: ) Lymphadenectomy (KGOG classification) □None PelvicLN/Level1                    □Rt LNS          □Rt LND          □Lt LNS           □Lt LND CommoniliacLN/Level2□Rt LNS         □Rt LND         □LtLNS         □Lt LND              Para-aorticLN(infra-IMA)/Level3□LNS              □LND Para-aorticLN(infra-renal)/Level4□LNS              □LND □Debulking (specifysite: ) □Others ( ) Otheroperation (procedure : )(surgeon: )   Intraoperativefindings     Frozenbiopsy Ascites Adhesion Ovariantumor Intraperitonealtumor Lymphnodeenlargement Extraperitonealtumor□No □No □No □No □No □No □No□Yes(specify,ifyes: ) □Yes( mL) □Yes(specify,ifyes: ) □Yes(largesttumorsize cm/residualtumorsize cm) □Yes(largesttumorsize cm/residualtumorsize cm) □Yes(specify,ifyes: ) □Yes(site:     largesttumorsize     cm/residualtumorsize     cm) Largestresidualtumor    □Nogrossresidual Anti-adhesiveused□≤0.5cm □≤1cm □≤2cm □>2cm □No □Yes ( ) Intraoperative injury    □Ureter  (specify, ifyes: ) □Vessel □Bowel □Others (specify, ifyes: ) (specify, ifyes: ) (specify, ifyes: )         Estimatedbloodloss ( mL) Transfusion □No □Yes (p-RBC pint, Pltconc pint, FFP pint, WB pint) Drain □No □Yes □LLQ□RLQ□LUQ□RUQ□Others( ) Gauzecount □Checked □Notchecked Woundclosure Peritoneum□No □Yes Fascia □No □Yes Subcutaneous□No □Yes Skin □No □Yes Remarks Fig.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"PUBMED  | CROSSREF 6/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers       Pathologicreportformforovarian,tubal,andperitonealcancers       Operation: □Oophorectomy(right/left/bilateral) □ Salpingo-oophorect omy(right/left/bilateral) □Salpingectomy(right/left/bilateral) □Hysterectomy □Omentectomy □Peritoneal biopsy(specify) □Lymphnodesampling/dissectio n(specify) □Other(specify)     Primarytumorsite: □Ovary(right/left/bilateral) □Fallopiantube(right/left/bilateral) □Peritoneum □Other(specify)     Tumorsize:   Greatestdimension: cm   Additio naldimensions(optional): × cm   Fragmented: gm,and/or × × cminaggregates     Histologictype: □High-gradeserous carcinoma □Low-gradeserouscarcinoma □Seroustubalintraepithelialcarcinoma(STIC)□Mucinouscarcinoma(expansile/infiltrative) □Endometrioidcarcinoma □Clearcellcarcinoma □MalignantBrennertumor □Seromucinouscarcinoma □Undifferentiatedcarcinoma □Carcinosarcoma □Other(specify)     Histologicgrade: □G1□G2□G3□Notapplicab le□Cannotbeassessed     Tumorextension:   (1)Ovariansurface involvement:absent/present(right/left/bilateral)   (2)Fallopiantubesurfaceinvolvement:absent/present(right/left/bilateral)   (3)Ovariancapsule:intact/ru ptured/opened(right/le ft/bilateral) (4)Pelvicextensionbelowpelvicbrim:absent/present (uterus,ovary,fallopiantube,pelvicperitoneum,urinarybladder,sigmoidcolon,rectum,anteriorcul-de-sac, posteriorcul-de-sac,rightpelvicwall,leftpelvicwall,other[specify]) (5)Involvementofextrapelvicperitoneum:absent/present(Greatestmetastatictumordimension:      mm) (omentum,abdominalperitoneum,stomach,smallbowel,mesentery,appendix,cecum,ascendi ngcolon, transversecolon,rightparacolicgutter,descendingcolon,leftparacolicgutter,diaphragm,liversurface, liverparenchyma,spleensurface, spleenparenchyma,other[specify])  Level3,para-aorticinfra-IMA:( / ) Level4,para-aorticinfra-renal:( / ) Other(specify)             Lymphnodemetastasis:□Absent □Present   Greatestmetastatictumordimension: mm   Extranodalextent:□Absent,□Present( mm) Level1,externalandinternaliliac(includingobturator):Right( /    ),Left(    /    ) Level2,commo niliac(includingpresacral):Right( / ),Left( / )               Vascular/lymphaticinvasion: □Absent □Present □Indeterminate     Additionalpathologicfindings: □Endometriosis(specifysite) □Endosalpingiosis(specifysite) □Other(specify)    Cytology(optional): Peritoneal washing:□Nomaligna ntcells □Malignantcells □Other(specify) Ascites:□Nomalignantcells □Malignantcells □Other(specify)     pTNM :pT( )pN( )M( ) Fig.",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"PUBMED 7/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
"PUBMED  | CROSSREF 8/8 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e6Surgical manual for ovarian, tubal, peritoneal cancers",Non-OADS,/arxiv_data1/oa_pdf/e0/39/jgo-28-e6.PMC5165074.pdf
1/12 http://ejgo.orgABSTRACT Objective:  In patients with advanced stage epithelial ovarian cancer (EOC) the volume of  residual tumor after debulking is known as prognostic factor for survival.,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"2017 Jan;28(1):e7 https://doi.org/10.3802/jgo.2017.28.e7 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Mar 8, 2016 Revised:  Aug 12, 2016 Accepted:  Aug 28, 2016 Correspondence to Roy FPM Kruitwagen Department of Obstetrics and Gynecology,  Maastricht University Medical Centre, P.O.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"ORCID Nienke Zwakman http://orcid.org/0000-0003-0337-5206 Rafli van de Laar http://orcid.org/0000-0002-7194-2797 Petra LM Zusterzeel http://orcid.org/0000-0001-9547-6367Nienke Zwakman,1 Rafli van de Laar,1,2 Toon Van Gorp,1,5 Petra LM Zusterzeel,2  Marc PML Snijders,3 Isabel Ferreira,4 Leon FAG Massuger,2 Roy FPM Kruitwagen1,5 1 Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, The  Netherlands 2 Department of Obstetrics and Gynecology, Radboud University Medical Centre, Nijmegen, The  Netherlands 3Department of Obstetrics and Gynecology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands 4 Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University  Medical Centre, Maastricht, The Netherlands 5 GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre,  Maastricht, The NetherlandsPerioperative changes in serum CA125  levels: a prognostic factor for disease- specific survival in patients with  ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
2/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Marc PML Snijders http://orcid.org/0000-0002-2434-7442 Isabel Ferreira http://orcid.org/0000-0003-1434-0607 Leon FAG Massuger http://orcid.org/0000-0002-1539-8985 Roy FPM Kruitwagen http://orcid.org/0000-0002-1305-9541 Conflict of Interest No potential conflict of interest relevant to this  article was reported.,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
Univariate  3/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"4/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Epithelial ovarian cancer (n=/four.LP/nine.LP/eight.LP) FIGO IIb-IV (n=/three.LP/seven.LP/seven.LP) Primary surgery and adjuvant chemotherapy (n=/two.LP/three.LP/seven.LP) FIGO I-IIa (n=/one.LP/two.LP/one.LP) No surgery, neo adjuvant chemotherapy or no chemotherapy (n=/one.LP/four.LP/zero.LP ) Pre- and postoperative CA /one.LP/two.LP/five.LP value available (n=/one.LP/eight.LP/seven.LP) Outcome surgery available (n=/one.LP/eight.LP/one.LP) CA/one.LP/two.LP/five.LP ≤/five.LP weeks before surgery CA/one.LP/two.LP/five.LP ≤/five.LP weeks after surgery CA/one.LP/two.LP/five.LP /greater.cap/three.LP/five.LP  U/mL CA/one.LP/two.LP/five.LP before chemotherapy (n=/one.LP/two.LP/three.LP) Missing surgery report (n=/six.LP) Missing CA /one.LP/two.LP/five.LP values (n=/five.LP/zero.LP) CA/one.LP/two.LP/five.LP /greater.cap/five.LP  weeks before surgery CA/one.LP/two.LP/five.LP /greater.cap/five.LP  weeks after surgery CA/one.LP/two.LP/five.LP ≤/three.LP/five.LP U/mL CA/one.LP/two.LP/five.LP after chemotherapy (n=/five.LP/eight.LP) Fig.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"Adjusting for potential confounders ( Table 2 , model 2) did not  5/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Table 1.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"Specifically, HR 50%– 79% =0.59 (95% CI: 0.34–1.05)  6/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Table 2.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
[ 7] combined the decline of serum CA125 with the result of  debulking surgery and showed that optimally debulked patients in the “high decline” group  (≥80% reduction in CA125 levels) were at lower risk of recurrence than patients with a smaller  7/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Number at risk <% () () () () () %– % () ()  () () () ≥% () () () () ()Time (mo)0.6 0.4 0.2 0 12 24 36 48 60Overall survival0.81.0 % %%  p= Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"In other words,  for patients with higher baseline values, any absolute reduction in CA125 levels will always  8/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Table 3.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"Furthermore, the group of patients with an optimal debulking includes patients with 1  9/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer Table 4.",Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
Perioperative changes  in serum CA125 levels were also associated with disease-specific survival and were a stronger  10/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
PUBMED  | CROSSREF 11/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
PUBMED  | CROSSREF 12/12 http://ejgo.org https://doi.org/10.3802/jgo.2017.28.e7Perioperative CA125 changes in ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/da/5a/jgo-28-e7.PMC5165075.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/f6/dew284.PMC5165077.pdf
Available: http://hdl.handle.net/ 10062/2885 .,Non-OADS,/arxiv_data1/oa_pdf/1c/f6/dew284.PMC5165077.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits no n-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/85/dew295.PMC5165079.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/be/dew297.PMC5165080.pdf
"http://allabouttheembryo.net/embryo_wp/?page_id =43(31 October 2016, date last accessed), 2013b.",Non-OADS,/arxiv_data1/oa_pdf/60/be/dew297.PMC5165080.pdf
"National Health and Medical Research Council (NHMRC), Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice andResearch .2 0 0 7 https://www.nhmrc.gov.au/_ ﬁles_nhmrc/publications/att achments/e78.pdf (26 June 2016, date last accessed) 2004, revised 2007.",Non-OADS,/arxiv_data1/oa_pdf/60/be/dew297.PMC5165080.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits no n-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"http://combateaedes.saude.gov.br/images/sala de-situacao/Microcefalia-Protocol o-de-vigilancia-e-resposta-10mar20 16-18h.pdf (29 May 2016b, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"http://dhsprogram.com/what-we- do/survey/survey-display-85.cfm (May 10 2016, date last accessed).",OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"Natl Health Stat Report 2015. http://www.cdc.gov/ nchs/data/nhsr/nhsr086.pdf (18 May 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
http://www.prb.,Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"http://www.unfpa.org/world- population-dashboard (22 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"http://www.cdc.gov/ zika/transmission/sexual-transmission.html (20 September 2016a, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"http://www.cdc.gov/ zika/pregnancy/women-and-their-partners.html (20 September 2016b, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"Unmet Need for Family Planning .http://www.who.int/reproductive health/topics/family_planning/unmet_need_fp/en/ (18 October 2016a, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"Situation report .http://www.who.int/emergencies/zika-virus/situation-report/ 15-september-2016/en/ (22 September 2016b, date last accessed).93 Zika virus and contraceptive sales in Brazil",Non-OADS,/arxiv_data1/oa_pdf/6e/69/dew310.PMC5165082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/ef/kqw169.PMC5165265.pdf
"Ministry of  Labour and Social Affairs, 2010. https://www.regjerin- gen.no/en/topics/labour/the-working-environment-and- safety/inclusive-working-life/ia-tidligere-avtaleperioder/ inkluderende-arbeidsliv.-avtaleperioden-2010-2013/ia- dokumenter/New-IA-agreement-and-stimulus-package- to-reduce-sick-leave-/id594043/  (18 November 2016, date  last accessed).",Non-OADS,/arxiv_data1/oa_pdf/34/ef/kqw169.PMC5165265.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Jean-Luc Raoul, Professor, Depart - ment of Medical Oncology, Paoli-Calmettes Institute, BP 156,  13273 Marseille, France.",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/WJH-8-1541.PMC5165267.pdf
Key words:  Tumor evaluation; Response evaluation  criteria in solid tumors; Sorafenib; Hepatocellular Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1541World J Hepatol   2016  December 18; 8(35): 1541-1546 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/2b/6e/WJH-8-1541.PMC5165267.pdf
World J Hepatol  2016;  8(35): 1541-1546  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/2b/6e/WJH-8-1541.PMC5165267.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/6e/WJH-8-1541.PMC5165267.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2b/6e/WJH-8-1541.PMC5165267.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript  Correspondence to:  Sebastian Mueller, MD, PhD,  Salem  Medical Center and Center for Alcohol Research, University of  Heidelberg, Zeppelinstraße 11-33, 69120 Heidelberg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/21/99/WJH-8-1547.PMC5165268.pdf
LS and serum markers were  prospectively studied in these patients with all stages Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1547World J Hepatol   2016  December 18; 8(35): 1547-1556 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/21/99/WJH-8-1547.PMC5165268.pdf
World J Hepatol  2016; 8(35): 1547-1556   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/v8/ i35/1547.,Non-OADS,/arxiv_data1/oa_pdf/21/99/WJH-8-1547.PMC5165268.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i35.1547 INTRODUCTION Alcoholic liver disease (ALD) is the most common chronic  liver disease in the Western world[1].,Non-OADS,/arxiv_data1/oa_pdf/21/99/WJH-8-1547.PMC5165268.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/21/99/WJH-8-1547.PMC5165268.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Amilcar L Morales, MD, Transplant  Hepatology Staff,  Hepatology Service, San Antonio Military  Medical Center, 3551 Roger Brooke Dr, Fort Sam Houston, San  Antonio, TX 78234, United States.",Non-OADS,/arxiv_data1/oa_pdf/27/71/WJH-8-1557.PMC5165269.pdf
The patients who started a new medication or had an  adjustment of baseline medical management for  hyper -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1557World J Hepatol   2016  December 18; 8(35): 1557-1563 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/27/71/WJH-8-1557.PMC5165269.pdf
World J Hepatol  2016; 8(35): 1557-1563  Available  from: URL:  http://www.wjgnet.com/ 1948-5182 /full/v8/i35/1557.,Non-OADS,/arxiv_data1/oa_pdf/27/71/WJH-8-1557.PMC5165269.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i35.1557 INTRODUCTION Hepatitis C virus (HCV) is a leading cause of chronic  liver disease, with a prevalence of infection in the United  States of approximately 1.6%[1].",Non-OADS,/arxiv_data1/oa_pdf/27/71/WJH-8-1557.PMC5165269.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/27/71/WJH-8-1557.PMC5165269.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Abhinav Goyal, MD,  Department of  Internal Medicine, Einstein Medical Center, 5501 Old York Road,  Suite 363, Klein Building, Philadelphia, PA 19141,  United States.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/WJH-8-1564.PMC5165270.pdf
"CONCLUSIONOur study suggests that in a large, nationally represen - tative sample of the United States population, cirrhosis  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1564World J Hepatol   2016  December 18; 8(35): 1564-1568 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/WJH-8-1564.PMC5165270.pdf
"World J Hepatol  2016; 8(35): 1564-1568  Available from: URL:   http://www.wjgnet.com/ 1948-5182 /full/v8/i35/1564.htm  DOI:  http://dx.doi.org/10.4254/wjh.v8.i35.1564 INTRODUCTION Cirrhosis is among the top ten leading causes of death  in the United States[1,2].",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/WJH-8-1564.PMC5165270.pdf
Available from: URL: http://www.hcup-us.ahrq.gov/nisoverview.,OADS,/arxiv_data1/oa_pdf/ef/4b/WJH-8-1564.PMC5165270.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/WJH-8-1564.PMC5165270.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Siddharth Sood, MBBS, BMedSci, PhD,  Head  of Hepatology, Department of Gastroenterology and  Hepatology, University of Melbourne, Royal Melbourne Hospital,  Royal Parade, Parkville, VIC 3050,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/9c/b9/WJH-8-1569.PMC5165271.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1569World J Hepatol   2016  December 18; 8(35): 1569-1575 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/9c/b9/WJH-8-1569.PMC5165271.pdf
World J Hepatol  2016;  8(35): 1569-1575  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/9c/b9/WJH-8-1569.PMC5165271.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/b9/WJH-8-1569.PMC5165271.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9c/b9/WJH-8-1569.PMC5165271.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Steven C Cunningham, MD, FACS,  Director of Pancreatic and Hepatobiliary Surgery,  Director of  Research, Department of Surgery, Saint Agnes Hospital, 900  Caton Avenue, MB 207, Baltimore, MD 21229,  United States.",Non-OADS,/arxiv_data1/oa_pdf/ac/74/WJH-8-1576.PMC5165272.pdf
The duration of therapy also correlated with  the initial white blood cell (WBC) count ( P = 0.048).Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1576World J Hepatol   2016  December 18; 8(35): 1576-1583 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ac/74/WJH-8-1576.PMC5165272.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ac/74/WJH-8-1576.PMC5165272.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to:  Habeeb Salameh, MD, CMQ,  Depart- ment of Internal Medicine, Division of Gastroenterology and  Hepatology, University of Texas Medical Branch, 301 University  Blvd, Galveston, TX 77555,  United States.",Non-OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
Nineteen on chronic he -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i35.1584World J Hepatol   2016  December 18; 8(35): 1584-1592 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
Available from:  URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.,Non-OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
Available from: URL:  http://handbook.cochrane.org/chapter_10/10_4_4_2_trim_and_fill.,OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cd/b6/WJH-8-1584.PMC5165273.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.LGBT Health Volume 3, Number 6, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/lgbt.2015.0069 461",Non-OADS,/arxiv_data1/oa_pdf/e9/74/lgbt.2015.0069.PMC5165658.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 25, Number 24, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2016.0099 1884",Non-OADS,/arxiv_data1/oa_pdf/da/69/scd.2016.0099.PMC5165660.pdf
"For hierarchical cluster- ing analysis (average linkage), Cluster 3.0 v1.50 (http://bonsai.hgc.jp/ *mdehoon/software/cluster/software.htm) was used and for visualization, Java TreeView v1.1.6r2 (http:// jtreeview.sourceforge.net) was used.Results Differentiation of hepatic lineage in ﬁve hPSC lines We computed an average gene expression score for the propensity for hepatic differentiation of the ﬁve hPSC linesH9, which is known to differentiate well [24,29–33,35– 37,39,46]; Tic and Dotcom, both of which are reported to differentiate well [34,35,37]; Squeaky, which was derivedfrom the same donor cell line as Tic and Dotcom; and201B7, which is reported to have a poor propensity for hepatic differentiation [47].",OADS,/arxiv_data1/oa_pdf/da/69/scd.2016.0099.PMC5165660.pdf
"doi/10.3824/stembook.1.52.1, http://www.stembook.org.",Non-OADS,/arxiv_data1/oa_pdf/da/69/scd.2016.0099.PMC5165660.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES Volume 26, Number 12, 2016Mary Ann Liebert, Inc.DOI: 10.1089/lap.2016.0334 1036",Non-OADS,/arxiv_data1/oa_pdf/41/8e/lap.2016.0334.PMC5165674.pdf
"1 3      http://www.medsci.org  977  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2016; 13(12): 977-983. doi: 10.7150/ ijms.16642  Research Paper   Genetic Analysis of BDNF , GNB3, MTHFR , ACE and APOE  Variants in Major and Recurrent Depressive Disorders  in Russia   EA Bondarenko1 , MI Shadrina 1, MN  Grishkina 2, TA  Druzhkova 2, RG Akzhigitov 2, NV  Gulyaeva 2,3, AB   Guekht 2, PA Slominsky 1   1.",Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
13     http://www.medsci.org  978  and an early -onset depression) [4].,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
"graphpad.com/), STATISTICA (data analysis  software  system, version 7, http://www.statsoft.",OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
Hardy−Weinberg equilibrium calcu lator software  (http://www.oege.org/software/hardy -weinberg.ht ml) was used to calculate the correspondence of the  genotype distribution in the population sample to the  Hardy−Weinberg equilibrium.,OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
13     http://www.medsci.org  979  determine the difference between the f requencies of  the genotypes and alleles in the control group and  patients with different types of depressive disorder.,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
"The SNP -SNP interactions was conducted using  the GMDR software  (Generalized multifactor  dimensionality reduction), (http://www.ssg.uab.",OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
1 3      http://www.medsci.org  980  The results of the analysis of the genotype  distribution at the polymorphic locus of the APOE   gene are presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
13     http://www.medsci.org  981  frequencies between patients and controls.,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
13     http://www.medsci.org  982  and three -locus models of interaction of the studied  genes were obtained.,OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
13     http://www.medsci.org  983  26.,Non-OADS,/arxiv_data1/oa_pdf/37/8c/ijmsv13p0977.PMC5165692.pdf
"1 3      http://www.medsci.org  984  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2016; 13(12): 984-991. doi: 10.7150/ ijms.16072  Research Paper   Pulsed radiofrequency  attenuates diabetic neuropathic  pain and suppresses formalin- evoked spinal glutamate  release in rats   Yu-Hsin Huang1*, Shao -Yun Hou1*, Jen -Kun Cheng2, Chih -Hsien Wu1, Chung -Ren Lin1,  1.",Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) lic ense  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
13     http://www.medsci.org  985  The excitatory amino acids such as glutamate  and aspartate  are major neurotransmitters released  from central and peripheral terminals of nociceptive  primary afferent fibres critically important in  modulating the transmission of peripheral painful  stimuli within the spinal cord [4].,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
13     http://www.medsci.org  986  thermal stimulation system was used to measure the  nociceptive response to heat [13].,OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
1 3      http://www.medsci.org  987    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
1 3      http://www.medsci.org  988  Effect of PRF on behaviour responses in  formalin test   The formalin- evoked flinching behaviour and  spinal glutamate release were measured in consc ious  and freely moving rats.,OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
13     http://www.medsci.org  989    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
13     http://www.medsci.org  990  afferent termin als to the spinal dorsal horn neurons in  diabetic rats.,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
"13     http://www.medsci.org  991  Acknowledgements   This work was supported, in part, by grant Nos.",Non-OADS,/arxiv_data1/oa_pdf/e4/d7/ijmsv13p0984.PMC5165693.pdf
@ERSpublications Biomonitoring of artificial stone-exposed workers http://ow.ly/Ut4J304amUr Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/98/5b/00093-2016.PMC5165721.pdf
E-mail: weiler@actcom.co.il Received: July 31 2016 | Accepted: Aug 05 2016Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com @ERSpublications Biometric monitoring in exposure to silica dust http://ow.ly/qRrB303lMDg Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/ff/4c/00086-2016.PMC5165722.pdf
@ERSpublications Particulate matter skews gene expression pattern in cigarette smoke-exposed mice towards an inflammatory phenotype http://ow.ly/Tpex3038fyC Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/c8/23/00029-2016.PMC5165723.pdf
@ERSpublications Isolated dysfunction in distal airways identifies pulmonary inflammation in asymptomatic smokers with normal airflow http://ow.ly/8bVk305aVkj Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/74/1f/00066-2016.PMC5165724.pdf
"6  801–821 https://doi.org/10.1083/jcb.201604112Introduction Our genomes are under constant assault, accumulating DNA  damage that must be repaired before the next cell division.",Non-OADS,/arxiv_data1/oa_pdf/08/59/JCB_201604112.PMC5166498.pdf
"6  875–889 https://doi.org/10.1083/jcb.201604136Introduction Natural killer (NK) cells are cytotoxic lymphocytes that play  a critical role in the elimination of transformed and virally in - fected cells (Vivier et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/8a/7f/JCB_201604136.PMC5166499.pdf
"6  779–788 https://doi.org/10.1083/jcb.201605030Introduction Autophagy is a catabolic cellular stress response that recycles  cytoplasmic components to facilitate cellular homeostasis and  adaptation (Onodera and Ohsumi, 2005; Ryter et al., 2013).",OADS,/arxiv_data1/oa_pdf/3f/50/JCB_201605030.PMC5166500.pdf
"6  789–799 https://doi.org/10.1083/jcb.201605080Introduction Cytokinesis, the process that completes cell division by par - titioning the contents of the mother cell to the two daughter  cells, requires the assembly and constriction of a contractile  ring (Green et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/7f/1a/JCB_201605080.PMC5166501.pdf
6  841–856 https://doi.org/10.1083/jcb.201605089Introduction Autophagy is a catabolic process occurring in all eukaryotic cells  so as to maintain cellular viability and homeostasis during basal  conditions by controlling long-lived proteins and damaged or - ganelles.,Non-OADS,/arxiv_data1/oa_pdf/ef/66/JCB_201605089.PMC5166502.pdf
"6  823–840 https://doi.org/10.1083/jcb.201606092Introduction The microtubule (MT) nucleating activity at MT-organizing  centers (MTOCs), such as the mammalian centrosome or the  yeast spindle pole body (SPB), primarily depends on γ-tubulin.",Non-OADS,/arxiv_data1/oa_pdf/f7/32/JCB_201606092.PMC5166503.pdf
"6  857–874 https://doi.org/10.1083/jcb.201607039Introduction Autophagy is a catabolic pathway essential for maintaining  cellular homeostasis through lysosome-mediated degradation  of cytosolic material (Lamb et al., 2013).",OADS,/arxiv_data1/oa_pdf/c2/21/JCB_201607039.PMC5166504.pdf
"6  769–778 https://doi.org/10.1083/jcb.201610031Introduction Eukaryotic cells are highly compartmentalized, with separate  organelles each characterized by specific protein and lipid  compositions.",Non-OADS,/arxiv_data1/oa_pdf/e3/8f/JCB_201610031.PMC5166505.pdf
6  761–763 https://doi.org/10.1083/jcb.201611116Macroautophagy (hereafter autophagy) is a major pathway  for endo-lysosomal degradation of cellular cargo sequestered  within double-membrane organelles called autophagosomes.,Non-OADS,/arxiv_data1/oa_pdf/e6/4f/JCB_201611116.PMC5166506.pdf
"6  757–759 https://doi.org/10.1083/jcb.201611177Autophagy involves the engulfment of a portion of cytosol in  the double-membrane autophagosome and its subsequent de - livery to lysosomes for degradation (Nakatogawa et al., 2009).",OADS,/arxiv_data1/oa_pdf/e2/a3/JCB_201611177.PMC5166507.pdf
"6  753–756 https://doi.org/10.1083/jcb.201611178The importance of DNA damage repair pathways was recog - nized by the award of the Nobel Prize in Chemistry in 2015 to  Tomas Lindahl, Paul Modrich, and Aziz Sancar, and is reflected  in the many genetic syndromes associated with mutations in  repair components.",Non-OADS,/arxiv_data1/oa_pdf/02/ab/JCB_201611178.PMC5166508.pdf
"6  765–767 https://doi.org/10.1083/jcb.201612003Cytotoxic lymphocytes, including natural killer (NK) cells and  cytotoxic T lymphocytes (CTLs), possess the unique capacity  to instruct infected or malfunctioning cells to undergo regulated  apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/70/02/JCB_201612003.PMC5166509.pdf
"7      http://www.jcancer .org 2408  JJoouurrnnaall  ooff  CCaanncceerr   2016; 7(15): 2408 -2419.  doi: 10.7150/ jca.15703  Research Paper   Brown  Seaweed  Fucoidan Inhibit s Cancer Progression  by Dual Regulation of mir -29c/ADAM12 a nd  miR-17-5p/PTEN  Axes in Human Breast Cancer Cells   Szu-Yuan Wu1,2,3,4, Ming -De Yan5, Alexander T.H.",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
"7    http://www.jcancer .org 2409  that microRNAs (miRNAs) play crucial role s in  tumorigene sis and metastasis, suggesting that  targeting miRNAs is  a promising approach for  treat ing human cancers [10, 11] .",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
"7    http://www.jcancer .org 2410  Tissue Cell Culture (Manassas, VA , USA).",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
"7    http://www.jcancer .org 2411  ADAM12  and PTEN  3’-UTR, which are  approximately 300 bp in length and contain miR -29c  and miR -17-5p binding site s, respectively, w ere  cloned into the downstream region of the luciferase  gene to create a pGL3 -ADAM12  and pGL3 -PTEN   3’-UTR.",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2412    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2413    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
Fucoidan increases miR-29c expression to  suppress ADAM12     The functional targets of miR -29c were  predict ed using the PicTar (http://pictar.mdc -  berlin.de/ ) and TargetScan ( http://targetscan.org/)  databases .,OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
"7    http://www.jcancer .org 2414  expression by fucoidan (Figure 4) , the luciferase  activity of the wild -type, but not the mutated,  ADAM12  3’-UTR reporter was repressed to  approximately 50% –60% in MCF -7 and MDA -MB-231  cells after treatment with fucoidan for 48 h (Figure 5 B,  black bars).",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
Fucoidan reduces m iR-17-5p expression to  restore  PTEN     The functional targets of  miR-17-5p were  predicted using the PicTar (http://pictar.mdc -  berlin.de/) and TargetScan (http://targetscan.org/)  databases .,OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2415    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2416    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2417  Recent experimental evidence reveals that  dietary nutraceuticals such as curcumin and  resveratrol have great potential as epigenetic agents.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
"7    http://www.jcancer .org 2418  the binding of Snail, Zeb, and Twist to the E -cadherin  promoter directly.",Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
7    http://www.jcancer .org 2419  targets.,Non-OADS,/arxiv_data1/oa_pdf/26/19/jcav07p2408.PMC5166552.pdf
This is an open access article under theCCBY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.11.006,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
"CA Cancer J Clin 61(2), 69 –90.http://dx.doi.org/10.3322/caac.20107 .",Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1002/ijc.25516 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
"B rJS u r g 89(7), 845 –860.http://dx.doi.org/10.1046/j.1365-2168.2002.02120.x .",Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1093/annonc/mdi098 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1158/1055-9965.EPI-09-0186 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1111/codi.12648 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1016/j.mayocp.2013.09.006 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1111/j.1463-1318.2008.01639.x .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1054/bjoc.2000.1554 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1038/sj.onc.1209758 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1038/sj.bjc.6690388 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/ 10.1002/mc.22315 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.2353/jmoldx.2007.060170 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
"JM o lD i a g n 10,1 3–27.http://dx.doi.org/10.2353/jmoldx.2008.070082 .",OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
"Vienna, Austria: R Foundation for Statistical Computing; 2012 [ISBN3-900051-07-0, URL http://www.R-project.org/ ].",Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1038/sj/onc/1205431 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1053/j.gastro.2006.06.005 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/ 10.1046/j.1440-1827.2002.01365.x .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1053/j.gastro.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
"Mol Cancer 9, 100. http://dx.doi.org/10.1186/1476-4598-9-100 .",Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1159/000151712 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.3892/ijo.32.3.575 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1093/hmg/ddt584 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/ 10.1136/jmedgenet-2013-102000 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1007/s00439-013-1390-4 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1007/s00438-014-0970-x .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1007/s00251-010-0494-4 .,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.1038/ejhg.2010.49 .,OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
http://dx.doi.org/10.3748/wjg.v21.i5.1457 .34 Genotype-Phenotype Correlation in Colorectal Cancer Arriba et al.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/main.PMC5166699.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.05.004,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
Available at:http://evs.gs.washington.edu/EVS/ .,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
Available at:http://homes.esat.kuleuven.be/ wbioiuser/endeavour/ tool/endeavourweb.php .,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
Available at: http://exac.broadinstitute.,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
Available at: http://www.biorxiv.org/content/ early/2015/10/30/030338 .,Non-OADS,/arxiv_data1/oa_pdf/56/8f/main.PMC5166708.pdf
"This EST apparently represented unspliced Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > Received 13 April 2016 | Accepted 12 December 2016 | Published 14 December 2016© 2016 Molecular Vision 1421Regulation of photoreceptor gene transcription via a highly  conserved transcriptional regulatory element by vsx gene products Yi Pan,1 Daniel F. Comiskey,2,3,4 Lisa E. Kelly,1 Dawn S. Chandler,2,3,4,5 Heithem M. El-Hodiri1,2,5 1Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’ s Hospital, Columbus, OH; 2Graduate  Program in Molecular, Cellular, and Developmental Biology, The Ohio State University, Columbus, OH; 3Center for Childhood  Cancer, The Research Institute at Nationwide Children’ s Hospital, Columbus, OH; 4Center for RNA Biology, Wexner Medical  Center, The Ohio State University, Columbus, OH; 5Department of Pediatrics, College of Medicine, The Ohio State University,  Columbus, OH Purpose:  The photoreceptor conserved element-1 (PCE-1) sequence is found in the transcriptional regulatory regions  of many genes expressed in photoreceptors.",Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1422genomic DNA (BC044049).,Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
"Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1423Renilla  luciferase as an internal control), and RNAs encoding  effectors as indicated in the figure legends.",Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1424intron 4 using splice site prediction software.,Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1425to speculate whether the binding of Srsf5 and/or Srsf6 can  mediate splicing of vsx2-s .,Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1426forms of Vsx2 exhibited different transcriptional regula - tory activities (Figure 4B).,Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1427rhodopsin gene.,Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
"Molecular Vision  2016; 22:1421-1428 <http://www.molvis.org/molvis/v 22/1421 > © 2016 Molecular Vision  1428Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/b1/a3/mv-v22-1421.PMC5166794.pdf
"Matrix metallopro - teinases (MMPs) are zinc-dependent extracellular proteases  that are required for the breakdown of the extracellular matrix Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > Received 8 August 2016 | Accepted 12 December 2016 | Published 14 December 2016© 2016 Molecular Vision 1429MMP19 expression in the human optic nerve Kathleen R. Chirco,1,2 Ralph J. Hazlewood,1,2,3 Kathy Miller,1,2 Grefachew Workalemahu,1,2 Lee M. Jampol,3 G.  Robert Lesser,4 Robert F. Mullins,1,2 Markus H. Kuehn,1,2 John H. Fingert1,2 (The first two authors contributed equally to this study.)",Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
"Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1430(ECM) in normal processes, such as embryonic develop - ment, cell surface receptor cleavage, apoptosis, and tissue  remodeling.",Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1431colorimetric and fluorescent immunohistochemical studies.,Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1432just posterior to the scleral canal.,Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1433MMP19 was further evaluated within the optic nerve  with colabeling studies using immunofluorescence micros - copy.,Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
"Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1434DISCUSSION The most striking feature of CODA is congenital excavation  of the optic disc, which is similar to cupping of the optic disc,  the key diagnostic sign of primary open-angle glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  14353.,Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
Molecular Vision  2016; 22:1429-1436 <http://www.molvis.org/molvis/v 22/1429 > © 2016 Molecular Vision  1436basement membrane degrading enzyme.,Non-OADS,/arxiv_data1/oa_pdf/99/40/mv-v22-1429.PMC5166795.pdf
"The  HCs are of interest because their regulation of the cell cycle Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > Received 31 May 2016 | Accepted 12 December 2016 | Published 14 December 2016© 2016 Molecular Vision 1405A regulatory sequence from the retinoid X receptor γ gene  directs  expression to horizontal cells and photoreceptors in the embryonic  chicken retina Maria K. E. Blixt, Finn Hallböök Department of Neuroscience, Faculty of Medicine, Uppsala University, Uppsala, Sweden Purpose:  Combining techniques of episomal vector gene-specific Cre expression and genomic integration using the  piggyBac transposon system enables studies of gene expression–specific cell lineage tracing in the chicken retina.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1406deviates from that of other retinal cells [ 15-17], and HCs are  candidates for being the “cell of origin” for retinoblastoma  [18].",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1407sequence from the chicken RXRγ gene  [41] was synthesized  by Eurofins Genomics (Eurofins Genomics, Ebergsberg,  Germany) and inserted into the Stacia3 construct at the SalI/ EcoRI restriction sites.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1408Primary antibodies are listed in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1409(Figure 2B´).,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1410vector (Stacia3-Otx2.294).,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1411 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1412The RXRγ208 element directs gene expression to the PRs  and the HCs:  We analyzed RXRγ208::GFP cells in seven  flatmounted intact stage 40/44 (E14/18) retinas that had been  electroporated at stage 22/25/28, and the results showed a  “stars in the sky”-like pattern of GFP+ cells.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1413expressing Lim1, and two axon-less subtypes (H2 and H3)  expressing Isl1 and the neurotransmitter γ-aminobutyric  acid (GABA) or Isl1 and the neurotrophin receptor TrkA,  respectively [ 20].",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1414Unfortunately, we were unable to find an antibody that could  detect the blue or violet opsin.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1415All retinal cells share a common progenitor [ 58], and  through the expression or absence of specific genes, the final  identity of the retinal cells is established.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1416later restricted to the ONL in the chicken and cow retina  [26,27] and to the ONL, INL, and GCL in the mouse [ 30].",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1417allows for site- and time-specific integration or expression,  which may be important if the gene that needs to be investi - gated causes gross malformations or is embryonically lethal.",Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1418generated consecutively during chick retinal development  from progenitors that are sensitive to follistatin.,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1419toxin-damaged chicken retina.,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
Molecular Vision  2016; 22:1405-1420 <http://www.molvis.org/molvis/v 22/1405 > © 2016 Molecular Vision  1420in the developing eye.,Non-OADS,/arxiv_data1/oa_pdf/c2/a6/mv-v22-1405.PMC5166796.pdf
"In previous work on the interaction of two important  AMD-related proteins, EFEMP1/Fibulin 3 (Fib3) and comple - ment factor H (CFH), in deposits in soft drusen in AMD  [15], we observed that human RPE-derived ARPE-19 cells  [17] survived in high-glucose serum-free medium for 7 days Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > Received 15 July 2016 | Accepted 8 December 2016 | Published 10 December 2016© 2016 Molecular Vision 1387Accumulation of cholesterol and increased demand for zinc in  serum-deprived RPE cells Sanghamitra Mishra,1 Katherine Peterson,1 Lili Yin,1 Alan Berger,2 Jianguo Fan,1 Graeme Wistow1 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1388without further feeding and that Fib3 secretion was detected  after 3 days of treatment.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1389non-essential amino acids, penicillin/streptomycin (100 unit  penicillin/100 μg streptomycin per ml), and 10% fetal bovine  serum (FBS) under 5% CO2 at 37 °C.",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1390For serum deprivation, growth medium was removed;  the cells were washed once and kept in serum-free medium  (SFM), Dulbecco's Modified Eagle Medium (Gibco Life  Technology, Gaithersburg MD: catalog#12634; DMEM)  with 1% penicillin/streptomycin (100 unit penicillin/100 μg  streptomycin per ml).",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  139110 min each wash at room temperature with TBST, and  the protein bands were detected using the LumiGold ECL  Western Blotting Detection Kit (VerII; Signagen Laborato - ries, Ijamsville, MD).",OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  13925′-triphosphate (dUTP) cross-linked to either Alexa Fluor 555  (green) or Alexa Fluor 647 (red) fluorescent dye (Molecular  Probes, Eugene, OR).",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1393to day 0 samples from the serum-starved HEK293 cells were  determined using microarrays as described above.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1394following the manufacturer’s instructions using the 2-ΔΔCt  method [ 26].,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1395serum.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1396room temperature.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1397(7:11:0.1) using a Polytron PT 1200 E homogenizer (Kine - matica, Bohemia, NY) followed by centrifugation for 10 min  at 15,000 × g. The organic phase was carefully transferred to  a new tube and dried in vacuum centrifuge at 50 °C.",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1398To confirm the array results for ARPE-19 in SFM, 24  DEGs were selected for assay with qPCR.",OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1399To test this, the expression levels of the genes for MTs,  the zinc transporter, and other ZBP genes in ARPE-19 cells in  SFM with and without zinc supplementation were compared  at day 0, 1, 3, 5, 7, and 9 with qPCR (Figure 7, Appendix 6).",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1400is an increased demand for zinc under serum deprivation,  perhaps driven by increased levels of several stress-related  zinc-binding proteins.",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1401APPENDIX 6.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1402factor h and fibulin3 in age-related macular degeneration.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  140341.,Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
"Molecular Vision  2016; 22:1387-1404 <http://www.molvis.org/molvis/v 22/1387 > © 2016 Molecular Vision  1404protein, suppresses MAPK signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/3a/98/mv-v22-1387.PMC5166821.pdf
Availability and Implementation: STAMS is implemented as an R package and is freely available at https://simtk.org/projects/stams.Contact: rbaltman@stanford.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/6a/3e/btw530.PMC5167061.pdf
"3815 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/3e/btw530.PMC5167061.pdf
We used the BatchQC pipeline on both simulated and real data to demonstrate the effectiveness of this software toolkit.Availability and Implementation: BatchQC is available through Bioconductor: http://bioconductor.org/packages/BatchQC and GitHub: https://github.com/mani2012/BatchQC.,OADS,/arxiv_data1/oa_pdf/f1/04/btw538.PMC5167063.pdf
"3836 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/04/btw538.PMC5167063.pdf
2 Methods BatchQC is a Shiny App (http://shiny.rstudio.com/) R-package (Rver.,OADS,/arxiv_data1/oa_pdf/f1/04/btw538.PMC5167063.pdf
Availability and Implementation: http://www.readxplorer.org Contact: readxplorer@computational.bio.uni-giessen.de Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/ee/f5/btw541.PMC5167064.pdf
"3702 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/f5/btw541.PMC5167064.pdf
", 2009 , http://compbio.cs.brown.edu/projects/gasv/) for integration.",Non-OADS,/arxiv_data1/oa_pdf/ee/f5/btw541.PMC5167064.pdf
"A link was added for cross-linking genomic features with an EC- number to a user configurable enzyme database (default: ExPASy,http://www.expasy.org/).",OADS,/arxiv_data1/oa_pdf/ee/f5/btw541.PMC5167064.pdf
"3.4 Web service To ease the use of ReadXplorer 2, we added it to the toolbox of ourGalaxy server at https://www.computational.bio.uni-giessen.de/galaxy/.",Non-OADS,/arxiv_data1/oa_pdf/ee/f5/btw541.PMC5167064.pdf
Availability and Implementation: Source code for MATLAB including examples is freely available for download at http://www.aibn.uq.edu.au/cssb-resources under Software.,OADS,/arxiv_data1/oa_pdf/f4/15/btw555.PMC5167067.pdf
"3807 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/15/btw555.PMC5167067.pdf
"The models used in this study can be downloaded from the BiGG Models database at http://bigg.ucsd.edu(King et al., 2016 ).",OADS,/arxiv_data1/oa_pdf/f4/15/btw555.PMC5167067.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(7) 1–4 DOI: 10.1177/2054270415598091",Non-OADS,/arxiv_data1/oa_pdf/07/03/10.1177_2054270415598091.PMC5167075.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(7) 1–6 DOI: 10.1177/2054270415593443",Non-OADS,/arxiv_data1/oa_pdf/b0/7e/10.1177_2054270415593443.PMC5167076.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(7) 1–8 DOI: 10.1177/2054270415593449",Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
"Obtained data from patents were: inventors and applicants, their nationalities, and sections, classesand subclasses of the International PatentClassiﬁcation (IPC), using eighth version 2008.01(http://www.wipo.int/classiﬁcations/ipc/en).",OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
"Geneva, May 10, 2010. http://www.wipo.int/pressroom/en/articles/2010/article_0013.html.6.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
"Geneva, March 5, 2012. http://www.wipo.int/press-room/en/articles/2012/article_0001.html.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
http://www.okeobservatory.gr/projpdf/pdf_texenid_53.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
"COM (2011) 48, Brussels, 9.2.2011. http://www.europarl.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
"Geneva, February 8, 2010. http://www.wipo.int/pressroom/en/articles/2010/article_0003.html.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/10.1177_2054270415593449.PMC5167081.pdf
Retrieved from http://www.chaitanyamahilasangha.,Non-OADS,/arxiv_data1/oa_pdf/5e/f3/10.1177_1049732316654871.PMC5167108.pdf
"Retrieved from http://www.karnataka.gov.in/ kswdc/Pages/Devadasi-Rehabilitation-Programme—.aspx Guta, A., Flicker, S., & Roche, B.",Non-OADS,/arxiv_data1/oa_pdf/5e/f3/10.1177_1049732316654871.PMC5167108.pdf
"Corrigendum Corrigendum to “Threatening faces induce fear circuitry hypersynchrony in soldiers with post-traumatic stress disorder ” Benjamin T. Dunkleya,b,c,*, Elizabeth W. Pangb,d, Paul A. Sedgee, Rakesh Jetlye, Sam M. Doesburga,b,c,f, Margot J. Taylora,b,c,f aDepartment of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Canada bNeuroscience & Mental Health Program, The Hospital for Sick Children Research Institute, Toronto, Canada cDepartment of Medical Imaging, University of Toronto, Toronto, Canada dDivision of Neurology, The Hospital for Sick Children, Toronto, Canada eDirectorate of Mental Health, Canadian Forces Health Services, Ottawa, Canada fDepartment of Psychology, University of Toronto, Toronto, Canada DOI of original article: http://dx.doi.org/10.1016/j.heliyon.2015.e00063 * Corresponding author at: Department of Diagnostic Imaging, 555 University Ave, Toronto M5G 1X8, Canada.",Non-OADS,/arxiv_data1/oa_pdf/52/1a/main.PMC5167234.pdf
e00145 http://dx.doi.org/10.1016/j.heliyon.2016.e00145 2405-8440/Crown Copyright © 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/52/1a/main.PMC5167234.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/1a/main.PMC5167234.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/31/main.PMC5167236.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.005 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/31/main.PMC5167236.pdf
"References [1] M. Akoad,  Gastric  volvulus, Emedicine (2002), http://www.imedicine.com.online.uchc.edu/DisplayTopic.asp?bookid= 6&topic  =  2714  Accessed  16  September  2016.",Non-OADS,/arxiv_data1/oa_pdf/85/31/main.PMC5167236.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.012,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/main.PMC5167240.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,4 4 –45 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/main.PMC5167240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.11.011 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 59 e60,Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
"30 (3) (2009 Feb) 256 e265, http://dx.doi.org/10.1093/eurheartj/ ehn597 .",Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
"28 (2007) 1250 e1257, http://dx.doi.org/10.1093/ eurheartj/ehl477 .",Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
"43 (6) (2014 Jun) 1691e1697, http://dx.doi.org/10.1183/09031936.00116313 .",Non-OADS,/arxiv_data1/oa_pdf/21/60/main.PMC5167241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/9b/main.PMC5167242.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.11.008,OADS,/arxiv_data1/oa_pdf/c5/9b/main.PMC5167242.pdf
Mutational status derived from Cosmic database ( http://cancer.sanger.ac.uk/cosmic ).,OADS,/arxiv_data1/oa_pdf/c5/9b/main.PMC5167242.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Obsessive-compulsive disorder OCD Functional connectivityStructural connectivityDTIgPPI 1.,Non-OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.007 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
"The fMRI task was created using the Presentation® soft- ware (Version 16.3, http://www.neurobs.com /).",OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.nicl.2016.12.007 .253 O.G.,OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
http://dx.doi.org/10.1097/YCT.0000000000000218 .,Non-OADS,/arxiv_data1/oa_pdf/71/16/main.PMC5167243.pdf
This paperReceived: 13 September 2016 Revised: 3 November 2016 Accepted: 8 December 2016 Heliyon 2 (2016) e00215 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
"The Wind Erosion Prediction System (WEPS) model ( Hagen, 1991 ;Wagner, 2013 ) was developed by the USDA-Agricultural Research Service, primarily for use by the USDA NaturalResources Conservation Service (NRCS) to: 1) assist land managers in controlling Article No~e00215 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
"1 , WEPS has a modular structure that consists of a user interface (programmed in Java), a science model (programmed in FORTRAN) with a main controlling routine and sixscience submodels (hydrology, management, soil, crop growth, crop residue Article No~e00215 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.",OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
"SWEEP requires input of 38 parameters (as described in Feng and Sharratt, 2009 ) that define crop and residue characteristics (e.g., growing and dead crop leaf area index and residueflat cover), soil properties (e.g., geometric mean diameter of aggregate size and Article No~e00215 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
"Wind barriers Wind barriers are typically, linear, vertical structures of live or artificial material put in place to reduce the force of the wind on the surface and thus reduce wind Article No~e00215 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Standing population Standing mass at 0.1 m heightFlat mass Soil loss Suspension loss (# stems m−2) (kg ha−1) (kg ha−1) (kg m−2yr−1) (kg m−2yr−1) 00 0 2 5 1 7 20 200 0 18 1250 500 0 3.2 2.1 50 500 300 0.6 0.3 100 1000 0 0.2 0.1 200 2000 0 0.03 0.02 Article No~e00215 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Grid side length Length of bales needed to grid a 25 ha fieldGross soil loss Net soil loss Net suspension loss (m) (m) (kg m−2yr−1) (kg m−2yr−1) (kg m−2yr−1) 5 10000 0 0 0 10 2500 0.02 0.02 0.001 50 1000 0.33 0.18 0.05 100 500 0.8 0.6 0.2 200 250 4.2 3.2 1.8300 167 9.6 9.6 4.8 Article No~e00215 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
"Erosion control practice Total soil loss Creep + saltation soil loss Suspension soil loss PM-10 soil loss (kg m−2) (kg m−2) (kg m−2) (kg m−2) Bare field (no control) 6.2 2.9 3.3 0.13 Barrier (upwind) 5.7 2.7 3.0 0.12 Barriers (upwind and mid-field) 3.4 1.6 1.8 0.06 Barriers (upwind, mid-field, and downwind) 2.6 0.9 1.7 0.05Dust suppressant 0.3 0.17 0.14 0.01 Crimped straw 0.0 0.0 0.0 0.0 Article No~e00215 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Application of the wind erosion prediction Article No~e00215 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Engineering 6 (7) doi:http://dx.doi.org/10.4236/ eng.2014.67038 .,OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Accessed October 2015. http://www1.ncdc.noaa.gov/pub/data/ccd-data/CCD- 2012.pdf .,OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
doi:http://dx.doi.org/ 10.1029/2007GL030208 .,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
Article No~e00215 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00215 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/39/main.PMC5167244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EpilepsyDelta activitySurgeryPersisting seizures 1.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.001 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
107:69 –83.http://dx.doi.org/10.1016/ S0013-4694(98)00051-0 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
16:85 –93.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.yebeh.2010.11.009 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0735-13.2013 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/ S0140-6736(11)60890-8 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.clinph.2003.12.008 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.3171/2012.1.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1111/epi.12389 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
(URL http://www.martinos.org/meg/manuals/MNE-manual-2.7.pdf accessed 12.9.15).,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
2012:201651. http://dx.doi.org/10.1155/2012/ 201651 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.seizure.2005.07.007 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
NeuroImage 13:15 –28.http://dx.doi.org/10.1006/nimg.2000.,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.3171/jns.2002.96.4.0724 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1093/brain/awl364 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.11.,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1097/ 01.WNP.0000173201.86774.D6 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/ 10.1111/j.1528-1167.2007.01271.x .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.seizure.2014.,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/ 10.1001/jamaneurol.2013.209 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
2011:156869. http://dx.doi.org/10.1155/2011/156869 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1111/j.1528-1157.1995.tb00990.x .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1093/brain/124.9.1683 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1212/ 01.WNL.0000147476.86575.A7 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1002/ana.23862 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.3171/2013.4.FOCUS1357 .,Non-OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
116:9 –17.http://dx.doi.org/10.1016/j.clinph.2004.07.032 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.06.040 .,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
15:70 –73.http://dx.doi.org/10.1109/TAU.1967.1161901 .263 M. Schönherr et al.,OADS,/arxiv_data1/oa_pdf/67/96/main.PMC5167245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/e8/main.PMC5167246.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.11.004,OADS,/arxiv_data1/oa_pdf/69/e8/main.PMC5167246.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/87/main.PMC5167247.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.11.058 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/87/main.PMC5167247.pdf
[20]  National  Comprehensive  Cancer  Network  (NCCN)  guidelines  on  gastric  cancer Available online at  http://www.nccn.org/professionals/physician gls/f guidelines.asp  last  accessed  September  2016.,Non-OADS,/arxiv_data1/oa_pdf/d5/87/main.PMC5167247.pdf
"Available  online  at  http://www.aiom.it/professionisti/ documenti-scientiﬁci/linee-guida/stomaco/1,7121 ,  last  accessed  September 2016.",Non-OADS,/arxiv_data1/oa_pdf/d5/87/main.PMC5167247.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/1c/main.PMC5167248.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.11.006,OADS,/arxiv_data1/oa_pdf/2f/1c/main.PMC5167248.pdf
Available from: http://www.cec.health.nsw.gov.au/__data/assets/ pdf_ﬁle/0007/136960/pfsc_toolkit.pdf 19.,OADS,/arxiv_data1/oa_pdf/24/77/JMRS-63-203.PMC5167277.pdf
Available from: http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/24/77/JMRS-63-203.PMC5167277.pdf
"pl [b]Dr.Z.Banaszkiewicz Depar tment ofSurgery,Faculty ofMedicine Nicolau sCopernic usUniv ersity inTorun´ Collegiu mM edicum inBydgo szcz Ujejskieg o75,85-168 Bydg oszcz (Poland) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160010 3.",Non-OADS,/arxiv_data1/oa_pdf/b7/bd/OPEN-5-550.PMC5167278.pdf
"[a]M.Y.Steve ns,Dr.S.Y.Chow,Dr.L.R.Odell Depar tment ofMedicinal Chemi stry Divisio nofOrganic Phar maceutica lChemistry ,UppsalaUniversit y 75123 Upps ala(Sweden) E-mail :luke.ode ll@orgfa rm.uu.s e [b]Dr.S.Estrada, V.Asplun d,Dr.O./C138berg Depar tment ofMedicinal Chemi stry Preclinic alPETPlatform, Uppsala Unive rsity 75183 Upps ala(Sweden) [c]Dr.J.Eriksson,Dr.A.Orlova ,B.Mitran, Dr.G.Anton i Depar tment ofMedicinal Chemi stry Divisio nofMolecular Imaging ,Uppsa laUniversit y 75183 Upps ala(Sweden) [d]Dr.M.Larhed Depar tment ofMedicinal Chemi stry Science forLifeLabor atory ,Uppsala Unive rsity 75123 Upps ala(Sweden) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160009 1.",Non-OADS,/arxiv_data1/oa_pdf/1f/a6/OPEN-5-566.PMC5167284.pdf
"644, 48080 Bilbao (Spain) E-mail :humbe rto.gonzalezd iaz@ehu .eus esther .lete@ehu.e us [b]Prof. H.Gonz /C181lez-D/C237az IKERBASQ UE Basque Founda tion forScience 48080 Bilbao (Spain) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160012 0.",Non-OADS,/arxiv_data1/oa_pdf/6a/49/OPEN-5-540.PMC5167290.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/53/tcrm-12-1849.PMC5167295.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1849–1853Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1849ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12421 2 Clinical features of brain metastases in breast  cancer: an implication for hippocampal-sparing  whole-brain radiation therapy san-gang Wu1,* Jia-Yuan sun2,* Qin T ong3 Feng-Yan li2 Zhen-Yu he2 1Department of Radiation Oncology,   Xiamen Cancer hospital, The First  affiliated hospital of Xiamen  University, Xiamen, 2Department  of Radiation Oncology, sun Yat-sen  University Cancer Center, state Key  laboratory of Oncology in south  China, Collaborative innovation  Center of Cancer Medicine,   guangzhou, 3Department of Radiation  Oncology, The First affiliated hospital  of University of south China,   hengyang, People’s Republic of China *These authors contributed equally  to this workObjective:  The objectives of this study were to describe the distribution of brain metastases  (BM) in breast cancer patients and investigate the risk factors for perihippocampal metas - tases (PHM).",Non-OADS,/arxiv_data1/oa_pdf/76/53/tcrm-12-1849.PMC5167295.pdf
"Existing studies recommend delaying WBRT to prevent neurocognitive  decline secondary to the observation of no benefit in the overall survival.2,3 The median  overall survival time for breast cancer patients with BM treated with WBRT or SRS  was 4–6 months and up to 16 months if solitary BM could be removed surgically.4,5 WBRT is associated with a range of toxicities, including significant deteriora - tion in neurocognitive function and quality of life (QoL).6,7 The hippocampus is Correspondence: Zhen-Yu he Department of Radiation Oncology, sun  Yat-sen University Cancer Center, state  Key laboratory of Oncology in south  China, Collaborative innovation Center  of Cancer Medicine, 651 Dongfeng  Road east, guangzhou 510060, People’s  Republic of China Tel +86 20 8734 3543 Fax +86 20 8734 3392 email hezhy@sysucc.org.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wu et al Running head recto: Risk of HM in metastatic breast cancer DOI: http://dx.doi.org/10.2147/TCRM.S124212",Non-OADS,/arxiv_data1/oa_pdf/76/53/tcrm-12-1849.PMC5167295.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/76/53/tcrm-12-1849.PMC5167295.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/53/tcrm-12-1849.PMC5167295.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/f2/tcrm-12-1841.PMC5167296.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1841–1847Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1841ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10528 0 Kinetics of circulating endothelial progenitor cells  in patients undergoing carotid artery surgery günay Kalender1 angela Kornberger2 Milan lisy1 andres Beiras-Fernandez2 Ulrich a stock2 1Deparment of general, Thoracic and  Vascular surgery, hoechst hospital,   2Department of Thoracic and  Cardiovascular surgery, University  hospital Frankfurt, Frankfurt am Main,   germanyAim:  Endothelial progenitor cells (EPCs) are primitive cells found in the bone marrow and  peripheral blood (PB).",Non-OADS,/arxiv_data1/oa_pdf/67/f2/tcrm-12-1841.PMC5167296.pdf
"Keywords:  endothelial, progenitor, cells, carotid, artery, surgery Introduction Endothelial progenitor cells (EPCs) are predifferentiated adult stem cells with  a potential to proliferate and differentiate into mature endothelial cells (ECs).1–3  In contrast to mature ECs, which are differentiated cells with low proliferative potential  and limited ability to regenerate damaged endothelium, EPCs have a high proliferative  potential, contribute to reendothelialization after vascular injury, and are involved  in neovascularization of ischemic tissues.4–6 Levels of circulating EPCs are known  to be reduced in patients with cardiovascular disease7 or patients at risk of cardio - vascular disorder.8 EPC levels have also been shown to be predictive of mortality in  patients with coronary artery disease.9,10 Recently, EPCs have gained more interest for  potential clinical applications as in vivo  endothelialization of biologic and prosthetic  materials.11 As a proof of concept, we have shown in previous works the capacity of Correspondence: andres Beiras- Fernandez Department of Thoracic and  Cardiovascular surgery, University  hospital Frankfurt, Theodor-stern-Kai 7,  60590 Frankfurt am Main, germany Tel +49 69 6301 6112 Fax +49 69 6301 4391 email andres.beiras@kgu.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kalender et al Running head recto: Circulating EPCs DOI: http://dx.doi.org/10.2147/TCRM.S105280",Non-OADS,/arxiv_data1/oa_pdf/67/f2/tcrm-12-1841.PMC5167296.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/67/f2/tcrm-12-1841.PMC5167296.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/f2/tcrm-12-1841.PMC5167296.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 497–503Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  497 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S120735Prevalence of cardiovascular risk factors among  workers at a private tertiary center in Angola Feliciano Chanana Paquissi1 Valdano Manuel2 Ana Manuel2 Guiomar Lote Mateus1 Bruna David2 Gertrudes Béu3 Anselmo Castela3 1Department of Medicine, 2Cardio- Thoracic Center, 3Service of  Endocrinology, Department of  Medicine, Clínica Girassol, Luanda,  AngolaBackground: The burden of cardiovascular diseases (CVD) is increasing in most countries of  sub-Saharan Africa.",Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"3,8 However, the health system of most countries in Correspondence: Feliciano Chanana  PaquissiDepartment of Medicine, Clínica Girassol, Comandante Gika 225, Luanda, AngolaTel +55 119 5702 1718Email fepaquissi@gmail.comJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: Paquissi et alRunning head recto: Prevalence of cardiovascular risk factors in AngolaDOI: http://dx.doi.org/10.2147/VHRM.S120735",Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
Available from: http://www.who.int/nmh/countries/gbr_en.pdf?ua= 1.,OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11234459.,Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
Available from: http://apps.who.int//iris/handle/10665/43588.,OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"Available from: https://scholar.google.com.br/scholar?cluster= 14268895851298319893&hl= en &as_sdt=2005&sciodt=0,5.",Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 503 Prevalence of cardiovascular risk factors in Angola 48.,Non-OADS,/arxiv_data1/oa_pdf/e2/ba/vhrm-12-497.PMC5167297.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/f9/tcrm-12-1855.PMC5167298.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1855–1860Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1855ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12301 1 impact of preoperative chronic renal failure on  liver transplantation: a population-based cohort  study Peter Chi-ho Chung1,2 hsiu-Pin Chen1,2 Jr-Rung lin3,4 Fu-Chao liu1,2 huang-Ping Yu1,2 1Department of anesthesiology, Chang  gung Memorial hospital, 2College of  Medicine, 3Clinical informatics and  Medical statistics Research Center,   4graduate institute of Clinical  Medicine, Chang gung University,   Taoyuan, TaiwanPurpose:  The purpose of this study was to assess whether preoperative chronic renal failure  (CRF) affects the rates of postoperative complications and survival after liver transplantation.",Non-OADS,/arxiv_data1/oa_pdf/56/f9/tcrm-12-1855.PMC5167298.pdf
"Materials and methods Data collection The Bureau of National Health Insurance established the National Health Insurance  Research Database (NHIRD) in 1992, and provides de-identified and computerized Correspondence: huang-Ping Yu Department of anesthesiology, Chang  gung Memorial hospital, 5 Fu-shin  street, Kwei-shan, Taoyuan 333, Taiwan Tel +886 3 328 1200 ext 2324 Fax +886 3 328 1200 ext 2787 email yuhp2001@adm.cgmh.org.t w Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Chung et al Running head recto: Preoperative renal failure on liver transplantation DOI: http://dx.doi.org/10.2147/TCRM.S123011",Non-OADS,/arxiv_data1/oa_pdf/56/f9/tcrm-12-1855.PMC5167298.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/56/f9/tcrm-12-1855.PMC5167298.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/f9/tcrm-12-1855.PMC5167298.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2531–2541Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2531OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11957 0 communication practices and awareness of  resources for acromegaly patients among  endocrinologists susan Polanco-Briceno1 Daniel glass1 cindy Plunkett2 1Deerfield institute, new Y ork,   nY, UsA; 2Department of internal  Medicine, Metabolism endocrinology  & Diabetes (M enD), University of  Michigan, Ann Arbor, M i, UsAPurpose:  This study was designed to assess the awareness and utilization of resources to  improve patients’ treatment experiences among endocrinologists who currently treat patients  with acromegaly.",Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
"Keywords:  financial support programs, emotional support programs, referrals Introduction Acromegaly, a complex disorder caused by hypersecretion of growth hormone by  somatotrophs in the pituitary gland, often due to a pituitary tumor,1,2 is associated with  significantly impaired quality of life (QoL).3 Symptoms of acromegaly, which com - monly include fatigue, joint pain, snoring, excessive sweating, and headaches, often  interfere with daily life activities.1,4 Acromegaly-related comorbidities and complica - tions (eg, cardiovascular disease, diabetes, cancer, kidney failure, hypothyroidism,  bone/joint abnormalities, and sleep apnea)1,5–9 further contribute to decreased QoL10 correspondence: susan Polanco-Briceno Deerfield Institute, 780 Third Avenue,  37th floor, New York, NY 10017, USA Tel +1 212 551 1600 email spolanco-briceno@deerfield.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Polanco-Briceno et al Running head recto: Communication practices for acromegaly patients DOI: http://dx.doi.org/10.2147/PPA.S119570",Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
pituitary.org.u k); Pituitary society ( www.pituitarysociety.or g); You and Your hormones ( http://www.yourhormones.inf o); Pituitary network Association ( www.pituitary.,Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
"#Significant  overall difference (chi-square P=0.004) between B and C; significant pairwise differences ( P,0.05) for “familiar with, but do not routinely refer” and for “not familiar  with.” Financial assistance for lanreotide ( http://acromegaly.somatulinedepot.com/resources/copay-savings-program s); Financial assistance for octreotide and pasireotide  (1-877-LAR-IN FO, peak Pituitary Education, Access, and Knowledge, www.endocrineaccessnow.co m).",Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
Available from: http://www.casro.org/?page =TheCASROCode201 4.,Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/05/66/ppa-10-2531.PMC5167300.pdf
"[20]These unique colloid albehav iors arise from physico chem ical properties ofthe surfac edsDNA layer , becau sethesecolloid albehaviors areobserved irrespective of[a]Dr.Y.Akiyama, Dr.G.Wang, S.Shiraishi, Dr.N.Kanayama ,Dr.T.Takarada, Prof. Dr.M.Maeda Bioeng ineering Labor atory ,RIKEN 2-1Hirosawa, Wako, Saita ma351-0198 (Japan) E-mail :ttkrd@r iken.jp [b]Dr.Y.Akiyama Faculty ofIndustr ialScience and Techno logy TokyoUniv ersity ofScience, 102-1 Tomino Oshamamb e-cho, Yamako shi-g un,Hokkaid o049-351 4(Japa n) [c]Dr.N.Kanayama Interdis ciplinary Grad uate Schoo lofScience and Technolo gy Shinshu Universi ty,4-7-1 Wakasato Nagano -shi, Nagano 380-8553 (Japan) ORCID identification numbe r(s)fortheautho r(s)ofthisarticle canbe found unde rhttp://dx.doi.o rg/10.1 002/ open.2016 00110.",OADS,/arxiv_data1/oa_pdf/db/d7/OPEN-5-508.PMC5167314.pdf
uk Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160010 1.,Non-OADS,/arxiv_data1/oa_pdf/63/12/OPEN-5-531.PMC5167317.pdf
Dr.H.Wang Schoo lofPharmac eutical Scienc es Sun Yat-senUnive rsity Guang zhou 510006 (P.R.China) E-mail :wanghg 3@mail .sysu.edu.cn Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160009 6.,Non-OADS,/arxiv_data1/oa_pdf/30/93/OPEN-5-535.PMC5167326.pdf
Available from: http://www.healthconsult.com.au/wp- content/uploads/knowledgebase/2009_Health ConsultRadOncWorkPlanFinalReportDoHA.pdff.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: https://members.air.asn.au/cms_ﬁles/policies_guidelines/ pps_air_dec2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: http://www.ranzcr.edu.au/quality-a-safety/ radiation-oncology/tripartite-radiation-oncology-practice- standards.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: https://members.air.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: https://www2.health.vic.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: https://www.astro.org/uploadedFiles/ Main_Site/Clinical_Practice/Patient_Safety/Blue_Book/ SafetyisnoAccident.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: http://www.who.int/patientsafety/activities/ technical/radiotherapy_risk_proﬁle.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
Available from: http://www.safetyandquality.gov.au/our-work/accreditation- and-the-nsqhs-standards/resources-to-implement-the- nsqhs-standards/#NSQHS-Standards.,Non-OADS,/arxiv_data1/oa_pdf/34/94/JMRS-63-209.PMC5167329.pdf
"[a]J.A.M.Lugg er,Prof.Dr.R.P.Sijbes ma Laborator yofMacro molecular and Organic Chemi stry and theInstitute forComplex Molec ular Systems Eindho venUniversit yofTechnology P.O.Box 513,5600 MBEindho ven(The Nethe rlands) E-mail :r.p.sijbesma @tue.nl Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160007 8.",Non-OADS,/arxiv_data1/oa_pdf/78/aa/OPEN-5-580.PMC5167330.pdf
Available from: http://www.eviQ.org.au.10.,Non-OADS,/arxiv_data1/oa_pdf/22/cc/JMRS-63-217.PMC5167335.pdf
"Gaithersburg, MD: National Institute of Standards and Technology, http://webbook.nist.gov (accessed: March 3,2016 ) Strupat K, Karas M, Hillenkamp F, Eckerskorn C, Lottspeich F ( 1994 ) Matrix- assisted laser desorption ionization mass spectrometry of proteins ª2016 The Authors The EMBO Journal Vol35|N o 24|2016Philip Lössl et al Mass spectrometry strategies in molecular biology The EMBO Journal 2655",Non-OADS,/arxiv_data1/oa_pdf/a9/35/EMBJ-35-2634.PMC5167345.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MappingTrait dissectionWheat MAGIC NAM Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
http://dx.doi.org/10.1016/j.atg.2016.10.002 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
The scripts used to implement these methods are available ( http://www.niab.,OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
The program is written in C++ and is available to download from http://www.niab.com/pages/id/326/Resources .,OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
PLoS One 11:1 –22.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
16:167. http://dx.doi.org/10.1186/s13059-015-0716-z .,Non-OADS,/arxiv_data1/oa_pdf/3d/90/main.PMC5167364.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Breast cancer Health care infrastructure Health policyAccessComparative analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/c6/main.PMC5167368.pdf
http://dx.doi.org/10.1016/j.atg.2016.09.001 2212-0661/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/d7/c6/main.PMC5167368.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/c6/main.PMC5167368.pdf
"Ticked boxes are linked to certain point values, which may be added up and, when the score is three or higher, indicate a need to refer a woman to one of the consortium centers (see http://www.konsortium- familiaerer-brustkrebs.de/medien/user_upload/8_Checkliste.pdf; accessed 14 July 2016).",Non-OADS,/arxiv_data1/oa_pdf/d7/c6/main.PMC5167368.pdf
"The contrast between this German practice and the situation in the Netherlands is perhaps the greatest, since genetic services in the latter are by law restricted to eight centers associated with academic hospitals (see http://wetten.overheid.nl/BWBR0014594/2009-03-05 , accessed 14 July 2016).",Non-OADS,/arxiv_data1/oa_pdf/d7/c6/main.PMC5167368.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Wheat quality Genomic selectionWheat breeding Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/e3/c1/main.PMC5167370.pdf
http://dx.doi.org/10.1016/j.atg.2016.10.004 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/c1/main.PMC5167370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/c1/main.PMC5167370.pdf
http://dx.doi.org/10.3835/plantgenome2016.01.0005 .,OADS,/arxiv_data1/oa_pdf/e3/c1/main.PMC5167370.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/j.atg.2016.10.001 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"With progressive ge- netic technologies in detecting disease-associated mtDNA mutations, over 300 rRNA/tRNA mutations ( http://www.mitomap.org/foswiki/ bin/view/MITOMAP/MutationsRNA ) and over 300 coding/control re- gion point mutations have now been identi ﬁed ( http://www.",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"They are the techniques that have been mentioned both in an ethical review of mtDNA disease prevention by the Nufﬁeld Council on Bioethics (2012) , as well as in the Human Fertilisation andEmbryology Authority (HFEA) public debates and review reports (summarised in an updated 2014 HFEA review, which can be accessed at: http://www.hfea.gov.uk/docs/Third_Mitochondrial_replacement_ scienti ﬁc_review.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 came into force on 29th October 2015 and can be accessed at: http://www.legislation.gov.uk/uksi/2015/572/pdfs/uksi_20150572_ en.pdf However, only one case of human pronuclear transfer has been re- ported, and it was performed in abnormally fertilised zygotes ( Craven et al., 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"125, 41 –52.http://dx.doi.org/10.1007/s00439-008- 0603-8 .",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1017/s0967199400002793 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"101, 31 –35.http://dx.doi.org/10.1016/j.fertnstert.2013.11.030 .",OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"21, 79 –83.http://dx.doi.org/10.1023/B:JARG.0000027018.02425.15 .",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"99, 18 –22.http://dx.doi.org/10.1016/j.fertnstert.2012.11.031 .Bentov, Y., Yavorska, T., Esfandiari, N., Jurisicova, A., Casper, R.F., 2011.",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1007/s10815-011-9588-7 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"Lancet 368, 87 –89.http://dx.doi.org/10.1016/ s0140-6736(06)68972-1 .",OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/j.jns.2005.03.012 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"Mitochondrion 11, 33 –39.http://dx.doi.org/10.1016/j.mito.2010.07.003 .",OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
10. http://dx.doi.org/10.1371/ journal.pgen.1004315 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"Nature 465, 82–85.http://dx.doi.org/10.1038/nature08958 .",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1093/ hmg/ddr373 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/ 10.1002/ana.75 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/ 10.1089/clo.2006.0082 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"(77), 6715 –6719 http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
4 http://dx.doi.org/10.1038/srep03844 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1101/gr.7160508 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/ 10.1089/cell.2012.0089 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1093/geronj/11.3.298 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/s0015- 0282(99)00309-x .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1093/humupd/dmi042 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"89, 24. http://dx.doi.org/10.1095/biolreprod.113.110098 .",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1146/ annurev.genet.29.1.151 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"17, 24 –38.http://dx.doi.org/10.1002/jbt.",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/s0891-5849(98)00208-1 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1038/ng.2393 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/ 10.1016/j.cell.2015.03.051 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1093/molehr/7.5.425 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/1357- 2725(95)00025-k .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"http://dx.doi.org/10.1126/science.1088434 .Steinborn, R., Schinogl, P., Zakhartchenko, V., Achmann, R., Schernthaner, W., Stojkovic, M., Wolf, E., Müller, M., Brem, G., 2000.",OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/ 10.1038/nature08368 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1038/nrg1606 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/ s1567-7249(01)00013-7 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"21, 23 –30.http://dx.doi.org/10.1093/molehr/gau042 .",Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1093/humrep/13.10.2857 .,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1016/j.gene.2005.05.001 .,OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
http://dx.doi.org/10.1210/me.,Non-OADS,/arxiv_data1/oa_pdf/46/b9/main.PMC5167373.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/85/ott-9-7563.PMC5167382.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7563–7571OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7563Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12398 6 lipopolysaccharide-induced α-catenin  downregulation enhances the motility of  human colorectal cancer cells in an nF- κB  signaling-dependent manner guoping cheng1,2 shifeng Yang1 gu Zhang1 Yanxia Xu3 Xiaoling liu3 Wenyong sun1,2 liang Zhu3 1Department of Pathology, Zhejiang  cancer hospital, 2cancer research  institute, Zhejiang cancer hospital  and Key laboratory Diagnosis and  Treatment Technology on Thoracic  Oncology of Zhejiang Province,   3school of Medicine, hangzhou  normal University, hangzhou,   Zhejiang, People’s republic of chinaAbstract:  α-Catenin is an important molecule involved in the maintenance of cell–cell  adhesion and a prognostic marker in cancer since its expression is essential for preventing cancer  metastasis.",Non-OADS,/arxiv_data1/oa_pdf/32/85/ott-9-7563.PMC5167382.pdf
"It functions as an interface between the cadherin–catenin pro - tein complex and the actin cytoskeleton, where it maintains the integrity of intercellular  adherens junctions by directly binding to actin filaments.2 Therefore, loss of α-catenin,  which has been reported in several malignancies, can weaken cell–cell adhesion and  promote abnormal cellular polarity, epithelial–mesenchymal transition (EMT), and  ultimately tumor metastasis.2–5 In addition, α-catenin is an inhibitor of multiple signaling  pathways involved in carcinogenesis and development, including the Wnt/ β-catenin,  Hippo-YAP, hedgehog, and NF- κB pathways.6–10 Although α-catenin is closely related  to cancer progression, little is known about its regulation in cancer cells.correspondence: liang Zhu school of Medicine, hangzhou normal  University, no 16 Xuelin rd, Xiasha  District, hangzhou, Zhejiang 310036,  People’s republic of china Tel +86 571 8812 8255 Fax +86 571 8812 8261 email zhuliang@zjcc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cheng et al Running head recto: Lipopolysaccharide and colorectal cancer cell motility DOI: http://dx.doi.org/10.2147/OTT.S123986",Non-OADS,/arxiv_data1/oa_pdf/32/85/ott-9-7563.PMC5167382.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/85/ott-9-7563.PMC5167382.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/85/ott-9-7563.PMC5167382.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Regenerative medicineCommercializationCell-based therapiesRegulationInstitutional changeCanada 1.,Non-OADS,/arxiv_data1/oa_pdf/79/b1/main.PMC5167439.pdf
http://dx.doi.org/10.1016/j.atg.2016.11.001 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/b1/main.PMC5167439.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/b1/main.PMC5167439.pdf
(http://ccrm.ca/industry-consortium )28 R. Isasi et al.,OADS,/arxiv_data1/oa_pdf/79/b1/main.PMC5167439.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 789–799Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 789 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S122300 Validation of celiac disease diagnoses recorded  in the Danish National Patient Register using  duodenal biopsies, celiac disease-specific  antibodies, and human leukocyte-antigen genotypes Stine Dydensborg Sander1–3 Ketil Størdal4,5 Tine Plato Hansen6 Anne-Marie Nybo  Andersen7 Joseph A Murray8 Søren Thue Lillevang9 Steffen Husby1,2 1Hans Christian Andersen Children’s  Hospital, Odense University Hospital,   2Institute of Clinical Research,   University of Southern Denmark,   3Odense Patient Data Explorative  Network (OPEN), Odense University  Hospital, Odense, Denmark; 4Mental  and Physical Health, Norwegian Institute of Public Health, Oslo,   5Department of Pediatrics, Ostfold  Hospital Trust, Fredrikstad, Norway;   6Department of Pathology, Hvidovre  Hospital, 7Department of Public  Health, University of Copenhagen,  Copenhagen, Denmark;  8Division of  Gastroenterology and Hepatology,  Mayo Clinic, Rochester, MN, USA;   9Department of Clinical Immunology,   Odense University Hospital, Odense,  DenmarkPurpose: The purpose of this study was to validate the celiac disease diagnoses recorded in  the Danish National Patient Register.",Non-OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
"It is characterized by various combinations of clinical manifestations, celiac disease-specific antibodies, human leukocyte antigens (HLAs) DQ2 or DQ8, and enteropathy.Correspondence: Steffen Husby Hans Christian Andersen Children’s Hospital, Odense University Hospital, 23C Kløvervænget, Odense C 5000, DenmarkTel +45 6541 2090Fax +45 6591 1862Email steffen.husby@rsyd.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Dydensborg Sander et alRunning head recto: Validation of celiac disease diagnosesDOI: http://dx.doi.org/10.2147/CLEP .S122300",Non-OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
"The Patobank The Patobank is a national Danish pathology database that includes pathology reports containing information on the dates of duodenal biopsies, macroscopic and microscopic descriptions of the biopsies, the conclusions, and topo-graphic, morphologic, and diagnostic codes based on the Systematized Nomenclature of Medicine (SNOMED; http://www.patobank.dk).",OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/f6/ca/clep-8-789.PMC5167452.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 187–194Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 187 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S117497Incidence and prevalence of elite male cricket  injuries using updated consensus definitions John W Orchard Alex Kountouris Kevin Sims 1National Cricket Centre, Cricket  Australia, Brisbane, AustraliaBackground: T20 (Twenty20 or 20 over) cricket has emerged in the last decade as the most  popular form of cricket (in terms of spectator attendances).",Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"The initial 2005 definitions contained many definitions that Correspondence: John W Orchard Sports Medicine at Sydney University, University of Sydney, Corner Western Avenue and Physics Road, NSW 2006, AustraliaTel +61 2 9351 8118Email john.orchard@sydney.edu.auJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Orchard et alRunning head recto: Incidence and prevalence of elite male cricket injuries DOI: http://dx.doi.org/10.2147/OAJSM.S117497",Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"This study used de-identified data extracted from the injury surveillance system, which presents no risk of harm to any of the current or past players, so it is also considered to be of negligible risk and therefore requires internal only rather than external ethical review under National Health and Medical Research Council guidelines (statement available from https://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/ethics/human_research/NS_low_risk_flow_chart.pdf; Accessed May 7, 2016).Results Injury incidence Match injury incidence is presented in Table 1 in the new  consensus unit of injuries per 1,000 days of play.",Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/a8/oajsm-7-187.PMC5167453.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/de/copd-11-3199.PMC5167454.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3199–3205International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3199OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11810 9 rates and predictors of depression status among  caregivers of patients with COPD hospitalized for  acute exacerbations: a prospective study roberto Bernabeu-Mora1–3 gloria garcía-guillamón2 Joaquina Montilla- herrador2,3 Pilar escolar-reina2,3 José antonio garcía-Vidal2 Francesc Medina-Mirapeix2,3 1Division of Pneumology, hospital  Morales Meseguer, 2Department  of Physical Therapy, University of  Murcia, 3Physiotherapy and Disability  research group, Instituto Murciano  de Investigación Biosanitaria Virgen de  la arrixaca (IMIB), Murcia, spainBackground:  Hospitalization is common for acute exacerbation of COPD, but little is known  about its impact on the mental health of caregivers.",Non-OADS,/arxiv_data1/oa_pdf/34/de/copd-11-3199.PMC5167454.pdf
"Depressive symptoms are  commonly reported by caregivers of patients with COPD,4–6 with a frequency similar to that  of depressive symptoms among caregivers of patients with mental illness or cancer.4Correspondence: roberto  Bernabeu-Mora Division of Pneumology, hospital  general Universitario Morales Meseguer,  avda Marqués de los Velez s/n,  30008 Murcia, spain Tel +34 968 360 900 Fax +34 968 360 994 email rbernabeumora@hotmail.c o Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Bernabeu-Mora et al Running head recto: Depression among caregiver of COPD DOI: http://dx.doi.org/10.2147/COPD.S118109",Non-OADS,/arxiv_data1/oa_pdf/34/de/copd-11-3199.PMC5167454.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/34/de/copd-11-3199.PMC5167454.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/de/copd-11-3199.PMC5167454.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/e1/cia-11-1805.PMC5167455.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1805–1813Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1805OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11086 5 A comparison between metatarsal head-resurfacing  hemiarthroplasty and total metatarsophalangeal  joint arthroplasty as surgical treatments for hallux  rigidus: a retrospective study with short- to  midterm follow-up Musa Ugur Mermerkaya1 houman Adli2 1Department of Orthopaedics and  Traumatology, Medical school,   Bozok University, 2Department of  Orthopaedics and Traumatology,   Y ozgat state hospital, Y ozgat, T urkeyPurpose:  We evaluated the short- to midterm outcomes of metatarsal head-resurfacing  hemiarthroplasty and total metatarsophalangeal joint arthroplasty (total joint replacement [TJR])  as surgical treatments for advanced-stage hallux rigidus (HR).",Non-OADS,/arxiv_data1/oa_pdf/59/e1/cia-11-1805.PMC5167455.pdf
"Keywords:  hallux rigidus, arthroplasty, surgical treatment, HemiCAP®, ToeFit-Plus® Introduction Hallux rigidus (HR) is a common degenerative foot disease characterized by pain and  a decreased range of motion (ROM) of the first metatarsophalangeal joint (MTPJ).1  HR can be either idiopathic or traumatic (micro- or macrotrauma to the cartilage of the  first MTPJ can damage, and trigger erosion of, joint surfaces) and is associated with  the production of dorsal osteophytes.2–7 Several conservative and surgical treatment  options have been reported in the literature; age, activity level, patient expectations, Correspondence: Musa Ugur Mermerkaya Department of Orthopaedics and  Traumatology, Medical school, Bozok  University, Yozgat 66200, Turkey Tel +90 532 334 6696 email drugurmermerkaya@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Mermerkaya and Adli Running head recto: MT head-resurfacing hemiarthroplasty versus total MTPJ arthroplasty DOI: http://dx.doi.org/10.2147/CIA.S110865",Non-OADS,/arxiv_data1/oa_pdf/59/e1/cia-11-1805.PMC5167455.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/59/e1/cia-11-1805.PMC5167455.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/59/e1/cia-11-1805.PMC5167455.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/52/dddt-10-4031.PMC5167456.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4031–4045Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4031Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12061 3 Transbuccal delivery of betahistine dihydrochloride  from mucoadhesive tablets with a unidirectional  drug flow: in vitro, ex vivo and in vivo evaluation Mohamed a el-n abarawi1 adel a ali2 heba M aboud2 amira h hassan2 amany h godah2 1Department of Pharmaceutics,   Faculty of Pharmacy, cairo University,   cairo, 2Department of Pharmaceutics,   Faculty of Pharmacy, Beni- suef  University, Beni-suef, egyptObjective:  Betahistine dihydrochloride (BH.2HCl), an anti-vertigo histamine analog used in  the treatment of Ménière’s disease, undergoes extensive first-pass metabolism and suffers from  short biological half-life.",Non-OADS,/arxiv_data1/oa_pdf/19/52/dddt-10-4031.PMC5167456.pdf
"Keywords:  betahistine dihydrochloride, transbuccal delivery, unidirectional drug flow,  permeation enhancer, relative bioavailability Introduction Mucoadhesive buccal delivery of drugs is considered as an alternative to oral  administration, especially for drugs which suffer from first-pass metabolism.1 The  buccal route can solve troubles encountered with oral administration of drugs such  as considerable hepatic metabolism, drug decomposition in the gastrointestinal  tract and avoidance of invasiveness of parenteral route.2 Several advantages of the  buccal route have been reported, including: 1) robustness of the epithelium; 2) better  accessibility; 3) easy removal of dosage form as needed and 4) relatively low suscep - tibility to enzymatic activity.3correspondence: adel a ali Department of Pharmaceutics, Faculty of  Pharmacy, Beni-suef University, el shahed  shehata ahmed hegazy st., Beni-suef,  egypt Tel +20 822 317 958 email adel.ali@pharm.bsu.edu.e g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: El-Nabarawi et al Running head recto: Transbuccal delivery of betahistine dihydrochloride DOI: http://dx.doi.org/10.2147/DDDT.S120613",Non-OADS,/arxiv_data1/oa_pdf/19/52/dddt-10-4031.PMC5167456.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/19/52/dddt-10-4031.PMC5167456.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/52/dddt-10-4031.PMC5167456.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6781–6794International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6781OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10710 7 Novel antimicrobial peptide–modified  azithromycin-loaded liposomes against methicillin- resistant Staphylococcus aureus Xiaowei liu1,* Zhan li1,* Xiaodong Wang2,3 Yujuan chen2,3 Fengbo Wu2,3 Ke Men1 Ting Xu2,3 Yan luo1 li Yang1 1state Key laboratory of Biotherapy/ collaborative Innovation center for  Biotherapy, 2Department of Thyroid  and Breast surgery, 3Department  of Pharmacy, West china hospital,   sichuan University, chengdu, People’s  republic of china *These authors contributed equally  to this workAbstract:  Infections caused by multidrug-resistant bacteria, such as methicillin-resistant  Staphylococcus aureus  (MRSA), have become a public threat; therefore, development of new  antimicrobial drugs or strategies is urgently required.",Non-OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
"Keywords:  DP7-C, azithromycin, antimicrobial resistance, MRSA infections, immune- regulation Introduction Antimicrobial resistance has reached alarming levels in many parts of the world,  which has induced high morbidity and mortality.1–3 In particular, infections caused  by methicillin-resistant Staphylococcus aureus  (MRSA), vancomycin-resistant  Enterococcus , and other resistant bacteria have posed significant clinical challenges  to physicians.4 However, although there is a rapid increase in antimicrobial resistance,  only a limited number of new antibiotic drugs are available; many new drugs having  failed to be developed further into the market because of poor hydrophilicity, high  toxicity, highly expensive production costs, and less financially lucrative.5–7 Several  strategies, such as the combination of antibiotics with other antibiotics8–10 or compound correspondence: Yan luo; li Yang state Key laboratory of Biotherapy/ collaborative Innovation center for  Biotherapy, West china hospital,  sichuan University, No 17 People’s  south road, chengdu, sichuan 610041,  People’s republic of china Tel +86 28 8550 2879 Fax +86 28 8550 2796 email yanluo300@sina.co m;   yl.tracy73@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Host-defense peptide–modified liposomes against S. aureus  infection DOI: http://dx.doi.org/10.2147/IJN.S107107",Non-OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
Available from:  http://www.who.int/drugresistance/documents/surveillancereport/en /.,OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/cb/ijn-11-6781.PMC5167457.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/2d/ijn-11-6743.PMC5167458.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6743–6751International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6743OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11960 7 a novel hydrodynamic approach of drag-reducing  polymers to improve left ventricular hypertrophy  and aortic remodeling in spontaneously  hypertensive rats Xinlu Zhang,1,* Xu Wang,2,*  Feng hu,1 Boda Zhou,3 hai-Bin  chen,1 Daogang Zha,1 Yili liu,1  Yansong guo,4 lemin Zheng,2  Jiancheng Xiu1 1Department of cardiology, Nanfang  hospital, southern Medical University,   guangzhou, 2The Institute of cardiovascular  sciences and Institute of systems  Biomedicine, school of Basic Medical  sciences, and Key laboratory of Molecular  cardiovascular sciences of Ministry of  education, Peking University health science  center, 3Department of cardiology, Key  laboratory of Molecular cardiovascular  sciences of Ministry of education, and Key  laboratory of cardiovascular Molecular  Biology and regulatory Peptides of Ministry  of health, Peking University Third hospital,   Beijing, 4Department of cardiovascular  Medicine, Fujian Provincial hospital, Fuzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  Drag-reducing polymers (DRPs), when added in minute concentrations, have  been shown to decrease peripheral vascular resistance.",Non-OADS,/arxiv_data1/oa_pdf/b9/2d/ijn-11-6743.PMC5167458.pdf
"Keywords:  aortic remodeling, drag-reducing polymers, ET-1, hypertension, left ventricular  hypertrophy Introduction In both human and animal models, hypertension is associated with cardiac and aortic  remodeling.1–4 Cardiac remodeling is defined as genome expression resulting in  molecular, cellular and interstitial changes and manifested clinically as myocardial  hypertrophy, fibrosis and cardiac decompensation.1,5 Aortic remodeling is characterized  by impaired endothelium-dependent vasodilation and structural vascular changes;6 thus,  endothelium plays a primary role in the modulation of vascular tone and structure.7  Previous research showed that both cardiac and aortic remodeling can be exacerbated  by endothelin-1 (ET-1) overactivation.8correspondence: Jiancheng Xiu  Department of cardiology, Nanfang hospital,  southern Medical University, No 1838 guang  zhou da dao bei, Baiyun District, guangzhou  510515, People’s republic of china Tel +86 20 6278 7389 Fax +86 20 6136 0416 email xiujc@126.co m  lemin Zheng The Institute of cardiovascular sciences and  Institute of systems Biomedicine, school of  Basic Medical sciences, and Key laboratory of  Molecular cardiovascular sciences of Ministry  of education, Peking University health science  center, No 38 Xueyuan road, haidian District,  Beijing 100191, People’s republic of china Tel +86 10 8280 5452 Fax +86 10 8280 2769 email zhengl@bjmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Effects of DRPs on left ventricular hypertrophy and aortic remodeling DOI: http://dx.doi.org/10.2147/IJN.S119607",Non-OADS,/arxiv_data1/oa_pdf/b9/2d/ijn-11-6743.PMC5167458.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b9/2d/ijn-11-6743.PMC5167458.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/2d/ijn-11-6743.PMC5167458.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ijn-11-6621.PMC5167459.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6621–6634International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6621OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11369 2 coalescence of functional gold and monodisperse  silver nanoparticles mediated by black Panax  ginseng  Meyer root extract Dandan Wang1 Josua Markus2 Yeon-Ju Kim1 chao Wang1 Zuly elizabeth Jiménez  Pérez2 sungeun ahn1 Verónica castro aceituno1 ramya Mathiyalagan2 Deok chun Yang1,2 1Department of Oriental Medicine  Biotechnology and ginseng Bank,   2Department of Biotechnology  and ginseng Bank, college of life  sciences, Kyung hee University,   Y ongin, republic of KoreaAbstract:  A rapid biological synthesis of multifunctional gold nanoparticle (AuNp) and  monodisperse silver nanoparticle (AgNp) was achieved by an aqueous extract of black Panax  ginseng  Meyer root.",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ijn-11-6621.PMC5167459.pdf
"P. ginseng  Meyer is a famous traditional medicinal plant widely used in China,  Republic of Korea, Japan, and other Asian countries.10 Its major principal and bioactive  components are ginsenosides; in recent decades, more than 180 ginsenosides have  been isolated and reported in various pharmacological and pharmaceutical studies.11,12 correspondence: Deok chun Yang;  Yeon-Ju Kim Department of Oriental Medicine  Biotechnology and ginseng Bank, college  of life sciences, Kyung hee University,  1732, Deogyeong-daero, giheung-gu,  Yongin-si, gyeonggi-do 17104,  republic of Korea Tel +82 31 201 2100 Fax +82 31 205 2688 email dcyang@khu.ac.k r;   yeonjukim@khu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Nanoparticles synthesized by black ginseng root extract DOI: http://dx.doi.org/10.2147/IJN.S113692",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ijn-11-6621.PMC5167459.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ijn-11-6621.PMC5167459.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ijn-11-6621.PMC5167459.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 199–202Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  199 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S106234A case of probable esomeprazole-induced  transient liver injury in a pregnant woman  with hyperemesis Binny Thomas1–3  Mahmoud Mohamed1,3,4  Moza Al Hail1–3  Fatma Alzahra Y Awwad1  Ramy M Wahba1  Sabir B Hassan1  Khalid Omar1  Wessam El Kassem1  Palivalappila Abdul Rouf1 1Hamad Medical Corporation, Doha,   Qatar; 2Robert Gordon University,   Aberdeen, Scotland, UK; 3Qatar  University, Doha, 4Weill Cornell  Medical College, Ar-Rayyan, QatarAbstract: We report a case of 22-year-old primigravida presented to Women’ s Hospital – Hamad  Medical Corporation emergency with severe epigastric pain, nausea, and vomiting.",Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
"A literature search of standard databases (MEDLINE, Embase, and Cumulative Index to Nursing and Allied Health Literature) conducted in September 2015 did not identify any similar reports in pregnant population.Correspondence: Binny Thomas Department of Pharmacy Women’s Hospital – Hamad Medical Corporation, PO Box 3050, Doha, QatarTel +974 66 010 620Email binnyinhmc@gmail.comJournal name: Clinical Pharmacology: Advances and Applications Article Designation: CASE REPORTY ear: 2016V olume: 8Running head verso: Thomas et alRunning head recto: Esomeprazole-induced transient liver injuryDOI: http://dx.doi.org/10.2147/CPAA.S106234",Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 202 Thomas et al Drug Information services.,Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431648.htm.,Non-OADS,/arxiv_data1/oa_pdf/60/f3/cpaa-8-199.PMC5167460.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/07/copd-11-3189.PMC5167461.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3189–3197International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3189OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11678 6 Indacaterol/glycopyrronium in symptomatic  patients with COPD (gOlD B and gOlD D)  versus salmeterol/fluticasone: ILLUMINATE/ lanTern pooled analysis Claus Vogelmeier1 nanshan Zhong2 Michael J Humphries3 Karen Mezzi4 robert Fogel5 giovanni Bader4 Francesco Patalano4 Donald Banerji5 1Department of Medicine, Pulmonary  and Critical Care Medicine, University  Medical Center Giessen and  Marburg, Philipps-University Marburg,   Member of the German Center  for Lung Research (DZL), Marburg,   germany; 2State Key Laboratory,   Guangzhou Institute of Respiratory  Diseases, First Affiliated Hospital,   Guangzhou Medical University,   Guangzhou, 3Beijing novartis  Pharma Co. Ltd., Shanghai, People’s  republic of China; 4novartis Pharma  AG, Basel, Switzerland; 5novartis  Pharmaceuticals Corporation, East  Hanover, NJ, USABackground:  Indacaterol/glycopyrronium (IND/GLY) is approved for maintenance treatment  of adult patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/e0/07/copd-11-3189.PMC5167461.pdf
"Patients with mild (GOLD I, forced expiratory volume in one  second [FEV1] $80% predicted) and moderate (GOLD II, 50 # FEV1 .80% predicted)  severities in lung function and high symptomatic burden (modified Medical Research  Council [mMRC] grade $2 or COPD assessment test score .10) with a lower risk  of exacerbation are categorized into GOLD B, whereas those with high symptomatic Correspondence: Claus Vogelmeier Department of Medicine, Pulmonary  and Critical Care Medicine, University  Medical Center Giessen and Marburg,  Philipps-University Marburg, Member of  the german Center for lung research  (DZL), Marburg 35043, Germany email claus.vogelmeier@med.uni- marburg.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Vogelmeier et al Running head recto: IND/GLY versus salmeterol/fluticasone in GOLD B and GOLD D patients DOI: http://dx.doi.org/10.2147/COPD.S116786",Non-OADS,/arxiv_data1/oa_pdf/e0/07/copd-11-3189.PMC5167461.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e0/07/copd-11-3189.PMC5167461.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/07/copd-11-3189.PMC5167461.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/1c/opth-10-2497.PMC5167462.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2497–2503Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2497Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12040 2 Evaluation of peripheral fundus autofluorescence  in eyes with wet age-related macular degeneration T etsuyuki suetsugu1,2 aki Kato1 Munenori Y oshida1 Tsutomu Yasukawa1 akiko nishiwaki1,3 norio hasegawa1 hideaki Usui1 Yuichiro Ogura1 1Department of Ophthalmology and  Visual science, nagoya City University  graduate school of Medical sciences,   2Department of Ophthalmology,   general Kamiiida Daiichi hospital,   3nishiwaki eye Clinic, nagoya,   aichi, JapanPurpose:  We aimed to evaluate the prevalence of abnormal peripheral fundus autofluorescence  (FAF) in wet age-related macular degeneration (AMD) using wide-field imaging instrument.",Non-OADS,/arxiv_data1/oa_pdf/37/1c/opth-10-2497.PMC5167462.pdf
"Currently, a wide-field imaging instrument,  the Optos®200Tx (Optos plc, Dunfermline, Scotland, UK), allows noninvasive, Correspondence: aki Kato Department of Ophthalmology and Visual  science, nagoya City University graduate  school of Medical sciences, 1 Kawasumi,  Mizuho-cho, Mizuho-ku, nagoya,  aichi 467-8601, Japan Tel +81 52 853 8251 Fax +81 52 841 9490 email akikato@med.nagoya-cu.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Suetsugu et al Running head recto: Evaluation of peripheral FAF in eyes with wet AMD DOI: http://dx.doi.org/10.2147/OPTH.S120402",Non-OADS,/arxiv_data1/oa_pdf/37/1c/opth-10-2497.PMC5167462.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/37/1c/opth-10-2497.PMC5167462.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/1c/opth-10-2497.PMC5167462.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 283–289Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  283 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S124426Hormonal and echocardiographic abnormalities in  adult patients with sickle-cell anemia in Bahrain Taysir S Garadah1,2 Ahmed A Jaradat3 Mohammed E Alalawi1 Adla B Hassan2 1Cardiac Unit, Salmaniya Medical  Complex, Ministry of Health,   2Department of Internal Medicine,   College of Medicine and Medical  Sciences, Arabian Gulf University,  Manama,  3Department of Family and  Community Medicine, Arabian Gulf University, Manama, BahrainBackground: Adrenal, thyroid, and parathyroid gland hormonal changes are recognized in children  with homozygous (HbSS) sickle-cell anemia (SCA), but are not clear in adult patients with SCA.",Non-OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
"Recurrent episodes of hemolytic anemia, vaso-occlusive crises with the entrapment of red blood cells (RBCs) in the microvasculature system cause Correspondence: Taysir S Garadah Department of Internal Medicine, Arabian Gulf University, PO Box 18725, Manama, BahrainFax +973 1728 9388Email garadaht@hotmail.comJournal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Garadah et alRunning head recto: Endocrine dysfunction in adult sickle-cell anemia patientsDOI: http://dx.doi.org/10.2147/JBM.S124426",Non-OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 289 Endocrine dysfunction in adult sickle-cell anemia patients  16.,Non-OADS,/arxiv_data1/oa_pdf/05/23/jbm-7-283.PMC5167463.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/9e/jaa-9-215.PMC5167464.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/9e/jaa-9-215.PMC5167464.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 215–221Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 215 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S123547T echnical and clinical validation of an  environmental exposure unit for ragweed Paul J Gomes1 Keith J Lane1 Endri Angjeli1 Linda Stein1 Mark B Abelson1,2 1Ora, Inc., Andover, MA, USA;   2Department of Ophthalmology,   Harvard Medical School,   Cambridge,  MA, USABackground: Allergic rhinitis is a common condition, with ragweed pollen one of the more  prevalent aeroallergens.",Non-OADS,/arxiv_data1/oa_pdf/48/9e/jaa-9-215.PMC5167464.pdf
"In addition, subjects in field studies are often  Correspondence:  Paul J Gomes Ora, Inc., 300 Brickstone Square,  Andover, MA 01810, USATel +1 978 689 8900Fax +1 978 689 0020Email pgomes@oraclinical.comJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Gomes et alRunning head recto: Validation of Allergen BioCube ® DOI: http://dx.doi.org/10.2147/JAA.S123547",Non-OADS,/arxiv_data1/oa_pdf/48/9e/jaa-9-215.PMC5167464.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/48/9e/jaa-9-215.PMC5167464.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/dddt-10-4061.PMC5167465.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4061–4071Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4061Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11590 9 Design and in vitro/in vivo evaluation of sustained- release floating tablets of itopride hydrochloride sayed M ahmed1 adel ahmed ali2 ahmed M a ali2,3 Omiya a hassan2,4 1Department of industrial Pharmacy,   Faculty of Pharmacy, assiut  University, assiut, 2Department of  Pharmaceutics, Faculty of Pharmacy,   Beni-suef University, Beni-suef, egypt;   3Department of Pharmaceutics,   Faculty of Pharmacy, Taif University,   Taif, Kingdom of Saudi Arabia;   4Department of Pharmaceutics,   Faculty of Pharmacy, Deraya  University, el-Minia gadida, egyptPurpose:  The aim of the present study was to improve the bioavailability of itopride (ITO)  and sustain its action by formulating as a floating dosage form.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/dddt-10-4061.PMC5167465.pdf
"The only available extended-release ITO per-oral dosage forms are effective in  gastric motility disorder treatment over 24 hours.3,4 ITO is soluble in water and its solubility is not much affected by the pH.5 Reference  ITO is a good choice for formulation as a gastroretentive dosage form because its  solubility in the stomach medium is high compared to its solubility in the small  intestine medium.6,7correspondence: Omiya a hassan Department of Pharmaceutics,  Faculty of Pharmacy, Deraya University,  44 el Tayaran street, PO Box 61768,  el-Minia gadida, egypt Tel +20 10 0933 2419 email moniaali33@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ahmed et al Running head recto: Floating tablets of itopride hydrochloride DOI: http://dx.doi.org/10.2147/DDDT.S115909",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/dddt-10-4061.PMC5167465.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/dddt-10-4061.PMC5167465.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/dddt-10-4061.PMC5167465.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/c4/ijn-11-6753.PMC5167466.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6753–6762International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6753OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12204 7 A polyethylenimine-modified carboxyl-poly(styrene/ acrylamide) copolymer nanosphere for co- delivering of cpg and TgF- β receptor I inhibitor  with remarkable additive tumor regression effect  against liver cancer in mice shuyan liang* Jun hu* Yuanyuan Xie Qing Zhou Yanhong Zhu Xiangliang Yang National engineering research center  for Nanomedicine, college of life  science and Technology, huazhong  University of science and T echnology,   Wuhan, People’s Republic of China *These authors contributed equally  to this workAbstract:  Cancer immunotherapy based on nanodelivery systems has shown potential for  treatment of various malignancies, owing to the benefits of tumor targeting of nanoparticles.",Non-OADS,/arxiv_data1/oa_pdf/2e/c4/ijn-11-6753.PMC5167466.pdf
"Transforming growth factor-beta (TGF- β) is one of the most influential cytokines  among a number of factors expressed in tumor stroma.11,12 Expression of TGF- β in  human cancers correlates with cancer progression and poor clinical outcome.13 TGF-β  regulates the progression of cancer through its effects on tumor microenvironment by  orchestrating a favorable microenvironment for tumor cell growth.11,14 Inhibitors for correspondence: Yanhong Zhu;  Xiangliang Yang National engineering research center  for Nanomedicine, college of life  science and Technology, huazhong  University of science and Technology,  1037 Luoyu Road, Wuhan 430074, Hubei,  People’s Republic of China Tel +86 27 8779 2147 Fax +86 27 8779 2234 email yhzhu@hust.edu.c n;  nanomedicine@hust.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liang et al Running head recto: Polyethylenimine-modified carboxyl-poly(styrene/acrylamide) PS DOI: http://dx.doi.org/10.2147/IJN.S122047",Non-OADS,/arxiv_data1/oa_pdf/2e/c4/ijn-11-6753.PMC5167466.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/c4/ijn-11-6753.PMC5167466.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/ijn-11-6753.PMC5167466.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/76/ott-9-7503.PMC5167467.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7503–7513OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7503Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11526 8 early detection of poor outcome in patients  with metastatic colorectal cancer: tumor kinetics  evaluated by circulating tumor cells Virgílio souza e silva1 ludmilla Thomé Domingos  chinen2 emne a abdallah2 aline Damascena2 Jociana Paludo3 rubens chojniak3 aldo lourenço abbade  Dettino1 celso abdon lopes  de Mello1 Vanessa s alves2 Marcello F Fanelli1 1Department of clinical Oncology,   2international research center, 3image  Department, a. c. camargo cancer  center, são Paulo, BrazilBackground:  Colorectal cancer (CRC) is the third most prevalent cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1c/76/ott-9-7503.PMC5167467.pdf
org.b r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Souza e Silva et al Running head recto: Patients with mCRC evaluated by CTCs DOI: http://dx.doi.org/10.2147/OTT.S115268,Non-OADS,/arxiv_data1/oa_pdf/1c/76/ott-9-7503.PMC5167467.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1c/76/ott-9-7503.PMC5167467.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/76/ott-9-7503.PMC5167467.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 447–452International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 447 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S114577Thicker carotid intima-media thickness and  increased plasma VEGF levels suffered by  post-acute thrombotic stroke patients Yuyun Yueniwati1 Ni Komang Darmiastini1 Eko Arisetijono2 1Radiology Department, Faculty of  Medicine, Brawijaya University, Malang,   Indonesia; 2Neurology Department,   Faculty of Medicine, Brawijaya University, Malang, IndonesiaBackground and objectives: Atherosclerosis causes reduction of the oxygen supply to structures  in the far arterial wall, provoking the release of factors that drive angiogenesis of vasa vasorum,  including VEGF .",Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
"7 Other studies have shown the existence of  inflammatory Correspondence: Yuyun Yueniwati Radiology Department, Faculty of Medicine, Brawijaya University, Jl Veteran Malang, 65145, IndonesiaTel +62 81 838 1800Fax +62 341 341 808Email yuyun@ub.ac.idJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Yueniwati et al Running head recto: CIMT and plasma VEGF levels in post-acute thrombotic stroke patientsDOI: http://dx.doi.org/10.2147/IJGM.S114577",Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
Availlabel from: http://www.yastroki.or.id/read.php?id=361.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 452 Yueniwati et al   5.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/ijgm-9-447.PMC5167469.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/fc/ijwh-8-721.PMC5167470.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 721–729International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  721RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S9997 0 Pregnancy after bariatric surgery: improving  outcomes for mother and child Irene González1 Albert Lecube2  Miguel Ángel Rubio3 Pedro Pablo García-Luna4 1endocrinology and Nutrition  Department, Complejo Hospitalario  Universitario de Huelva, Huelva,   Spain; 2endocrinology and  Nutrition Department, Arnau de  vilanova University Hospital, Lleida  Biomedicine Research Institute  (IRB-Lleida), CIB eR in Diabetes and  Associated Metabolic Disorders  (CIBeRDeM), Lleida University,   Lleida, Spain; 3endocrinology and  Nutrition Department, Hospital  Clínico San Carlos, IDISSC, Madrid,   Spain; 4endocrinology and Nutrition  Department, Hospitales Universitarios  virgen del Rocío, Seville, SpainAbstract:  The significant increase in the prevalence of obesity has led to an increase in the  number of obese women who become pregnant.",Non-OADS,/arxiv_data1/oa_pdf/be/fc/ijwh-8-721.PMC5167470.pdf
"Malabsorptive weight loss procedures Correspondence: Albert Lecube endocrinology and Nutrition  Department, Arnau de vilanova  University Hospital, Avda Rovira  Roure 80, 25198 Lleida, Spain Tel +34 973 70 51 83 email alecube@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: González et al Running head recto: Maternal and fetal outcomes after bariatric surgery DOI: http://dx.doi.org/10.2147/IJWH.S99970",Non-OADS,/arxiv_data1/oa_pdf/be/fc/ijwh-8-721.PMC5167470.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/be/fc/ijwh-8-721.PMC5167470.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/fc/ijwh-8-721.PMC5167470.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/91/cia-11-1815.PMC5167471.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1815Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c5/91/cia-11-1815.PMC5167471.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c5/91/cia-11-1815.PMC5167471.pdf
"On page 1086, Table 1 should be replaced by the following  table: On page 1087, Table 2 should be replaced by the following  table:Journal name: Clinical Interventions in Aging Article Designation: Corrigendum Y ear: 2016 Volume: 11 Running head verso: Lindberg et al Running head recto: Prevalence of unknown and untreated arrhythmias in an older outpatient population DOI: http://dx.doi.org/10.2147/CIA.S125257 Table 1  Age distribution and medical history in the older outpatient study population Total, n (%)Males,  n (%)Females,  n (%)P-value for sex  differences Sex 200 (100) 88 (44.0) 112 (56.0) n.s Age cohorts (years) 66–80 125 (62.5) 51 (57.9) 74 (66.1) 0.040 .80 75 (37.5) 37 (42.1) 38 (33.9) n.s Heart failure 11 (5.5) 3 (3.4) 8 (7.1) n.s Hypertension 99 (49.5) 46 (52.3) 53 (47.3) n.s diabetes 9 (4.5) 4 (4.5) 5 (4.4) n.s Stroke 13 (6.5) 6 (6.8) 7 (6.2) n.s Ischemic cardiac disease 20 (10) 11 (12.5) 9 (8.0) n.s Hyper/hypothyroidism 20 (10) 3 (3.4) 17 (15.1) n.s Smoking 10 (5) 5 (5.6) 5 (4.4) n.s medical treatment (eg, ASA and Warfarin) 17 (8.5) 11 (12.5) 6 (5.3) n.s Abbreviations:  ASA, acetylsalicylic acid; n.s, not significant.",Non-OADS,/arxiv_data1/oa_pdf/c5/91/cia-11-1815.PMC5167471.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/c1/dddt-10-4047.PMC5167476.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4047–4060Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4047Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11357 3 Spotlight on fluticasone furoate/vilanterol  trifenatate for the once-daily treatment of asthma:  design, development and place in therapy Timothy e Albertson1–3 Samuel w Bullick1,3 Michael Schivo1 Mark e Sutter2,3 1Division of Pulmonary, Critical Care  and Sleep Medicine, Department  of Internal Medicine, 2Department  of Emergency Medicine, School of  Medicine, UC Davis, Sacramento,   3Department of Medicine, Veterans  Administration Northern California  Health Care System, Mather, CA, USAAbstract:  The use of inhaled corticosteroids (ICSs) plays a key role in the treatment of asthmatic  patients, and international guidelines have designated ICSs as an early maintenance therapy  in controlling asthma symptoms.",Non-OADS,/arxiv_data1/oa_pdf/88/c1/dddt-10-4047.PMC5167476.pdf
"Early clinical trials of  the LABA salmeterol (SAL) noted a nonstatistically significant increase in all-cause  mortality in asthmatic patients treated over 16  weeks when compared to those using Correspondence: Timothy E Albertson Department of Internal Medicine,  Division of Pulmonary, Critical Care  and Sleep Medicine, School of Medicine,  UC Davis, 4150 V Street, Suite 3100,  Sacramento, CA, 95817, USA email tealbertson@ucdavis.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Albertson et al Running head recto: Spotlight on FF/VI DOI: http://dx.doi.org/10.2147/DDDT.S113573",Non-OADS,/arxiv_data1/oa_pdf/88/c1/dddt-10-4047.PMC5167476.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/88/c1/dddt-10-4047.PMC5167476.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/c1/dddt-10-4047.PMC5167476.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/40/ndt-12-3205.PMC5167477.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3205–3212Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3205OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11981 7 incidence, risk factors, and phenomenological  characteristics of postoperative delirium in patients  receiving intravenous patient-controlled analgesia:  a prospective cohort study Yao Tsung lin1 Kuo Mao lan1 li-Kai Wang1 chin-chen chu1 su-Zhen Wu1 chia-Yu chang2 Jen-Yin chen1,3 1Department of anesthesiology,   2Department of Neurology, chi Mei  Medical center, 3Department of the  senior citizen service Management,   chia Nan University of Pharmacy  and science, Tainan, TaiwanBackground:  Intravenous patient-controlled analgesia (IVPCA) is a common method of  relieving pain which is a risk factor of postoperative delirium (POD).",Non-OADS,/arxiv_data1/oa_pdf/72/40/ndt-12-3205.PMC5167477.pdf
"Postoperative delirium (POD) occurs after surgery  and is associated with prolonged hospitalization, greater health care costs, and  higher mortalities.1 Risk factors of POD include old age, the American Society of  Anesthesiologists (ASA) physical status of III or more, severe illness, types of surgery correspondence: Jen-Yin chen Department of anesthesiology,   chi Mei Medical center, Number 901,  Zhonghua road, Yongkang District,  Tainan 71004, Taiwan Tel +886 6 2812811 email chenjenyin@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Lin et al Running head recto: Postoperative delirium and pain management DOI: http://dx.doi.org/10.2147/NDT.S119817",Non-OADS,/arxiv_data1/oa_pdf/72/40/ndt-12-3205.PMC5167477.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/40/ndt-12-3205.PMC5167477.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/40/ndt-12-3205.PMC5167477.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/64/dddt-10-4017.PMC5167478.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4017–4030Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12035 6 Preparation and physicochemical characterization  of spray-dried and jet-milled microparticles  containing bosentan hydrate for dry powder  inhalation aerosols hyo-Jung lee1 Ji-hyun Kang1 hong-goo lee1 Dong-Wook Kim2 Yun-seok rhee3 Ju-Y oung Kim4 eun-seok Park5 chun-Woong Park1 1college of Pharmacy, chungbuk  national University, 2Department of  Pharmaceutical engineering, cheongju  University, cheongju, 3college of  Pharmacy and research institute of  Pharmaceutical sciences, gyeongsang  national University, Jinju, 4college  of Pharmacy, Woosuk University,   Wanju-gun, 5school of Pharmacy,   sungkyunkwan University, suwon,   republic of KoreaAbstract:  The objectives of this study were to prepare bosentan hydrate (BST) microparticles  as dry powder inhalations (DPIs) via spray drying and jet milling under various parameters, to  comprehensively characterize the physicochemical properties of the BST hydrate microparticles,  and to evaluate the aerosol dispersion performance and dissolution behavior as DPIs.",Non-OADS,/arxiv_data1/oa_pdf/3b/64/dddt-10-4017.PMC5167478.pdf
"It decreases both  pulmonary vascular resistance and systemic vascular resistance and hence increases  cardiac output without increasing the heart rate.1,2 BST hydrate was approved by the  US Food and Drug Administration (FDA) in 2001 under the brand name of Tracleer®  (Bosentan), which is orally administered to alleviate the symptoms of pulmonary  arterial hypertension (PAH).3correspondence: chun-Woong Park college of Pharmacy, chungbuk national  University, 194-31, Osongsaengmyeong  1-ro, Osong-eup, heungdeok-gu,  cheongju, chungcheongbuk-do 28160,  republic of Korea Tel +82 43 261 3330 Fax +82 43 268 2732 email cwpark@cbnu.ac.k r  eun-seok Park school of Pharmacy, sungkyunkwan  University, 2066, seobu-ro, Jangan-gu,  suwon, gyeonggi-do 16419,   republic of Korea Tel +82 31 290 7729 Fax +82 31 290 7729 email espark@skku.ed uJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lee et al Running head recto: Bosentan hydrate for dry powder inhalation aerosols DOI: http://dx.doi.org/10.2147/DDDT.S120356",Non-OADS,/arxiv_data1/oa_pdf/3b/64/dddt-10-4017.PMC5167478.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3b/64/dddt-10-4017.PMC5167478.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/64/dddt-10-4017.PMC5167478.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/8b/ndt-12-3195.PMC5167479.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3195–3198Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3195Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12037 4 Blonanserin treatment in patients with  methamphetamine-induced psychosis comorbid  with intellectual disabilities Kosuke Okazaki Manabu Makinodan Kazuhiko Yamamuro T omoyo Takata T oshifumi Kishimoto Department of Psychiatry, Nara  Medical University school of  Medicine, Kashihara, JapanObjective:  Methamphetamine (MA) use has recently been associated with high levels of  psychiatric hospitalization and serious social dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/a7/8b/ndt-12-3195.PMC5167479.pdf
"Therefore, dopamine antagonists, including atypical  antipsychotics, have potential for the treatment of patients with MAP.11 People with intellectual disabilities (ID) suffer disproportionately from substance  abuse problems, including use of MA.12 The prevalence of use and misuse of several  illicit drugs is relatively higher among people with ID than among people without ID.13  However, treatment of individuals with MAP comorbid with ID can be challenging  since patients with ID are more likely to experience adverse effects, such as tardive  dyskinesia, akathisia, weight gain, and sedation with antipsychotics treatment,14 which Correspondence: Manabu Makinodan Department of Psychiatry, Nara Medical  University school of Medicine, 840  shijo-cho Kashihara, Nara 634-8521,  Japan Tel +81 744 22 3051 Fax +81 744 22 3854 email mmm@naramed-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case series Y ear: 2016 Volume: 12 Running head verso: Okazaki et al Running head recto: Blonanserin for methamphetamine-induced psychosis DOI: http://dx.doi.org/10.2147/NDT.S120374",Non-OADS,/arxiv_data1/oa_pdf/a7/8b/ndt-12-3195.PMC5167479.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a7/8b/ndt-12-3195.PMC5167479.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/8b/ndt-12-3195.PMC5167479.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/03/cia-11-1817.PMC5167483.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1817–1822Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1817OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11672 4 A genetic screen of the mutations in the Korean  patients with early-onset Alzheimer’s disease seong soo An,1,* sun Ah Park,2,*  eva Bagyinszky,1 sun Oh Bae,1  Y oon-Jeong Kim,2 Ji Y oung Im,2  Kyung Won Park,3 Kee hyung  Park,4 eun-Joo Kim,5 Jee hyang  Jeong,6 Jong hun Kim,7 hyun  Jeong han,8 seong hye Choi,9  sangYun Kim10 1Department of Bionano T echnology, gachon  University, seongnam-si, 2Department of  neurology, soonchunhyang University  Bucheon hospital, Bucheon, 3Department  of neurology, Dong-A University College of  Medicine and Institute of Convergence Bio- health, Busan, 4Department of neurology,  gachon University gil Medical Center,  Incheon, 5Department of neurology,  Pusan national University hospital, Busan,  6Department of neurology, ewha Womans  University Mokdong hospital, seoul,  7Department of neurology, Ilsan hospital,  national health Insurance Corporation,  8Department of neurology, Myongii hospital,  goyang, 9Department of neurology, Inha  University school of Medicine, Incheon,  10Department of neurology, seoul  national University College of Medicine  & neurocognitive Behavior Center, seoul  national University Bundang hospital,  seongnam-si, republic of Korea *These authors contributed equally  to this workAbstract:  Early-onset Alzheimer’s disease (EOAD) has distinct clinical characteristics in com - parison to late-onset Alzheimer’s disease (LOAD).",Non-OADS,/arxiv_data1/oa_pdf/39/03/cia-11-1817.PMC5167483.pdf
"The clinical progression of EOAD is more rapid, demonstrating frequent  early non-amnesic deficits and intense behavioral, including psychotic, symptoms.1−4  The deterioration of functional connectivity of the neural networks is more extensive  in EOAD, involving neocortex rather than being confined to medial temporal region Correspondence: seong hye Choi Department of neurology, Inha University  school of Medicine, 7-206 sinheung-dong 3-ga,  Jung-gu, Incheon 400-711, republic of Korea Tel +82 32 890 3659 Fax +82 32 890 3864 email seonghye@inha.ac.k r sangYun Kim Department of neurology, seoul  national University College of Medicine &  neurocognitive Behavior Center, seoul  national University Bundang hospital,  300 gumidong, Bundang-gu, seongnam-si,  gyeonggi-do 463-707, republic of Korea Tel +82 31 787 7462 Fax +82 31 719 6815 email neuroksy@snu.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: An et al Running head recto: Mutations in Korean patients with EOAD DOI: http://dx.doi.org/10.2147/CIA.S116724",Non-OADS,/arxiv_data1/oa_pdf/39/03/cia-11-1817.PMC5167483.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/39/03/cia-11-1817.PMC5167483.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/39/03/cia-11-1817.PMC5167483.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/f5/ijn-11-6763.PMC5167484.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6763–6769International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6763OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10989 7 coating with spermine-pullulan polymer enhances  adenoviral transduction of mesenchymal stem cells li Wan,1,* Xinglei Yao,1–3,*  Francesco Faiola,3 Bojun liu,4  Tianyuan Zhang,2 Yasuhiko  Tabata,5 hiroyuki Mizuguchi,6  shinsaku Nakagawa,7 Jian-Qing  gao,2 robert chunhua Zhao1 1Institute of Basic Medical sciences,   chinese academy of Medical sciences,   school of Basic Medicine Peking Union  Medical college, Peking Union Medical  college hospital, center of excellence  in Tissue engineering chinese academy  of Medical sciences, Beijing, 2Institute  of Pharmaceutics, Zhejiang University,   hangzhou, 3state Key laboratory  of environmental chemistry and  ecotoxicology, research center for  eco-environmental sciences, chinese  academy of sciences, 4Y ouan hospital,   capital Medical University, Beijing, People’s  republic of china; 5Department of  Biomaterials, Field of Tissue engineering,   Institute for Frontier Medical sciences,   Kyoto University, Kyoto, 6Department  of Biochemistry and Molecular Biology,   graduate school of Pharmaceutical  sciences, Osaka University, Osaka,   7Department of Biotechnology and  Therapeutics, graduate school of  Pharmaceutical sciences, Osaka University,   suita, Osaka, Japan *These authors contributed equally  to this workAbstract:  Mesenchymal stem cells (MSCs) are adult stem cells with multilineage potential,  which makes them attractive tools for regenerative medicine applications.",Non-OADS,/arxiv_data1/oa_pdf/57/f5/ijn-11-6763.PMC5167484.pdf
"Spermine–pullulan (SP), one kind of correspondence: Jian-Qing gao Institute of Pharmaceutics, Zhejiang University,  866 Yuhangtang road, hangzhou 310058,  People’s republic of china email gaojianqing@zju.edu.c n  robert chunhua Zhao Institute of Basic Medical sciences, chinese  academy of Medical sciences, school of Basic  Medicine Peking Union Medical college,  Peking Union Medical college hospital,  center of excellence in Tissue engineering  chinese academy of Medical sciences,  5# Dongdansantiao, 100005 Beijing, People’s  republic of china email zhaochunhua@vip.163.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wan et al Running head recto: Coating with SP polymer enhances adenoviral transduction of MSCs DOI: http://dx.doi.org/10.2147/IJN.S109897",Non-OADS,/arxiv_data1/oa_pdf/57/f5/ijn-11-6763.PMC5167484.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/57/f5/ijn-11-6763.PMC5167484.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/f5/ijn-11-6763.PMC5167484.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7545–7553OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7545Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11902 7 Different levels of serum micrornas in prostate  cancer and benign prostatic hyperplasia: evaluation  of potential diagnostic and prognostic role giovanni cochetti1 giulia Poli2 gabriella guelfi3 andrea Boni1 Maria giulia egidi1 ettore Mearini1 1Department of surgical and  Biomedical sciences, institution of  Urological, andrological surgery  and Minimally invasive T echniques,   2Department of experimental  Medicine, section of T erni,   3Department of Veterinary Medicine,   University of Perugia, Perugia, italyIntroduction:  Diagnosis of prostate cancer (PCa) is based on prostate biopsy that is performed  when prostate specific antigen (PSA) is persistently altered over time and/or abnormal digital  rectal examination is found.",Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"s. andrea delle Fratte,  06156 Perugia, italy Tel +39 338 351 9999 Fax +39 0744 20 5822 email mariagiuliaegidi@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cochetti et al Running head recto: Serum microRNAs in prostate cancer and benign prostatic hyperplasia DOI: http://dx.doi.org/10.2147/OTT.S119027",Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"For this  purpose, TargetScan Release 6.2 ( http://www.targetscan.",Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"org),11 MicroCosm Targets Version 5 ( http://www.ebi.ac.uk/ enright-srv/microcos m),12 and microrna.or g13 prediction algo - rithms were used.",OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/26/ott-9-7545.PMC5167485.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6771–6780International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6771OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12109 6 Nanoscaled hydrated antimony (V) oxide as a  new approach to first-line antileishmanial drugs antonia M r Franco1 Iryna grafova2 Fabiane V soares1,3 gennaro gentile4 claudia Dc Wyrepkowski1,3 Marcos a Bolson5 Ézio Sargentini Jr5 Cosimo Carfagna4 Markku leskelä2 andriy grafov2 1laboratory of leishmaniasis and  Chagas Disease, National Institute of  amazonian research (INP a), Manaus,   amazonas, Brazil; 2Department of  chemistry, University of helsinki,   helsinki, Finland; 3Multi-Institutional  Post-Graduate Program in  Biotechnology, Federal University of  amazonas, Manaus, amazonas, Brazil;   4Institute for Polymers, composites,   and Biomaterials, National research  council, Pozzuoli, Naples Province,   Italy; 5laboratory of environmental  chemistry, National Institute of  amazonian research (INP a), Manaus,   amazonas, BrazilBackground:  Coordination compounds of pentavalent antimony have been, and remain, the  first-line drugs in leishmaniasis treatment for .70 years.",Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
"Virtasen aukio 1, 00014  University of helsinki, Finland Tel +358 2 9415 0221 Fax +358 2 9415 0198 email andriy.grafov@helsinki.fi  Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Franco et al Running head recto: Hydrated antimony oxide nanoparticles as an antileishmanial drug DOI: http://dx.doi.org/10.2147/IJN.S121096",Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs375/en /.,Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
Available from: https://clinam.org/images/stories/pdf/conference2015.,Non-OADS,/arxiv_data1/oa_pdf/fe/6f/ijn-11-6771.PMC5167486.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/b2/ndt-12-3199.PMC5167487.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3199–3203Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3199Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11564 8 Non-24-hour sleep–wake syndrome improved by  low-dose valproic acid: a case report Masatake Kurita1–3 Takahiro Moriya2 satoshi Nishino2,4 eishin Hirata4 Noriyasu Hirasawa5 Y oshiro okubo3 Tadahiro sato4 1Wakamiya Hospital, Koutokukai,   Y oshihara, Yamagata, 2Department  of Cellular signaling, Graduate  school of p harmaceutical sciences,   T ohoku University, sendai, Miyagi,   3Department of p sychiatry and  Behavioral science, Graduate  school of Medicine, Nippon Medical  school, sendagi, T okyo, 4sato  Hospital, Koutokukai, Kunugizuka,   Nanyo, Yamagata, 5Laboratory of  pharmacotherapy of Life- style  related Diseases, Graduate school  of pharmaceutical sciences, Tohoku  University, sendai, Miyagi, JapanAbstract:  A woman was diagnosed with non-24-hour sleep–wake syndrome and depressive  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/45/b2/ndt-12-3199.PMC5167487.pdf
"The depressive symptoms were evaluated using the  Montgomery–Åsberg Depression Rating Scale (MADRS)11; remission of depressive  symptoms is defined as a score of #8 on the MADRS.12 Blood sampling and depres - sion assessment were performed at the same time of day.Correspondence: Masatake Kurita Wakamiya Hospital, Koutokukai, 2-15-3  Yoshihara, Yamagata 990-2451, Japan Tel +81 23 643 8222 Fax +81 23 644 1950 email kurita@koutoku.or.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Kurita et al Running head recto: Improvement of sleep–wake syndrome by valproic acid DOI: http://dx.doi.org/10.2147/NDT.S115648",Non-OADS,/arxiv_data1/oa_pdf/45/b2/ndt-12-3199.PMC5167487.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/45/b2/ndt-12-3199.PMC5167487.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/b2/ndt-12-3199.PMC5167487.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ott-9-7493.PMC5167488.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7493–7501OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7493Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12411 8 Overexpression and clinical significance of  MYC-associated zinc finger protein in pancreatic  carcinoma Xiaonian Zhu1,* Wei luo2,* Wenjin liang2 Fen Tang3 chunhua Bei1 Yuan ren1 linyuan Qin1 chao Tan1 Ying Zhang1 shengkui Tan1 1School of Public Health, Guilin  Medical University, Guilin, People’s  Republic of China; 2Department  of Hepatobiliary Surgery, The  Affiliated Hospital of Guilin Medical  University, Guilin, People’s Republic  of China; 3Department of Hepatology,   Nanxishan Hospital of Guangxi  Zhuang autonomous region, guilin,   People’s Republic of China *These authors contributed equally  to this workAbstract:  This study aimed to investigate the expression and clinical significance of  MYC-associated zinc finger protein (MAZ) in pancreatic carcinoma (PC), and the biological  functions of MAZ in PC cells.",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ott-9-7493.PMC5167488.pdf
"Current studies find that genetic  and epigenetic regulations play an important role in pathogenesis of PC, such as acti - vation and mutation of KRAS  gene;6 deletion of tumor suppressor genes p16, TP53 ,  SMAD4/DPC4 , and BPCA2 ; and deregulation of microRNAs.7,8 However, there is  currently no specific marker for the diagnosis of PC, although carbohydrate antigen  19-9 (CA199) is considered to be the gold standard for detection of PC.9 The increased  CA199 is used for the diagnosis of PC by European Group on Tumor Markers and  the US National Academy of Clinical Biochemistry,10 but increased levels of CA199  are also seen in nontumor patients, such as those with acute and chronic pancreatitis, correspondence:  shengkui Tan School of Public Health, Guilin Medical  University, 109 huancheng north  road 2, guilin 541004, guangxi,  People’s Republic of China Tel/fax +86 773 221 6868 email sktan2008@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: MAZ is involved in pathogenesis of PC DOI: http://dx.doi.org/10.2147/OTT.S124118",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ott-9-7493.PMC5167488.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ott-9-7493.PMC5167488.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ott-9-7493.PMC5167488.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hepatic Medicine: Evidence and Research 2016:8 135–142Hepatic Medicine: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  135 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S120477Knowledge and attitude of health care  professionals regarding hepatitis B virus infection  and its vaccination, University of Gondar Hospital,  Ethiopia Mohammed Biset Ayalew1 Boressa Adugna Horssa1 Nardose Getachew2 Sitotaw Amare2 Ashenafi Getnet2 1Department of Clinical Pharmacy,   School of Pharmacy, 2School of  Pharmacy, College of Medicine and  Health Sciences, University of Gondar,  Gondar, EthiopiaBackground: Hepatitis B is a global public health problem affecting approximately 10% of  the world population.",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
"1–3 There is high prevalence of  HBV infection among Blacks.2 It is also a major public health problem in Ethiopia.4–8 Health care professionals (HCPs) are at increased risk of acquiring hepatitis B  infection due to occupational exposure.1,3,9 In one study, HCPs were shown to have up Correspondence: Mohammed Biset  AyalewDepartment of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 9394 96171Email mb6767@gmail.comJournal name: Hepatic Medicine: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Ayalew et alRunning head recto: Health care professionals’ knowledge and attitude regarding HBVDOI: http://dx.doi.org/10.2147/HMER.S120477",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
Available from: https://stacks.cdc.gov/view/cdc/20711.,OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
"Hepatic Medicine: Evidence and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hepatic­medicine­evidence­and­research­journalHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease; Investigation and treat-ment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 142 Ayalew et al,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/hmer-8-135.PMC5167489.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1221–1230Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1221 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S118329Nicoboxil/nonivamide cream effectively and safely  reduces acute nonspecific low back pain – a  randomized, placebo-controlled trial Zuzana Blahova1 Janina Claudia Holm1 Thomas Weiser2 Erika Richter2 Matthias Trampisch2 Elena Akarachkova3 1Boehringer Ingelheim RCV GmbH &  Co KG, Vienna, Austria; 2Boehringer  Ingelheim Pharma GmbH & Co  KG, Ingelheim am Rhein, Germany;   3I.M.",Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
"5 Usually, acute low back pain is nonspecific, self-limiting, and with a high percent- age of remission within 6 weeks.6 Nevertheless, low back pain accounts for high direct Correspondence: Janina Claudia Holm Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121 Vienna, AustriaTel +43 1 8010 57753Email claudia.holm@boehringer-ingelheim.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Blahova et alRunning head recto: Nicoboxil/nonivamide cream relieves acute low back painDOI: http://dx.doi.org/10.2147/JPR.S118329",Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
Available from: http://www.eumusc.net/myUploadData/files/Musculoskeletal%20Health%20in%20Europe%20Report%20v5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
Available from: http://www.leitlinien.de/mdb/downloads/nvl/kreuzschmerz/kreuzschmerz-1aufl-vers5-short.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1230 Blahova et al 19.,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/jpr-9-1221.PMC5167490.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2016:8 101–109Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 101 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S110774 Development and validation of evaluation tools of  nursing students’ clinical pharmacology unit Nasrin Navabi   Fatemeh Ghaffari   Abbas Shamsalinia   Safieh Faghani Nursing and Midwifery Department,   Babol University of Medical Sciences,  Mazandaran, IranIntroduction: The need for valid, reliable, and objective tools has always been emphasized  in studies related to the clinical assessment of nursing students.",Non-OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
"2 Clinical care can be regarded as being of a high quality when the assessment of  nursing skills is highly favorable.3 Clinical education has always been an important Correspondence: Fatemeh Ghaffari Babol University of Medical Sciences, Ramsar Nursing Care Research Center, Mazandaran, Postal Code: 4691714141, Iran Tel +98 (11) 55225151 Email ghafarifateme@yahoo.comJournal name: Drug, Healthcare and Patient Safety Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Navabi et alRunning head recto: Evaluation tools of nursing students’ clinical pharmacology unitDOI: http://dx.doi.org/10.2147/DHPS.S110774",Non-OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
"Drug, Healthcare and Patient Safety 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 109 Evaluation tools of nursing students’ clinical pharmacology unit 25.,Non-OADS,/arxiv_data1/oa_pdf/a5/bd/dhps-8-101.PMC5167491.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3163–3177International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3163RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9284 0 Efficacy of tiotropium–olodaterol fixed-dose  combination in COPD eric Derom Guy G Brusselle Guy F Joos Department of Respiratory  Medicine, Ghent University  Hospital, Ghent, BelgiumAbstract:  Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled  fixed-dose combination (FDC) of a long-acting muscarinic antagonist (LAMA) and a long- acting β2-agonist (LABA), commercialized under the name of Spiolto or Stiolto.",Non-OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
"Parenchymal destruction and  loss of alveoli (emphysema) further enhance that airflow limitation and are also   responsible for an abnormal increase in static lung volumes and a decrease in forced Correspondence: eric Derom Department of Respiratory Medicine,  Ghent University Hospital – 7 K12 IE,  185 De Pintelaan, Ghent 9000, Belgium Tel +32 9 332 2359 Fax +32 9 332 2341 email eric.derom@ugent.b e Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Derom et al Running head recto: Efficacy of olodaterol and tiotropium in COPD DOI: http://dx.doi.org/10.2147/COPD.S92840",Non-OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
"Avail - able from: http://mri.medagencies.org/download/NL_H_3157_001_ FinalPI.pd f. Accessed October 15, 2016.",OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/7d/copd-11-3163.PMC5167492.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1797–1804Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1797OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12131 3 effects of different doses of high-speed resistance  training on physical performance and quality of life  in older women: a randomized controlled trial rodrigo ramirez-Campillo,1–3  Daniela Diaz,4 Cristian  Martinez-salazar,5 Pablo  Valdés-Badilla,6 Pedro  Delgado-Floody,5 guillermo  Méndez-rebolledo,7 rodrigo  Cañas-Jamet,8,9 Carlos  Cristi-Montero,10 Antonio  garcía-hermoso,11 Carlos  Celis-Morales,12 Jason  Moran,13 Thomas W Buford,14  leocadio rodriguez-Mañas,15  Alicia M Alonso-Martinez,16  Mikel Izquierdo16 1Department of Physical Activity sciences,  2laboratory of Measurement and Assessment in  sports, research nucleus in health, Physical Activity  and sports, Universidad de los lagos, Osorno, 3Unit  of Integrative Physiology, laboratory of exercise  sciences, M eDs Clinic, santiago, Chile; 4school of  Occupational Therapy, Faculty of health, Universidad  santo T omás, Osorno, 5Department of Physical  education, sport and recreation, Universidad de la  Frontera, 6Institute of Physical Activity and health,  Universidad Autónoma de Chile, T emuco, 7school  of Kinesiology, Faculty of health, University santo  T omás, Talca, 8laboratory of Physiology, Department  of Biological sciences, Faculty of Biological sciences,  Universidad Andres Bello, Viña del Mar, 9school of  Kinesiology, Faculty of Medicine, Universidad Diego  Portales, santiago, 10Irys group, Physical education  school, Pontificia Universidad Católica de Valparaíso,  Valparaíso, 11laboratory of Physical Activity  sciences, sport and health, Faculty of Medical  sciences, Universidad de santiago de Chile, UsACh,  santiago, Chile; 12BhF glasgow Cardiovascular  research Centre, Institute of Cardiovascular and  Medical sciences, University of glasgow, glasgow,  13Centre for sports and exercise science, school of  Biological sciences, University of essex, Colchester,  UK; 14Department of Aging and geriatric research,  Institute of Aging, University of Florida, College of  Medicine, gainesville, Florida, UsA; 15Division of  geriatric Medicine, University hospital of getafe,  Madrid, 16Department of health sciences, Public  University of navarre, navarre, spainObjective:  This study aimed to compare the effects of two frequencies of high-speed resistance  training (HSRT) on physical performance and quality of life of older women.",Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
"In  this context, a resistance training frequency of 2 days/week has been recommended  for older women.18 A reduced training frequency might motivate a long-term physi - cally active lifestyle19 and a more gradual training progression.20 However, although  HSRT seems to be an adequate stimulus to improve physical functions in an older Correspondence: Mikel Izquierdo Department of health sciences, Public University of  navarre, Campus of Tudela, Av de Tarazona s/n, 31500  Tudela, navarre, spain Tel +34 948 417 876 email mikel.izquierdo@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ramirez-Campillo et al Running head recto: High-speed resistance training in older women DOI: http://dx.doi.org/10.2147/CIA.S121313",Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
"Participants who meet the inclusion criteria were  electronically ( https://www.randomizer.or g) randomized by  blocked-design into three arms: a control group (CG), a group  that completed two HSRT sessions/week (RT2), and a group  that completed three HSRT sessions/week (RT3).",Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
This proce - dure was established according to the “CONSORT” statement  (http://www.consort-statement.or g).,Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
Available from: http://apps.who.int/iris/bi tstream/10665/44399/1/9789241599979_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/39/cia-11-1797.PMC5167493.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ott-9-7555.PMC5167496.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7555–7561OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7555Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11182 9 Evaluation of the efficacy of chemoradiotherapy  in cervical cancer using diffusion-weighted imaging  and apparent diffusion coefficient Fa-Jun Ju Department of radiology, Yishui  central hospital, linyi, People’s  republic of chinaObjective:  This study aims to evaluate the efficacy of chemoradiotherapy (CRT) in cervical cancer  using diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) values.",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ott-9-7555.PMC5167496.pdf
"Diffusion-weighted imaging (DWI) provides qualitative and quantitative func - tional information concerning the microscopic movements of water at the cellular  level.5 It can be used to measure apparent diffusion coefficients (ADCs), which is a correspondence: Fa-Jun Ju Department of radiology, Yishui central  hospital, no 17, Jiankang road, linyi  276400, shangdong Province, People’s  republic of china Tel +86 539 226 0337 email fajunju_ab@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ju Running head recto: ADC predicting CRT efficacy in cervical cancer DOI: http://dx.doi.org/10.2147/OTT.S111829",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ott-9-7555.PMC5167496.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ott-9-7555.PMC5167496.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ott-9-7555.PMC5167496.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/f4/ijn-11-6795.PMC5167497.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6795–6808International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6795OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11910 8 Rehmannia glutinosa  polysaccharide liposome as a  novel strategy for stimulating an efficient immune  response and their effects on dendritic cells Yee huang1 Tao Qin2 Yifan huang2 Zhenguang liu1 ruonan Bo1 Yuanliang hu1 Jiaguo liu1 Yi Wu1 Deyun Wang1,2 1college of Veterinary Medicine,   Institute of Traditional chinese  Veterinary Medicine, college of  Veterinary Medicine, Nanjing  agricultural University, Nanjing,   2college of animal science and  Veterinary Medicine, Fujian  agriculture and Forestry University,   Fuzhou, People’s republic of chinaAbstract:  Nanomedicine, the medical application of nanotechnology, promises a seemingly  limitless range of applications from drug delivery to adjuvants and therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/67/f4/ijn-11-6795.PMC5167497.pdf
"Thus, improving the bioavailability  of RGP in clinical applications is of great importance.correspondence: Deyun Wang Institute of Traditional chinese  Veterinary Medicine, college  of Veterinary Medicine, Nanjing  agricultural University, Nanjing 210095,  People’s republic of china Tel +86 25 8439 5203 Fax +86 25 8439 8669 email dywang@njau.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Huang et al Running head recto: Rehmannia glutinosa  for an efficient immune response DOI: http://dx.doi.org/10.2147/IJN.S119108",Non-OADS,/arxiv_data1/oa_pdf/67/f4/ijn-11-6795.PMC5167497.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/67/f4/ijn-11-6795.PMC5167497.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/f4/ijn-11-6795.PMC5167497.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2016:10 167–176Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  167 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S87396Centrosome – a promising anti-cancer target Yainyrette Rivera-Rivera Harold I Saavedra Department of Pharmacology, Ponce  Health Sciences University-School of Medicine, Ponce Research Institute,  Ponce, Puerto RicoAbstract:  The centrosome, an organelle discovered >100 years ago, is the main microtubule- organizing center in mammalian organisms.",Non-OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
"6 The daughter centriole eventually matures and transforms into a mother  centriole.7 In animal cells the centrioles form a cilium in dormant cells, while cells Correspondence: Harold I Saavedra Department of Pharmacology, Ponce Research Institute, Ponce Health Sciences University-School of Medicine, 395 Research Building Zona Industrial Reparada 2, Ponce 00716-2348, Puerto RicoTel +1 787 840 2575Fax +1 787 841 5150Email hsaavedra@psm.eduJournal name: Biologics: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 10Running head verso: Rivera-Rivera and SaavedraRunning head recto: Centrosome – a promising anti-cancer targetDOI: http://dx.doi.org/10.2147/BTT.S87396",Non-OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
"Biologics: Targets and Therapy 2016:10submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 176 Rivera-Rivera and Saavedra,Non-OADS,/arxiv_data1/oa_pdf/cd/43/btt-10-167.PMC5167523.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 673–680Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 673 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S115149 Physicians’ attitudes toward, use of, and perceived  barriers to clinical guidelines: a survey among  swiss physicians Tanja Birrenbach1 simone Kraehenmann1 Martin Perrig1 christoph Berendonk2 soeren huwendiek2 1Department of general internal  Medicine, inselspital, Bern University  hospital, University of Bern, Bern,   switzerland; 2Department of  Assessment and Evaluation, institute  of Medical Education, Medical Faculty Bern, Bern, switzerlandBackground: Little is known about the attitudes toward, use of, and perceived barriers to  clinical guidelines in Switzerland, a country with no national guideline agency.",Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
"2–5 A recent Cochrane review including 27 studies, noted that length of stay  was the most commonly employed outcome measure with most studies reporting correspondence: Tanja Birrenbach Department of general internal Medicine,  inselspital, Bern University hospital, University of Bern, Freiburgstrasse, ch-3010 Bern, switzerlandTel +41 31 632 2111Email tanja.birrenbach@insel.chJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Birrenbach et alRunning head recto: Physicians’ thoughts on clinical practice guidelines in SwitzerlandDOI: http://dx.doi.org/10.2147/AMEP .S115149",Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 680 Birrenbach et al 10.,Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
Available from: http://www.ewi-psy.fu-berlin.de/einrichtungen/arbeitsbereiche/ppg/media/projekte/hausaerzte/kunz_2005.pdf?1286350984.,Non-OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
Available from: http://goldcopd.org/gold-reports/.,OADS,/arxiv_data1/oa_pdf/c7/3a/amep-7-673.PMC5167524.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2016:8 91–100Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 91 Original reSearcH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S119073 implementation of co-trimoxazole preventive  therapy policy for malaria in HiV-infected  pregnant women in the public health facilities in  Tanzania appolinary ar Kamuhabwa richard gordian ritah F Mutagonda Department of clinical Pharmacy and  Pharmacology, School of Pharmacy,  Muhimbili University of Health and allied Sciences, Dar es Salaam,  TanzaniaBackground: In 2011, Tanzania adopted a policy for provision of daily co-trimoxazole pro- phylaxis to HIV -infected pregnant women for prevention of malaria and other opportunistic  infections.",Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
"Keywords: SP , policy change, ANCs, health care providers, IPTp Introduction Malaria infection during pregnancy has been reported to have adverse effects including  maternal anemia, low birth weight (LBW), intrauterine growth retardation,  intrauterine correspondence: appolinary ar  KamuhabwaDepartment of clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and allied Sciences, PO Box 65013, Dar es Salaam, TanzaniaTel +255 75 557 6985Fax +255 22 215 0465email enali2012@gmail.comJournal name: Drug, Healthcare and Patient Safety Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Kamuhabwa et alRunning head recto: Prevention of malaria in HIV -infected pregnant womenDOI: http://dx.doi.org/10.2147/DHPS.S119073",Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.who.int/hiv/pub/prev_care/malariahiv.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.nbs.go.tz/nbstz/index.php/english/statistics-by-subject/health-statistics/hiv-and-malaria-survey/679-2007-08-tanzania-hiv-aids-and-malaria-indicator-survey-thmis-report.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.nbs.go.tz/tnada/index.php/catalog/23.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.nbs.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Avail-able from: http://pmtct.or.tz/pmtct-tanzania/pmtct-in-tanzania.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.unaids.org/ sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf.,OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua= 1.,OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: https://cdn2.sph.harvard.edu/wp-content/uploads/sites/32/2014/09/HSPH-Tanzania5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Available from: http://www.who.int/hiv/pub/tuapr_2009_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
"Drug, Healthcare and Patient Safety 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 100 Kamuhabwa et al  34.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/dhps-8-091.PMC5167525.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Core Evidence 2016:11 49–61Core Evidence Dovepress submit your manuscript | www.dovepress.com Dovepress 49 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S114094 Iloperidone in the treatment of schizophrenia: an  evidence-based review of its place in therapy Fernanda S T onin1  Astrid Wiens2  Fernando Fernandez- Llimos3  Roberto Pontarolo2 1Pharmaceutical Sciences Postgraduate  Program, 2Department of Pharmacy,   Federal University of Parana,   Curitiba, Brazil; 3Department of  Social Pharmacy, Faculty of Pharmacy,  Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, PortugalIntroduction: Schizophrenia is a chronic and debilitating mental disorder that affects the  patient’ s and their family’ s quality of life, as well as financial costs and health care settings.",Non-OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
"Prof. Lothario Meissner 632, Curitiba 80210-170, Brazil Tel +55 41 3360 4094   Email pontarolo@ufpr.brJournal name: Core Evidence Article Designation: REVIEWY ear: 2016V olume: 11Running head verso: Tonin et alRunning head recto: Iloperidone for schizophreniaDOI: http://dx.doi.org/10.2147/CE.S114094 Core evidence clinical impact summary for iloperidone in schizophrenia Outcome measure Evidence Implications Disease-oriented evidence Schizophrenia  pathophysiology and iloperidone mechanism of actionFrom clinical trials and observational studies: moderateIloperidone arises as a potential alternative to treat schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
"Core Evidence 2016:11submit your manuscript | www.dovepress.com Dovepress Dovepress Core Evidence Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/core-evidence-journalCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to post launch.",Non-OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 61 Iloperidone for schizophrenia  57.,Non-OADS,/arxiv_data1/oa_pdf/d4/a0/ce-11-049.PMC5167526.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 483–489Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 483 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S99225 Acne keloidalis nuchae: prevalence, impact, and  management challenges Adebola Ogunbiyi Dermatology Unit, Department  of Medicine, College of Medicine, University of Ibadan,  University College Hospital Ibadan,   Oyo State, Nigeria Abstract:  Acne keloidalis nuchae (AKN) also known as folliculitis keloidalis nuchae (FKN)  is a chronic form of scarring folliculitis seen mostly in men of African descent.",Non-OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
"The inciting agents appear to be multifactorial with various factors such as androgens, inflammation, infection, trauma, genetics, and Correspondence: Adebola Ogunbiyi Dermatology Unit, Department of Medicine, College of Medicine, University of Ibadan, University College Hospital Ibadan, Queen Elizabeth Road, Ibadan, Oyo State, Nigeria Tel +234 803 335 3170Email adebolaogunbiyi@yahoo.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: OgunbiyiRunning head recto: Acne keloidalis nuchaeDOI: http://dx.doi.org/10.2147/CCID.S99225",Non-OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 489 Acne keloidalis nuchae  25.,Non-OADS,/arxiv_data1/oa_pdf/d1/d1/ccid-9-483.PMC5167527.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 243–252Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 243 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S121610 Expression and functionality of TRPV1 in breast  cancer cells Lea V Weber1  Klaudia Al-Refae1  Gerhard Wölk2  Gabriele Bonatz3  Janine Altmüller4  Christian Becker4  Günter Gisselmann1  Hanns Hatt1 1Department of Cell Physiology,   Ruhr -University Bochum, Bochum,   2Herz-Jesu-Krankenhaus, Dernbach,   3Augusta Kliniken Bochum, Bochum,   4Cologne Center for Genomics,   University of Cologne, Cologne,   GermanyAbstract:  Transient receptor potential (TRP) channels contribute to the regulation of intracel- lular calcium, which can promote cancer hallmarks in cases of dysregulation of gene transcription  and calcium-dependent pro-proliferative or anti-apoptotic mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
"150, 44801 Bochum, Germany Tel +49 234 32 26756   Email Lea.weber@gmx.deJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Weber et alRunning head recto: TRP channels in breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S121610",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 252 Weber et al  10.,Non-OADS,/arxiv_data1/oa_pdf/9f/3a/bctt-8-243.PMC5167528.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1777–1781Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1777LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S12414 8 Balanced discussion of second-generation  antihistamines’ data Rossen Boev1 Jürgen WG Bentz2 1UCB Pharma, Bulle, Switzerland;   2UCB Pharma, Brussels, BelgiumDear editor It is with interest that we read the paper “Treatment of allergic rhinitis and urticaria:  a review of the newest antihistamine drug bilastine” by Wang et al,1 in which the  authors provide insights into the burden of allergic diseases in the Asia-Pacific region.",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"A 12-month open-label safety analysis7 was described by the authors as “the  longest analysis to date with any antihistamine”; however, safety analyses from Correspondence: Rossen Boev UCB Farchim SA, Chemin De Croix  Blanche 10, 1630 Bulle, Switzerland  email rossen.boev@ucb.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Boev and Bentz Running head recto: Balanced discussion of second-generation antihistamines’ data DOI: http://dx.doi.org/10.2147/TCRM.S124148",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
Available from: http://www.mhra.gov.uk/spc-pil/index.,OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"htm; http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/ con1470373127139.pd f. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ AC/03/briefing/3999B1_23_Zyrtec.pd f. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"Available from: http://www.fda.gov/downloads/ AdvisoryCommittees /CommitteesMeetingMaterials/PediatricAdvisory   Committee/UCM235280.pd f. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
Available from: http://www.mhra.gov.uk/spc-pil/index.,OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
htm; http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/ con1470373127139.pd f).,Non-OADS,/arxiv_data1/oa_pdf/3f/9f/tcrm-12-1777.PMC5167562.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgRisk Factors and Adverse Outcomes of Severe  Hypoglycemia in Type 2 Diabetes Mellitus Jae-Seung Yun, Seung-Hyun Ko Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea,  Suwon, Korea Hypoglycemia has been considered as a major barrier to achieving the proper glycemic target in type 2 diabetes mellitus patients.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Keywords:  Diabetes mellitus, type 2; Hypoglycemia; Risk factors Corresponding author: Seung-Hyun Ko    http://orcid.org/0000-0003-3703-1479   Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University  of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea   E-mail: kosh@catholic.ac.kr Received: Aug. 3, 2016; Accepted: Aug. 24, 2016INTRODUCTION Hypoglycemia is common and may have serious clinical con - sequences for diabetes treatment.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
RISK FACTORS OF SEVERE HYPOGLYCEMIA Intensive glycemic control  Many clinical practice guidelines for patients with T2DM rec -Review Complications https://doi.org/10.4093/dmj.2016.40.6.423 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:423-432,Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Yun JS, et al.424 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgommend targeting an HbA1c level less than 6.5% to 7.0%  [9,10].",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
Severe hypoglycemia in type 2 diabetes mellitus425 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgpairment [25].,Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Yun JS, et al.426 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgTable 1.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Severe hypoglycemia in type 2 diabetes mellitus427 Diabetes Metab J 2016;40:423-432 http://e-dmj.org19.5% in those who had experienced at least one episode of SH  and 9.0% in those who had not (HR, 3.27; 95% CI, 2.29 to 4.65)  [27].",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Yun JS, et al.428 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgin patients with T2DM.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
Severe hypoglycemia in type 2 diabetes mellitus429 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgto 2.64 in patients with three or more SH episodes) [54].,Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Yun JS, et al.430 Diabetes Metab J 2016;40:423-432 http://e-dmj.orgmia in type 2 diabetes: a patient-centered approach: position  statement of the American Diabetes Association (ADA) and  the European Association for the Study of Diabetes (EASD).",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
Severe hypoglycemia in type 2 diabetes mellitus431 Diabetes Metab J 2016;40:423-432 http://e-dmj.org31.,Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"Yun JS, et al.432 Diabetes Metab J 2016;40:423-432 http://e-dmj.org54.",Non-OADS,/arxiv_data1/oa_pdf/b2/45/dmj-40-423.PMC5167706.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgMetabolic Surgery for Type 2 Diabetes Mellitus:  Experience from Asia Wei-Jei Lee1, Lwin Aung2 1Department of Surgery, Min-Sheng General Hospital, National Taiwan University, Taoyuan, Taiwan,  2Department of Surgery, Ng Teng Fong General Hospital, Singapore Type 2 diabetes mellitus (T2DM) is a current global health priority and Asia is the epicenter of this epidemic disease.",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Keywords:  Asian continental ancestry group; Bariatric surgery; Diabetes mellitus, type 2; Obesity  Corresponding author: Wei-Jei Lee    http://orcid.org/0000-0001-7091-3006   Department of Surgery, Min-Sheng General Hospital, National Taiwan  University, No 168, Chin Kuo Road, Taoyuan, Taiwan   E-mail: wjlee_obessurg_tw@yahoo.com.tw Received: Sep. 2, 2016; Accepted: Oct. 25, 2016INTRODUCTION Type 2 diabetes mellitus (T2DM) has reached to a pandemic  level and is currently a significant challenge to health care sys - tem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Bariatric surgery, a weight reduc - tion surgery, has been shown not only an effective treatment for  severe obesity (body mass index [BMI] >35 kg/m2) but also re -Review Obesity and metabolic syndrome https://doi.org/10.4093/dmj.2016.40.6.433 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:433-443",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Lee WJ, et al.434 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgsult in marked improvement of T2DM control [5].",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
Metabolic surgery for T2DM435 Diabetes Metab J 2016;40:433-443 http://e-dmj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Lee WJ, et al.436 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgA meta-analysis also supported the superiority of LGB over  LSG for T2DM treatment [31].",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
Metabolic surgery for T2DM437 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgThe remission rate was higher in high BMI group.,Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Lee WJ, et al.438 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgRCT compared cost effectiveness between LSG and RYGB with  2-year follow-up [29].",OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
Metabolic surgery for T2DM439 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgbetes remission after metabolic surgery is intriguing.,Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Lee WJ, et al.440 Diabetes Metab J 2016;40:433-443 http://e-dmj.orga major complication rate of 2% with a mortality rate 0.2%  [31].",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Metabolic surgery for T2DM441 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgsurgery for the treatment of T2DM, including patients with a  BMI <35 kg/m2.",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"Lee WJ, et al.442 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgwa S, Fukuda Y , Sonoda K. Has laparoscopic bariatric surgery  been accepted in Japan?",Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
http://doi.org/10.1007/ s00268-016-3690-z .,Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
Metabolic surgery for T2DM443 Diabetes Metab J 2016;40:433-443 http://e-dmj.orgmellitus with hypertension: a randomized controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/b1/40/dmj-40-433.PMC5167707.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/94/dmj-40-444.PMC5167708.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgDeterminants of the Risk of Diabetic Kidney Disease  and Diabetic Retinopathy Independent of Glucose  Exposure Bo Kyung Koo Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of  Medicine, Seoul, Korea Corresponding author: Bo Kyung Koo    http://orcid.org/0000-0002-6489-2656 Department of Internal Medicine, Seoul Metropolitan Government Seoul  National University Boramae Medical Center, Seoul National University  College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea E-mail: bokyungkoomd@gmail.comThe Diabetes Control and Complications Trial (DCCT) con - firmed that intensive glucose control reduced the risk of dia - betic mellitus retinopathy (DMR) and diabetic kidney disease  (DKD) development by 76% and 34% and 44%, respectively,  compared with standard treatment [1].",Non-OADS,/arxiv_data1/oa_pdf/b5/94/dmj-40-444.PMC5167708.pdf
Genetic factors might explain the susceptibility to DMR and Editorial Complications https://doi.org/10.4093/dmj.2016.40.6.444 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:444-446,Non-OADS,/arxiv_data1/oa_pdf/b5/94/dmj-40-444.PMC5167708.pdf
Risk of diabetic kidney disease and diabetic retinopathy445 Diabetes Metab J 2016;40:444-446 http://e-dmj.orgDKD independently of glucose exposure.,Non-OADS,/arxiv_data1/oa_pdf/b5/94/dmj-40-444.PMC5167708.pdf
Koo BK446 Diabetes Metab J 2016;40:444-446 http://e-dmj.org363:233-44.,Non-OADS,/arxiv_data1/oa_pdf/b5/94/dmj-40-444.PMC5167708.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgFactors Associated with Participation in Diabetes  Education: The Korea National Health and Nutrition  Examination Survey 2007 to 2009 Jung Min Kim1,*, Jae Won Hong2,*, Jung Hyun Noh2, Dong-Jun Kim2 1 Department of Internal Medicine, Cardiovascular and Metabolic Disease Center, Inje University Sanggye Paik Hospital, Inje University College of Medicine,  Seoul,  2Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Background:  A recent study revealed that the participation rate in diabetes education among diabetic patients was only about  50% in Korea.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Keywords:  Diabetes; Education; Education level; Korea; Participation Corresponding author: Dong-Jun Kim    https://orcid.org/0000-0002-5459-097X   Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje  University College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380,  Korea   E-mail: djkim@paik.ac.kr * Jung Min Kim and Jae Won Hong contributed equally to this study as first  authors.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
Diabetes self-management education  (DSME) involves teaching individuals to manage their diabe -Original Article Clinical Care/Education https://doi.org/10.4093/dmj.2016.40.6.447 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:447-453,Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Kim JM, et al.448 Diabetes Metab J 2016;40:447-453 http://e-dmj.orgtes through knowledge of the disease and development of the  skills and abilities necessary for self-management [7].",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Factors associated with receiving diabetes education449 Diabetes Metab J 2016;40:447-453 http://e-dmj.orgEthics statement Our study was approved by the Institutional Review Board of  Inje University Ilsan Paik Hospital, Republic of Korea (IB-2- 1312-054).",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Kim JM, et al.450 Diabetes Metab J 2016;40:447-453 http://e-dmj.orgStatistical analyses  The KNHANES participants were not sampled randomly.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Factors associated with receiving diabetes education451 Diabetes Metab J 2016;40:447-453 http://e-dmj.orgels, occupation, and household income had no significant ef - fect on receiving diabetes education.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Kim JM, et al.452 Diabetes Metab J 2016;40:447-453 http://e-dmj.organd the impression that they had sufficient knowledge of dia - betes [22].",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
Available from:  http://kostat.go.kr/portal/korea/kor_nw/2/1/index.board?,Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"Factors associated with receiving diabetes education453 Diabetes Metab J 2016;40:447-453 http://e-dmj.orgmunity-based diabetes self-management education (DSME)  program in San Juan, Batangas, Philippines.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/dmj-40-447.PMC5167709.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgReduction of Sulfonylurea with the Initiation of Basal  Insulin in Patients with Inadequately Controlled Type  2 Diabetes Mellitus Undergoing Long-Term  Sulfonylurea-Based Treatment Y eoree Y ang1, Jeong-Ah Shin2, Hae Kyung Y ang1, Seung-Hwan Lee1, Seung-Hyun Ko3, Yu-Bae Ahn3, Kun-Ho Y oon1,   Jae-Hyoung Cho1 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, Seoul, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Serim Hospital, Incheon, 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea,  Suwon, Korea Background:  There were a limited number of studies about β-cell function after insulin initiation in patients exposed to long du - rations of sulfonylurea treatment.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Keywords:  Basal insulin; Beta-cell; Diabetes mellitus, type 2; Recovery; Sulfonylurea  Corresponding author: Jae-Hyoung Cho    http://orcid.org/0000-0003-2235-8874 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic  University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea   E-mail: drhopper@catholic.ac.kr Received: Dec. 9, 2015; Accepted: Aug. 8, 2016INTRODUCTION Insulin resistance and defective β-cell function are well-known  pathophysiological mechanisms for the development of type 2  diabetes mellitus (T2DM) [1].",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"As one of the oldest hypoglycemic agents, sulfonylurea stim -Original Article Clinical Care/Education https://doi.org/10.4093/dmj.2016.40.6.454 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:454-462",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
Sulfonylurea efficacy with basal insulin455 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgulates pancreatic β-cells to release insulin in a rather glucose- independent manner.,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Y ang Y , et al.456 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgfasting blood glucose levels were less than 6.7 mmol/L (120 mg/ dL).",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
Sulfonylurea efficacy with basal insulin457 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgence from 65.0±2.3 to 65.7±2.2 kg in the SR group ( P=0.074).,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Y ang Y , et al.458 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgglucose at OGTT was significantly decreased, and plasma in - sulin was significantly increased 20% to 30% after the adminis - tration of insulin in both groups.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Sulfonylurea efficacy with basal insulin459 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgISI, representing insulin resistance, showed no significant  changes from baseline to the end of the follow-up period in the  two study groups.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Y ang Y , et al.460 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgurea-based treatments.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
Sulfonylurea efficacy with basal insulin461 Diabetes Metab J 2016;40:454-462 http://e-dmj.org3.,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"Y ang Y , et al.462 Diabetes Metab J 2016;40:454-462 http://e-dmj.orgschoor L. Twice daily insulin therapy in patients with type 2 di - abetes and secondary failure to sulphonylureas.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/dmj-40-454.PMC5167710.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgBaseline-Corrected QT (QTc) Interval Is Associated  with Prolongation of QTc during Severe Hypoglycemia  in Patients with Type 2 Diabetes Mellitus Seon-Ah Cha1, Jae-Seung Yun1, Tae-Seok Lim1, Y oon-Goo Kang1, Kang-Min Lee1, Ki-Ho Song1, Ki-Dong Y oo2,   Y ong-Moon Park3, Seung-Hyun Ko1, Yu-Bae Ahn1 Divisions of 1Endocrinology and Metabolism, 2Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul,  Korea, 3Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA Background:  We investigated an association between baseline heart rate-corrected QT (QTc) interval before severe hypoglyce - mia (SH) and prolongation of QTc interval during SH in patients with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Keywords:  Diabetes mellitus, type 2; Severe hypoglycemia; QT interval Corresponding author: Yu-Bae Ahn    http://orcid.org/0000-0001-8658-2731 Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University  of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea E-mail: ybahn@catholic.ac.kr  Received: Nov. 12, 2015; Accepted: Jun.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
Weight gain and significantly  increased hypoglycemia episodes have been thought to con - tribute to this unfavorable outcome in the intensive treatment Original Article Complications https://doi.org/10.4093/dmj.2016.40.6.463 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:463-472,Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Cha SA, et al.464 Diabetes Metab J 2016;40:463-472 http://e-dmj.orggroup.",OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"QT prolongation during severe hypoglycemia465 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgthe QT interval, which was defined as the interval from the  onset of the QRS complex to the end of the T-wave in the car - diac electric cycle.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Cha SA, et al.466 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgdependent of the patient’s age, sex, diabetes duration, BMI,  habit of smoking, presence of hypertension and CKD, previous  SH, and use of insulin or sulfonylurea, the prolongation of the QTc interval at baseline was strongly associated with a pro - longed QTc interval during SH (OR, 2.92; 95% CI, 1.22 to 6.96;  P=0.016) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"QT prolongation during severe hypoglycemia467 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgCardiovascular outcomes during follow-up period During 6 months follow-up after SH, one episode of acute myo - cardial infarction developed within 3 months after SH, and five  patients were diagnosed with atrial fibrillation during SH epi - sodes.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Cha SA, et al.468 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgtachycardia or ventricular fibrillation 1 month after an episode  of SH, and one patient died of sudden death 6 months after  SH, showing pulseless electrical activity on arrival at the emer - gency department.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"QT prolongation during severe hypoglycemia469 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgindependent predictor of a prolonged QTc interval during SH  in patients with T2DM after adjusting for age, sex, diabetes du - ration, BMI, the habit of smoking, presence of hypertension,  CKD, previous SH, and the use of insulin or sulfonylurea.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Cha SA, et al.470 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgdepolarization and repolarization, a prolonged QTc interval is  associated with an increased risk of ventricular arrhythmia,  which could lead to sudden cardiac death [32].",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
QT prolongation during severe hypoglycemia471 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgcations in Japanese patients with non-insulin-dependent dia - betes mellitus: a randomized prospective 6-year study.,Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"Cha SA, et al.472 Diabetes Metab J 2016;40:463-472 http://e-dmj.orgCouncil on Clinical Cardiology; American College of Cardiol - ogy Foundation; Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a7/9e/dmj-40-463.PMC5167711.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgRisk Factors for the Development and Progression of  Diabetic Kidney Disease in Patients with Type 2  Diabetes Mellitus and Advanced Diabetic Retinopathy Kyung-Jin Yun1, Hye Ji Kim1, Mee Kyoung Kim1, Hyuk-Sang Kwon1, Ki-Hyun Baek1, Y oung Jung Roh2, Ki-Ho Song1 Departments of 1Internal Medicine, 2Ophthalmology, Y eouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Background:  Some patients with type 2 diabetes mellitus (T2DM) do not develop diabetic kidney disease (DKD) despite the  presence of advanced diabetic retinopathy (DR).",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Keywords:  Cholesterol, HDL; Diabetes mellitus, type 2; Diabetic nephropathies; Diabetic retinopathy; Hemoglobin A1c protein,  human; Triglycerides Corresponding author: Ki-Ho Song    http://orcid.org/0000-0003-1883-7039 Department of Internal Medicine, Y eouido St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, 10 63-ro, Y eongdeungpo-gu,  Seoul 07345, Korea E-mail: kihos@catholic.ac.kr Received: Nov. 22, 2015; Accepted: Apr.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"In the Italian multi - center Renal Insufficiency and Cardiovascular Events (RIACE)  study, 637 of 1,540 patients (41.4%) with type 2 diabetes melli - tus (T2DM) and advanced DR—including severe non-prolif - erative DR (non-PDR), pre-PDR, maculopathy, or blindness— showed no evidence of DKD, which is characterized by nor -Original Article Complications https://doi.org/10.4093/dmj.2016.40.6.473 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:473-481",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
Risk factors of DKD in patients with advanced DR475 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgcalculated for each patient as the intraindividual standard de - viation (SD) of serial HbA1c values (HbA1c-SD) during the  preceding 2 years.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Yun KJ, et al.476 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgCompared with the no DKD group, the severe DKD group had  higher systolic BP (127.99±10.88 mm Hg vs. 132.65±10.65  mm Hg, P=0.01); lower HDL-C (1.21±0.30 mmol/L vs. 1.03±  0.29 mmol/L, P<0.01); higher TG (1.18 [1.09 to 1.29] mmol/L  vs. 1.64 [1.47 to 1.83] mmol/L, P<0.01); and higher TG/HDL- C ratio (2.3 [2.1 to 2.6] vs. 3.8 [3.3 to 4.3], P<0.01) by post hoc   analysis.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Risk factors of DKD in patients with advanced DR477 Diabetes Metab J 2016;40:473-481 http://e-dmj.org0.17, P<0.01; adj-HbA1c-SD, r=0.17, P<0.01; HbA1c-CV , r=  0.18, P<0.01).",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Yun KJ, et al.478 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgglobin, mean HbA1c levels, and HbA1c-SD.",OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
Risk factors of DKD in patients with advanced DR479 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgthat HbA1c variability affected the DKD phenotype with both  albuminuria and reduced eGFR (severe DKD in the present  study) more than average HbA1c [6].,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"Yun KJ, et al.480 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
Risk factors of DKD in patients with advanced DR481 Diabetes Metab J 2016;40:473-481 http://e-dmj.orgtients with type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/dmj-40-473.PMC5167712.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgClinical Course and Risk Factors of Diabetic  Retinopathy in Patients with Type 2 Diabetes Mellitus  in Korea Jae-Seung Yun1, Tae-Seok Lim1, Seon-Ah Cha1, Yu-Bae Ahn1, Ki-Ho Song2, Jin A Choi3, Jinwoo Kwon3, Donghyun Jee3,   Y ang Kyung Cho3, Y ong-Moon Park4, Seung-Hyun Ko1 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea,  Suwon,  2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Y eouido St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, Seoul,  3Department of Ophthalmology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea, 4 Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services,  Research Triangle Park, NC, USA Background:  We investigated clinical course and risk factors for diabetic retinopathy (DR) in patients with type 2 diabetes melli - tus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Conclusion:  This prospective cohort study demonstrates that glycemic control, diabetes duration, age, and albuminuria are im - portant risk factors for the development of DR. More aggressive retinal screening for T2DM patients diagnosed with DR should  be required in order to not miss rapid progression of DR. Keywords:  Diabetes mellitus, type 2; Diabetic retinopathy; Risk factors Corresponding author: Seung-Hyun Ko    http://orcid.org/0000-0003-3703-1479 Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University  of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea E-mail: kosh@catholic.ac.kr Received: Jan. 25, 2016; Accepted: Apr.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"In Korea, the prevalence of retinopathy in  diabetes was reported to be 18.6% according to the 2011 Korea Original Article Complications https://doi.org/10.4093/dmj.2016.40.6.482 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:482-493",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
Diabetic retinopathy in type 2 diabetes mellitus483 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgNational Health and Nutritional Examination Survey [3].,Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Yun JS, et al.484 Diabetes Metab J 2016;40:482-493 http://e-dmj.orghistory of coronary artery disease or cerebrovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
Diabetic retinopathy in type 2 diabetes mellitus485 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgwith DR and without DR.,Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Yun JS, et al.486 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgFig.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Diabetic retinopathy in type 2 diabetes mellitus487 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgThe univariable analysis for incidence of DR showed that  age, diabetes duration, use of insulin, FPG, baseline HbA1c,  mean HbA1c, and albuminuria were revealed as potential risk  factors of DR. After adjusting for confounding factors, the group  who had poor glycemic control during the follow-up (mean  HbA1c ≥9%) showed 4.32 times higher risk of DR than those  who had good glycemic control (mean HbA1c <7%) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Yun JS, et al.488 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgTable 3.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
Diabetic retinopathy in type 2 diabetes mellitus489 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgappear to be associated with DR in T2DM [33].,Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Yun JS, et al.490 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgIn conclusion, we suggest that risk factors such as glycemic  control, duration of diabetes, age, and albuminuria are the im - portant risk factors for the development of DR.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Diabetic retinopathy in type 2 diabetes mellitus491 Diabetes Metab J 2016;40:482-493 http://e-dmj.orgRM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Ham - ilton BP , Hoogwerf B, Karl D, Katz L, Krikorian A, O’Connor P ,  Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A,  Weiss D, Hramiak I; ACCORD trial group.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"Yun JS, et al.492 Diabetes Metab J 2016;40:482-493 http://e-dmj.org33.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/dmj-40-482.PMC5167713.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgInvestigating Susceptibility to Diabetes Using Features  of the Adipose Tissue in Response to In Utero   Polycyclic Aromatic Hydrocarbons Exposure Worlanyo E. Gato1, Daniel A. Hunter1, Shamaya L. Whitby1, Christopher A. Mays1, Wilson Y au2 1Department of Chemistry, Georgia Southern University, Statesboro, GA,  2Department of Pathology, University of Georgia College of Veterinary Medicine, Athens, GA, USA Background:  In recent times, there has been an increase in the incidence of type 2 diabetes mellitus (T2DM) particularly in chil - dren.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Keywords:  Adipocytes; Adiponectin; Diabetes; Gene expression; Interleukin-6; Serum glucose; 2-Anthramine Corresponding author: Worlanyo E. Gato    http://orcid.org/0000-0002-4781-8577 Department of Chemistry, Georgia Southern University, 1332 Southern Dr,  Statesboro, GA 30458, USA E-mail: wgato@georgiasouthern.edu  Received: Mar.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Original Article Pathophysiology https://doi.org/10.4093/dmj.2016.40.6.494 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:494-508,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Investigating susceptibility to diabetes495 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgFurthermore, current research indicates that disturbances in  the intrauterine environment may cause offspring to be sus - ceptible to type 2 diabetes mellitus (T2DM) and cardiovascular  disease [10].",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.496 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgdered-diet and then mixed with the rest of the diet for even  distribution.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes497 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgdards and samples were pipetted into a microplate precoated  with a polyclonal antibody specific for adiponectin.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.498 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgwas higher than the rats with no or high dose of 2AA for both  groups of diet.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes499 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgcant histologic changes are evident between the groups on his - tologic examination (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.500 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgly fewer CD68+ cells in comparison to 2AA treated and mod - erate high fat groups.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes501 Diabetes Metab J 2016;40:494-508 http://e-dmj.orghigher serum glucose levels (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.502 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgFig.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes503 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgcompared to the control groups (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.504 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgtion of the underlying factors for the failure of weight gain.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes505 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgThis study was undertaken to assess whether neonatal expo - sure outcomes can be predictive of disease susceptibility in  adult rats.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"Gato WE, et al.506 Diabetes Metab J 2016;40:494-508 http://e-dmj.orgRobison L, Schell L, Suk W A. Children’s health and the envi - ronment: a new agenda for prevention research.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Available from: http://www.atsdr.cdc.gov/ToxProfiles/ tp69.pdf (cited 2016 Jul 20).,OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
Investigating susceptibility to diabetes507 Diabetes Metab J 2016;40:494-508 http://e-dmj.org38.,Non-OADS,/arxiv_data1/oa_pdf/d8/c2/dmj-40-494.PMC5167714.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/dmj-40-509.PMC5167715.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgInvestigating Susceptibility to Diabetes Using Features  of the Adipose Tissue in Response to In Utero   Polycyclic Aromatic Hydrocarbons Exposure ( Diabetes  Metab J  2016;40:494-508) Myoung Jin Ji, Sung Hee Choi Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Corresponding author: Sung Hee Choi    http://orcid.org/0000-0003-0740-8116  Department of Internal Medicine, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro  173beon-gil, Bundang-gu, Seongnam 13620, Korea E-mail: shchoimd@gmail.comPolycyclic aromatic hydrocarbons (PAHs) is known as an envi - ronmental contaminant (there are more than 200 PAHs),  which has multiple aromatic rings.",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/dmj-40-509.PMC5167715.pdf
"Bentsen RK, Halgard K, Noto H, Daae HL, Ovrebo S. Correla - tion between urinary 1-hydroxypyrene and ambient air pyrene Letter https://doi.org/10.4093/dmj.2016.40.6.509 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:509-510",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/dmj-40-509.PMC5167715.pdf
Diabetes Metab J 2016;40:509-510 http://e-dmj.orgmeasured with an inhalable aerosol sampler and a total dust  sampler in an electrode paste plant.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/dmj-40-509.PMC5167715.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/a2/dmj-40-511.PMC5167716.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgInvestigating Susceptibility to Diabetes Using Features  of the Adipose Tissue in Response to In Utero   Polycyclic Aromatic Hydrocarbons Exposure ( Diabetes  Metab J  2016;40:494-508)  Worlanyo E. Gato1, Daniel A. Hunter1, Shamaya L. Whitby1, Christopher A. Mays1, Wilson Y au2 1Department of Chemistry, Georgia Southern University, Statesboro, GA,  2Department of Pathology, University of Georgia College of Veterinary Medicine, Athens, GA, USA Corresponding author: Worlanyo E. Gato     http://orcid.org/0000-0002-4781-8577   Department of Chemistry, Georgia Southern University, 1332 Southern Dr,  Statesboro, GA 30458, USA  E-mail: wgato@georgiasouthern.edu We appreciate your interest and comments on our article enti - tled “Investigating susceptibility to diabetes using features of the  adipose tissue in response to in utero  polycyclic aromatic hydro - carbons exposure” that was published in Diabetes & Metabolism  Journal  [1].",Non-OADS,/arxiv_data1/oa_pdf/13/a2/dmj-40-511.PMC5167716.pdf
Y our observation that obesity and adipocyte inflammation are Response https://doi.org/10.4093/dmj.2016.40.6.511 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:511-512,Non-OADS,/arxiv_data1/oa_pdf/13/a2/dmj-40-511.PMC5167716.pdf
Diabetes Metab J 2016;40:511-512 http://e-dmj.orgcritical drivers of diabetes is accurate.,Non-OADS,/arxiv_data1/oa_pdf/13/a2/dmj-40-511.PMC5167716.pdf
Available from: http://www.hse.gov.uk/reach/whatisreach.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Availablefrom: http://www.hse.gov.uk/pubns/priced/hsg167.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/research/rrpdf/rr828.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from:http://www.hse.gov.uk/research/rrpdf/rr963.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Availablefrom: http://ec.europa.eu/social/BlobServlet?docId = 6935&langId = en.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://ec.europa.eu/social/BlobServlet?docId = 3853&langId = en.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://ec.europa.eu/social/BlobServlet?docId = 3851&lan gId = en.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: https://www.osha.gov/pls/oshaweb/owa disp.show_document?p_t able = STANDARDS&p_id = 13096.,OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: https://www.osha.gov/dts/chemicalsampling/data/CH_256200.html.,OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.atsdr.cdc.gov/toxpro ﬁles/tp15.pdf.,OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from:http://ec.europa.eu/social/BlobServlet?docId = 10158&langId = en.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Nickel and nickel alloy electroplating operations: controlling the risk of skin exposure Available from: http://www.hse.gov.uk/surfaceengineering/nickelexposure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/surfaceengineering/chromicacid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/surfaceengineering/chromicacidmist.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/surfaceengineering/eh2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/surfaceengineering/hexavalentchromium.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.astm.org/Standards/D6966.htm.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.astm.org/Standards/D7296.htm.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from:http://www.astm.org/Standards/E1728.htm.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/pubns/priced/hsg173.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/pubns/mdhs/pdfs/mdhs14-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Avail- able from: http://www.inchem.org/documents/ehc/ehc/ehc61.htm.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.inchem.org/documents/ehc/ehc/ehc108.htm.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
"ISBN 978-0-7176-6582-2, 2013.Available from http://www.hse.gov.uk/pubns/priced/l5.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available from: http://www.hse.gov.uk/research/rrpdf/rr1042.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Use of BM to assess exposure in the electroplating industry Beattie et al 55 Journal of Exposure Science and Environmental Epidemiology (2017), 47 –55",Non-OADS,/arxiv_data1/oa_pdf/e0/33/jes201567a.PMC5167995.pdf
Available at http://www.e-importz.com/coffee-statistics.php (accessed on 15 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/37/ijos201625a.PMC5168413.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information for this article can be found on the International Journal of Oral Science website (http://www.nature.com/ijos)Dental pulp stem cells YY Chen et al 222 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/18/c3/ijos201633a.PMC5168414.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014390).,Non-OADS,/arxiv_data1/oa_pdf/14/79/bmjopen-2016-014390.PMC5168488.pdf
Methods commentary: risk of bias in randomized trials 1 http://distillercer.com/resources/methodological-resources/risk-of-bias-commentary/ (accessed 31 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/14/79/bmjopen-2016-014390.PMC5168488.pdf
RevMan 5. http://tech.cochrane.org/revman/download (accessed 31 Jan 2015).,OADS,/arxiv_data1/oa_pdf/14/79/bmjopen-2016-014390.PMC5168488.pdf
"White V, Bariola E. Australian secondary schools students ’use of tobacco, alcohol and over-the-counter and illicit substances in 2011.2012. http://www.nationaldrugstrategy.gov.au/internet/ drugstrategy/Publishing.nsf/content/BCBF6B2C638E1202CA257ACD0020E35C/$File/National%20Report_FINAL_ASSAD_7.12.pdf(accessed 19 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012688.PMC5168489.pdf
http://www.abs.gov.au/AUSSTATS.,Non-OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012688.PMC5168489.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012717).,Non-OADS,/arxiv_data1/oa_pdf/d2/55/bmjopen-2016-012717.PMC5168490.pdf
"The question- naires in Norwegian, Sami and English languages maybe accessed at http://www.saminor.no.",Non-OADS,/arxiv_data1/oa_pdf/d2/55/bmjopen-2016-012717.PMC5168490.pdf
"Hospital discharge data Hospital discharge data were taken from the CVDNOR project (http://www.cvdnor.no), which is a collaborativeproject between the University of Bergen and the Norwegian Knowledge Centre for the Health Services.",OADS,/arxiv_data1/oa_pdf/d2/55/bmjopen-2016-012717.PMC5168490.pdf
2006. http://www.cis.rit.edu/~ejipci/Reports/On_Using_and_Computing_the_Kappa_Statistic.pdf 16.,OADS,/arxiv_data1/oa_pdf/d2/55/bmjopen-2016-012717.PMC5168490.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013947).,Non-OADS,/arxiv_data1/oa_pdf/97/e7/bmjopen-2016-013947.PMC5168491.pdf
"Quebec government, 2015. http://www.msss.gouv.qc.ca/en/reseau/reorganisation/portrait (accessed 23 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/c5/39/bmjopen-2016-014023.PMC5168494.pdf
"This trial is registered on the Australian New Zealand Clinical TrialsRegistry, which can be accessed at http://www.anzctr.org.",Non-OADS,/arxiv_data1/oa_pdf/3f/05/bmjopen-2016-013375.PMC5168495.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/05/bmjopen-2016-013375.PMC5168495.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012008).,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
Competing interests All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/MigrationIntegration/Migrationshintergrund2010220147004.pdf?__ blob=publicationFile 2.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
http://www.who.int/hac/events/consultation_report_health_migrants_colour_web.pdf?ua=1 12.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
http://www.versorgungsleitlinien.de/themen/kreuzschmerz 20.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
http://www.depression.versorgungsleitlinien.de 21.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/bmjopen-2016-012008.PMC5168496.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.p9b21.,OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
"Geneva, Switzerland: Office of the UNHCR,Communications and Public Information Service, 1951 and 1967.http://www.unhcr.org/4ec262df9.html (accessed 29 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
Asylum statistics September 2015. http://www.cgra.be/sites/ default/files/asylumstat_september_2015.pdf (accessed 29 Jun 2016).,OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
Record number of over 1.2 million first time asylum seekers registered in 2015. http://ec.europa.eu/eurostat/web/products-press-releases/-/3-04032016-AP (accessed29 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
http://www.euro.who.int/en/health-topics/health-determinants/migration-and-health/migrant-health-in-the-european-region/migration-and-health-key-issues (accessed 29 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
"UNHCR, 2014. https://data.unhcr.org/syrianrefugees/ download.php?id=5635 (accessed 29 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/12/bmjopen-2016-013963.PMC5168497.pdf
2013. https://www.sportengland.org/research/who-plays-sport/national-picture/ (accessed 1 Jun 2016).5.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/bmjopen-2016-011670.PMC5168498.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013151).,Non-OADS,/arxiv_data1/oa_pdf/7d/4b/bmjopen-2016-013151.PMC5168499.pdf
The National Health Insurance (NHI) programme is a mandatory uni-versal health insurance system covering more than 99% of Taiwan ’s 23.74 million population (http://nhird.nhri.,Non-OADS,/arxiv_data1/oa_pdf/7d/4b/bmjopen-2016-013151.PMC5168499.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012573).,Non-OADS,/arxiv_data1/oa_pdf/a3/ff/bmjopen-2016-012573.PMC5168503.pdf
"Left and right amygda- lae are used as separate seed regions of interest (ROI).FC maps from each individual seed will then be calcu- lated for each individual subject using Resting-State fMRI Data Analysis Toolkit (REST , http://www.restfmri.net).",OADS,/arxiv_data1/oa_pdf/a3/ff/bmjopen-2016-012573.PMC5168503.pdf
Negative and inconclusive as well as positive results will be published or made publicly available through the study website http://www.umassmed.edu/keepingweightoff.,Non-OADS,/arxiv_data1/oa_pdf/a3/ff/bmjopen-2016-012573.PMC5168503.pdf
"2010. http://www.cdc.gov/ nchs/data/hestat/obesity_adult_11_12/obesity_adult_11_12.htm Fulwiler C, et al.BMJ Open 2016; 6:e012573.",Non-OADS,/arxiv_data1/oa_pdf/a3/ff/bmjopen-2016-012573.PMC5168503.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013321).,Non-OADS,/arxiv_data1/oa_pdf/01/2c/bmjopen-2016-013321.PMC5168504.pdf
"http://www.mrw.interscience.wiley.com/ 6 Furuta M, et al.BMJ Open 2016; 6:e013697.",OADS,/arxiv_data1/oa_pdf/cb/c2/bmjopen-2016-013697.PMC5168505.pdf
"National Institute for Health and Clinical Excellence, 2005. http://guidance.nice.org.uk/CG26/Guidance/pdf/English 24.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/bmjopen-2016-013697.PMC5168505.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012801).,Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
London: NICE 2008. https://www.nice.org.uk/guidance/cg66.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
https://www.nice.org.uk/guidance/cg87.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
2013.http://www.nice.org.uk/Guidance/ta288 ifneeded 8.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
NHS Digital 2016. http://qof.digital.nhs.uk/.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
"Quality and Outcomes Framework —prevalence, achievements and exception reports, England, 2014-15, 2015. http://content.digital.nhs.uk/catalogue/PUB18887/qof-1415-annex3-DQandFAQ.pdf 41.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
"WHO, 2006. http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ 43.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
"WHO, 2011. http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/ 44.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
2011. https://www.ons.gov.uk/census/2011census 45.,OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
"2015. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015, 2015 48.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/bmjopen-2016-012801.PMC5168506.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013177).,Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
"London, UK: Worldwide Palliative Care Alliance, 2014. http://www.thewhpca.org/resources/global-atlas-on-end-of-life-care 2.",Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
"Adelaide: Australian Medicines Handbook Pty, 2015; https://shop.amh.net.au/faq/58.",Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals forHuman Use ; 1996. http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf(accessed 23 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
"Canberra, ACT, 2009. http://www.pbs.gov.au/info/industry/ useful-resources/manual 66.",Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
"EudraCT Number: 2015-004064-11. http://www.clinicaltrialsregister.eu 12 Watts GJ, et al.BMJ Open 2016; 6:e013177.",Non-OADS,/arxiv_data1/oa_pdf/98/8f/bmjopen-2016-013177.PMC5168508.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013610).,Non-OADS,/arxiv_data1/oa_pdf/70/d0/bmjopen-2016-013610.PMC5168510.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.j9q7h.,OADS,/arxiv_data1/oa_pdf/70/d0/bmjopen-2016-013610.PMC5168510.pdf
Disponible on: http://www.fondation-abbe-pierre.fr/21e-rapport-etat-mal-logement-2016 4.,Non-OADS,/arxiv_data1/oa_pdf/70/d0/bmjopen-2016-013610.PMC5168510.pdf
http://www.framinghamheartstudy.org/risk/gencardio.html# 14.,Non-OADS,/arxiv_data1/oa_pdf/05/11/bmjopen-2015-009195.PMC5168513.pdf
2011. http://scolarite.fmp-usmba.ac.ma/cdim/mediatheque/e_theses/32-11.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/05/11/bmjopen-2015-009195.PMC5168513.pdf
2010. http://www.who.int/countryfocus/ cooperation_strategy/ccs_tun_en.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/05/11/bmjopen-2015-009195.PMC5168513.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013324).,Non-OADS,/arxiv_data1/oa_pdf/03/62/bmjopen-2016-013324.PMC5168514.pdf
http://www.hse.gov.uk41.,Non-OADS,/arxiv_data1/oa_pdf/03/62/bmjopen-2016-013324.PMC5168514.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013940).,Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
"We did not use the Health on the Net Foundation HONcode (http://www.healthonnet.org/HONcode/ Conduct.html) to assess websites, as it was outside thescope of this investigation, which may be a limitation of our study.",Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
https://www.nice.org.uk/guidance/cg156/chapter/Recommendations#initial-advice-to-people-concerned-about-delays-in-conception (accessed 18 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
https://www.nice.org.uk/guidance/cg156/chapter/Recommendations#initial-advice-to-people-concerned-about-delays-in-conception (accessed 18 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
http://www.dailymail.co.uk/health/article-3592661/ The-great-IVF-rip-Clinics-preying-anxious-couples-selling-add- ons-not-work-harmful.html (accessed 18 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
"http://www.kup.at/kup/pdf/9085.pdf, pp 66/147) (accessed August2016).",Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
"Published February 2013, last updated August 2016. https://www.nice.org.uk/guidance/cg156?unlid=373307668201622815432 (accessed 18 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/39/ef/bmjopen-2016-013940.PMC5168515.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012894).,Non-OADS,/arxiv_data1/oa_pdf/2d/d7/bmjopen-2016-012894.PMC5168516.pdf
"We used Cox proportional hazard regression models (SPSS for Windows, V .22, http://www.spss.com) to calcu- late age-speci ﬁc (40 –69 years) HRs for total, cardiovas- cular and non-cardiovascular mortality.",OADS,/arxiv_data1/oa_pdf/2d/d7/bmjopen-2016-012894.PMC5168516.pdf
"Competing interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no support from any organisationfor the submitted work, no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/2d/d7/bmjopen-2016-012894.PMC5168516.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010643).,Non-OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2015-010643.PMC5168517.pdf
URL: http://datadryad.org/review?doi=doi:10.5061/dryad.3t6sc.,OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2015-010643.PMC5168517.pdf
Food and Drug Administration Amendments Act (FDAAA) of 2007. http://www.fda.gov/downloads/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/FDAAAImplementationChart/UCM213016.pdf (accessed 4 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2015-010643.PMC5168517.pdf
2007. http://www.sfda.gov.cn/WS01/ CL0053/24529.html (accessed 4 Aug 2015).,OADS,/arxiv_data1/oa_pdf/86/21/bmjopen-2015-010643.PMC5168517.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013459).,Non-OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
2008. http://www.who.int/whr/2008/en/(30 Mar 2016).,OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
2011. http://www.nhshealthquality.org/nhsqis/8837.html (7 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
2013. http://media.wix.,Non-OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
"2011.http://cqrmg.cochrane.org/supplemental-handbook-guidance,Cochrane Collaboration Qualitative Methods Group.",OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
2011.http://cqrmg.cochrane.org/supplemental-handbook-guidance.,OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
2015. http://qim.cochrane.org/supplemental-handbook-guidance (7 Jan 2016).,OADS,/arxiv_data1/oa_pdf/42/1c/bmjopen-2016-013459.PMC5168518.pdf
"Reykjavík: 2015. http://www.statice.is/ 10 Sturlaugsdottir R, et al.BMJ Open 2016; 6:e012457.",Non-OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-012457.PMC5168519.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013386).,Non-OADS,/arxiv_data1/oa_pdf/b9/ce/bmjopen-2016-013386.PMC5168521.pdf
doi:10.1136/bmjopen-2016- 014082 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014082).,Non-OADS,/arxiv_data1/oa_pdf/4a/ac/bmjopen-2016-014082.PMC5168522.pdf
Alzforum 2012. http://www.alzforum.org/news/research-news/clinical- trials-intravenous-bapineuzumab-halted 10.,Non-OADS,/arxiv_data1/oa_pdf/4a/ac/bmjopen-2016-014082.PMC5168522.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012983).,Non-OADS,/arxiv_data1/oa_pdf/a8/0f/bmjopen-2016-012983.PMC5168524.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011957).,Non-OADS,/arxiv_data1/oa_pdf/fa/e2/bmjopen-2016-011957.PMC5168525.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012464).,Non-OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012464.PMC5168527.pdf
J Sleep Disord Ther 2013;2:141. http://omicsgroup.org/journals/tai-chi-improves-sleep-quality-in-healthy-adults-and-patients-with-chronic-conditions-a-systematic-review-and-metaanalysis-2167-0277-2-141.pdf (accessed21 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012464.PMC5168527.pdf
2014. http://www.ptsd.va.gov/professional/assessment/ adult-sr/ptsd-checklist.asp (accessed 21 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012464.PMC5168527.pdf
http://www.research.va.gov/currents/0416-5.cfm (accessed 3Aug 2016).,OADS,/arxiv_data1/oa_pdf/21/c8/bmjopen-2016-012464.PMC5168527.pdf
(4) The ICBT-i trial by Espie et al : This study used an internet application (http://www.sleepio.com) thatinvolved a 6-week intervention.,Non-OADS,/arxiv_data1/oa_pdf/06/70/bmjopen-2015-010707.PMC5168528.pdf
"In the 2013 study, an additional internet application (http://www.slaapgezonder.nl) was added.",Non-OADS,/arxiv_data1/oa_pdf/06/70/bmjopen-2015-010707.PMC5168528.pdf
"(7)The ICBT-i trial by Ho et al : This study used an inter- net application (http://www.sleephk.com) that lasted for6 weeks, with treatment materials delivered once per week.",Non-OADS,/arxiv_data1/oa_pdf/06/70/bmjopen-2015-010707.PMC5168528.pdf
https://www.ncbi.nlm.nih.gov/books/NBK225187/ (accessed 10 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
http://www.ihi.org/resources/Pages/Tools/MedicationReconciliationReview.aspx (accessed 16 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
https://www.jointcommission.org/ improving_americas_hospitals_the_joint_commissions_annual_ report_on_quality_and_safety_-_2006/ (accessed 16 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
"London, 2007. http://www.nice.org.uk/PSG001 (accessed 16 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
"Ottawa, 2004. http://www.accreditation.ca (accessed 16 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
http://www.safetyandquality.gov.au/our-work/medication-safety/medication-reconciliation/ (accessed16 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
http://www.moh.gov.et/amharahb (accessed16 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
http://www.ahrq.gov/professionals/quality-patientsafety/patientsafetyculture/hospital/index.html (accessed 16 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
https://www.safetyandquality.,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/bmjopen-2016-012322.PMC5168529.pdf
http://idsp.nic.in/WriteReadData/OldSite/usermanaul/manual_for_MO.pdf (accessed 24 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/3d/b6/bmjopen-2016-012638.PMC5168530.pdf
http://www.census2011.co.in/census/city/ 365-mumbai.html (accessed Apr ’16).,Non-OADS,/arxiv_data1/oa_pdf/3d/b6/bmjopen-2016-012638.PMC5168530.pdf
1999. http://www.cdc.gov/cholera/pdf/Laboratory-Methods-for-the-Diagnosis-of-Epidemic-Dysentery-and-Cholera.pdf (accessed Apr ’16).,Non-OADS,/arxiv_data1/oa_pdf/3d/b6/bmjopen-2016-012638.PMC5168530.pdf
http://www.indiawaterportal.org/sites/ indiawaterportal.org/files/imd_district-wise_rainfalldata_2004 –2010.,Non-OADS,/arxiv_data1/oa_pdf/3d/b6/bmjopen-2016-012638.PMC5168530.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011987).,Non-OADS,/arxiv_data1/oa_pdf/fd/b8/bmjopen-2016-011987.PMC5168532.pdf
"Ministry of Health, Labour and Welfare, National health and nutrition examination survey in 2013. http://www.mhlw.go.jp/bunya/kenkou/eiyou/h25-houkoku.html 39.",Non-OADS,/arxiv_data1/oa_pdf/fd/b8/bmjopen-2016-011987.PMC5168532.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013280).,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.bfs.admin.ch/bfs/portal/ en/index/themen/01/06/blank/key/04/04.html 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.html?publicationID=5818 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.agla.ch 14.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
https://www.blsa.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.bag.admin.ch/gesundheit2020/index.html?lang=en17.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.sapaldia.ch/en/19.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.colaus.ch/en/ cls_home/cls_pro_home.htm 21.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.skipogh.ch/index.php/News 22.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://p3.snf.ch/project-14847025.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.bag.admin.ch/gesundheit2020/index.html?lang=de 28.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
http://www.cdc.gov/ steadi/materials.html48.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/bmjopen-2016-013280.PMC5168533.pdf
"http://www.ClinicalTrials.gov, as required by U.S. Law.",Non-OADS,/arxiv_data1/oa_pdf/5b/3f/bmjopen-2016-013649.PMC5168534.pdf
http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/UCM291085.pdf (accessed 28 Dec 2015).,OADS,/arxiv_data1/oa_pdf/5b/3f/bmjopen-2016-013649.PMC5168534.pdf
http://www.wma.net/en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/5b/3f/bmjopen-2016-013649.PMC5168534.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012047).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
2009. http://publicationethics.org/files/retraction%20guidelines.pdf (accessed Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
"Eden L. The Ethicist Blog Retraction: mistake or misconduct?, 2013. http://ethicist.aom.org/2013/10/retraction-mistake-or-misconduct/(accessed Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://retractionwatch.com/2014/07/ 08/sage-publications-busts-peer-review-and-citation-ring-60-papers- retracted/ (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
"2012. http://blogs.plos.org/speakingofmedicine/ 6 Moylan EC, Kowalczuk MK.",Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://retractionwatch.com/2014/09/16/what-should-an-ideal-retraction-notice-look- like-we-want-your-input/ (accessed Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
"COPE Forum Discussion Topic: Standard retraction form, 2014. http://publicationethics.org/forum-discussion-topic-comments-please-0 12.",Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://www.biomedcentral.com/ search (accessed Jan 2015).,OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://grants.nih.gov/grants/research_integrity/research_misconduct.htm (accessed Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
"http://www.scopus.com/ (accessed Feb 2016).19. von Elm E, Altman DG, Egger M, et al.",OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://blogs.biomedcentral.com/bmcblog/2014/05/13/implementing-reproducible-research-the-role-of-publishers-an-interview-with-iain-hrynaszkiewicz-peter-li-and-scott-edmunds/(accessed May 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
http://nuffieldbioethics.org/project/research-culture/ (accessed May 2015).,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
Bibliometrics: The Leiden Manifesto for research metrics 22 April 2015. http://www.nature.com/news/bibliometrics-the-leiden-manifesto-for-research-metrics-1.,Non-OADS,/arxiv_data1/oa_pdf/bd/f7/bmjopen-2016-012047.PMC5168538.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011898).,Non-OADS,/arxiv_data1/oa_pdf/51/44/bmjopen-2016-011898.PMC5168539.pdf
(http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp(accessed 4 Mar 2016)).,Non-OADS,/arxiv_data1/oa_pdf/51/44/bmjopen-2016-011898.PMC5168539.pdf
"Grading of Recommendations Assessment, Development and Evaluation(GRADE) Working Group (http://www.gradeworkinggroup.org/publications/JCE_series.htm (accessed 4 Mar 2016)).",Non-OADS,/arxiv_data1/oa_pdf/51/44/bmjopen-2016-011898.PMC5168539.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013314).,Non-OADS,/arxiv_data1/oa_pdf/57/96/bmjopen-2016-013314.PMC5168541.pdf
2014. http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tb-canada-7/index-eng.php (accessed 21 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
2016. http://www.healthycanadians.gc.ca/publications/diseases-conditions-maladies-affections/tuberculosis-2014-tuberculose/index-eng.php (accessed 19 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
2016. https://data.oecd.org/migration/ foreign-born-population.htm (accessed 17 May 2016).,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
2015. https://www12.statcan.gc.ca/nhs-enm/2011/as-sa/fogs-spg/Pages/FOG.cfm?lang=E&level=2&GeoCode=59 (accessed6 Jun 2016).,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://epe.lac-bac.gc.ca/100/202/301/ immigration_statistics-ef/index.html (accessed 26 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://open.canada.ca/data/en/ dataset/ad975a26-df23-456a-8ada-756191a23695 (accessed 26Sep 2016).,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.cic.gc.ca/english/ (accessed 20 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
https://www.popdata.bc.ca/data/internal/demographic/CICpermres (accessed 20 Apr 2016).,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
Population Data BC https://www.popdata.bc.ca/ (accessed 20 Apr 2016).,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 22.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 23.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 24.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 25.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 26.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
StatsCanada (2014).http://www.popdata.bc.ca/data 27.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
StatsCanada (2014).http://www.popdata.bc.ca/data 28.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 29.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 30.,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.bccdc.ca/ resource-gallery/Documents/Statistics%20and%20Research/Statistics%20and%20Reports/TB/TB_Annual_Report_2012-2013.pdf (accessed 30-May-2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 35.,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
2015. http://www.bccdc.ca/resource-gallery/ Documents/Statistics%20and%20Research/Statistics%20and%20Reports/STI/HIV_Annual_Report_2014-FINAL.pdf (accessed 30May 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.popdata.bc.ca/data 37.,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.bccancer.bc.ca/ health-professionals/professional-resources/bc-cancer-registry (accessed 30 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www2.gov.,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
2011.http://www.phac-aspc.gc.ca/tbpc-latb/pdf/guidelinesform-eng.pdf(accessed 20 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.who.int/tb/country/data/ download/en/ (accessed 22 Apr 2016).41.,OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
http://www.bcgatlas.org/ (accessed 22 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
Medical Surveillance Handout: Inactive Tuberculosis or other Complex Non-Infectious Tuberculosis.http://www.cic.gc.ca/english/resources/tools/medic/physicians/ documents/PDF/english.pdf (accessed 22 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/05/82/bmjopen-2016-013488.PMC5168543.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011768).,Non-OADS,/arxiv_data1/oa_pdf/ab/20/bmjopen-2016-011768.PMC5168545.pdf
"βvalues from both targeted bisul- ﬁte pyrosequencing and array probe interrogation were compared using three-way ANOV As and across relevant genomic features (eg, a gene ’s promoter) annotated by a gene browser (http://www.ensembl.org).",OADS,/arxiv_data1/oa_pdf/ab/20/bmjopen-2016-011768.PMC5168545.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.k67kf.,OADS,/arxiv_data1/oa_pdf/ab/20/bmjopen-2016-011768.PMC5168545.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012486).,Non-OADS,/arxiv_data1/oa_pdf/dc/65/bmjopen-2016-012486.PMC5168547.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/65/bmjopen-2016-012486.PMC5168547.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013270).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
"80 81Additionally, the work of the Equator (Enhancing the Quality and Transparency Ofhealth Research) Network (http://www.equator-network.",Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2015. http://www.un.org/sustainabledevelopment/(accessed 6 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2015. http://www.who.int/classifications/icd/factsheet/en/(accessed 15 Feb 2016).,OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2002. http://www.prb.org/pdf/hiddensufferingeng.pdf(accessed 23 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2010. http://www.who.int/ sdhconference/resources/ConceptualframeworkforactiononSDH_ eng.pdf (accessed 18 Sep 2014).,OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2014.http://www.everynewborn.org/every-newborn-action-plan/ (accessed14 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2015. http://who.int/reproductivehealth/topics/maternal_perinatal/epmm/en/ (accessed 28 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
1993. http://www.ohchr.org/Documents/ProfessionalInterest/vienna.pdf (accessed 22 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2014. http://www.who.int/violence_injury_prevention/violence/status_report/2014/en/ (accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2005. http://www.who.int/reproductivehealth/publications/violence/24159358X/en/ (accessed 2 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2015. http://www.everywomaneverychild.org/global-strategy-2 (accessed3 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
"Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2015. https:// http://www.npeu.ox.ac.uk/ (accessed 15 Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
"Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2014. https://www.npeu.ox.ac.uk/downloads/files/mbrrace-uk/reports/Saving%20Lives%20Improving%20Mothers%20Care%20report%202014%20Full.pdf (accessed 27 Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2001. http://www.hqip.org.uk/national-programmes/a-z-of-clinical-outcome-review-programmes/ cmace-reports/ (accessed 2 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2004. http://www.hqip.,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2016. http://data.worldbank.org/about/country-and-lending-groups (accessed 4 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
2014. http://cccrg.cochrane.,Non-OADS,/arxiv_data1/oa_pdf/e0/dd/bmjopen-2016-013270.PMC5168548.pdf
"2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267100/Applying_Behavioural_Insights_to_Organ_Donation.pdf (access date: November 24, 2016) 14.",Non-OADS,/arxiv_data1/oa_pdf/96/0b/bmjopen-2016-012009.PMC5168560.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010776).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
2008. http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/ (accessed 27 Aug2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1203008864027 (accessed 23 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
https://www.gov.uk/government/ organisations/health-protection-agency (accessed 17 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/227651/8515_DoH_Complete_Imm_schedule_A4_2013_09.pdf; (accessed 29 Aug 2014).,OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
JCVI minutes Pneumococcal sub-committee meeting held on 30 May 2012. http://webarchive.nationalarchives.gov.uk/20120907090205/https://www.wp.dh.gov.uk/transparency/files/2012/ 07/JCVI-minutes-Pneumococcal-sub-committee-meeting-held-on-30- May-2012.pdf (accessed 28 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.pfizer.co.jp/pfizer/company/press/2013/ documents/20131028_01.pdf (accessed 15 Aug 2014).20.,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.ons.gov.uk/ons/datasets-and-tables/index.html (accessed 11 Jun 2015).,OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk –england-and- wales –scotland-and-northern-ireland/population-estimates- timeseries-1971-to-current-year/index.html (accessed 1 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.hscic.gov.uk/catalogue/PUB16722/hosp-outp-acti-2013-14-prim-diag-tab.xlsx (accessed 25 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.hscic.gov.uk/catalogue/PUB16722/hosp-outp-acti-2013-14- main-proc-inte-tab.xlsx (accessed 25 Sep 2015).,OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
"Curtis L. Unit costs of health and social care 2007, Personal Social Services Research Unit, University of Kent , Canterbury, 2007. http:// http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007.pdf (accessed 28 Aug2014).",Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
https://www.gov.uk/government/statistics/cover-of- vaccination-evaluated-rapidly-cover-programme-2014-to-2015- quarterly-data (accessed 11 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
1996. http://www.archive.official-documents.,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/000973/WC500054350.pdf (accessed 2Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
Pneumococcal disease infections caused by serotypes in Prevenar 13 and not in Prevenar 7. https://www.gov.uk/government/publications/pneumococcal-disease-caused-by-strains-in-prevenar-13-and-not-in-prevenar-7-vaccine/pneumococcal-disease-infections-caused-by-serotypes-in-prevenar-13-and-not-in-prevenar-7 (accessed 23 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.nice.org.uk/media/955/4F/Clarification_to_section_5.6_of_the_Guide_to_Methods_of_Technology_Appraisals.pdf (accessed 8 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
http://www.ons.gov.uk/ons/dcp171778_256900.pdf (link to Excel file contained therein)(accessed 28 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
2007. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4127649 (accessed 1 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/b8/54/bmjopen-2015-010776.PMC5168567.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/f0/bmjopen-2016-013749.PMC5168595.pdf
doi:10.1136/bmjopen-2016- 012951 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012951).,Non-OADS,/arxiv_data1/oa_pdf/b4/e6/bmjopen-2016-012951.PMC5168596.pdf
Data will be published on http://www.clinicalstudyresult.org in case the resultsare not accepted by a scienti ﬁc peer-reviewed journal.,Non-OADS,/arxiv_data1/oa_pdf/b4/e6/bmjopen-2016-012951.PMC5168596.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012970).,Non-OADS,/arxiv_data1/oa_pdf/e3/80/bmjopen-2016-012970.PMC5168597.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/80/bmjopen-2016-012970.PMC5168597.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014102).,Non-OADS,/arxiv_data1/oa_pdf/a7/cd/bmjopen-2016-014102.PMC5168599.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013241).,Non-OADS,/arxiv_data1/oa_pdf/f0/95/bmjopen-2016-013241.PMC5168600.pdf
http://www.ageuk.org.uk/professional-resources-home/www.ageuk.org.uk/ (accessed June 2015).,Non-OADS,/arxiv_data1/oa_pdf/af/23/bmjopen-2016-013179.PMC5168602.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012210).,Non-OADS,/arxiv_data1/oa_pdf/27/2f/bmjopen-2016-012210.PMC5168603.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012537).,Non-OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
2014. http://apps.who.int/iris/bitstream/10665/128494/1/9789241507585_eng.pdf?ua=1 2.,Non-OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
2014. http://www.aidsdatahub.org/sites/ default/files/publication/UNAIDS_Gap_report_en.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
http://www.moh.gov.et/documents/26765/0/Annual+Perfomance+Report+2006+EFY/4f5a6b33-3ef1-4430-a0a0-21fa13221343?version=1.0 6.,OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.,OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
